id	sid	tid	token	lemma	pos
iajs-108	1	1	microsoft	microsoft	PROPN
iajs-108	1	2	word	word	NOUN
iajs-108	1	3	171	171	NUM
iajs-108	1	4	-	-	SYM
iajs-108	1	5	184	184	NUM
iajs-108	1	6	chemistry	chemistry	NOUN
iajs-108	1	7	|	|	ADV
iajs-108	1	8	171	171	NUM
iajs-108	1	9	2016	2016	NUM
iajs-108	1	10	)	)	PUNCT
iajs-108	1	11	عام	عام	ADP
iajs-108	1	12	2العدد	2العدد	NUM
iajs-108	1	13	(	(	PUNCT
iajs-108	1	14	29مجلة	29مجلة	NUM
iajs-108	1	15	إبن	إبن	VERB
iajs-108	1	16	الهيثم	الهيثم	ADJ
iajs-108	1	17	للعلوم	للعلوم	NOUN
iajs-108	1	18	الصرفة	الصرفة	NOUN
iajs-108	2	1	و	و	PRON
iajs-108	2	2	التطبيقية	التطبيقية	ADV
iajs-108	2	3	المجلد	المجلد	VERB
iajs-108	2	4	ibn	ibn	PROPN
iajs-108	2	5	al	al	PROPN
iajs-108	2	6	-	-	PUNCT
iajs-108	2	7	haitham	haitham	PROPN
iajs-108	2	8	jour	jour	X
iajs-108	2	9	.	.	PROPN
iajs-108	3	1	for	for	ADP
iajs-108	3	2	pure	pure	ADJ
iajs-108	3	3	&	&	CCONJ
iajs-108	3	4	appl	appl	PROPN
iajs-108	3	5	.	.	PUNCT
iajs-108	4	1	sci	sci	PROPN
iajs-108	4	2	.	.	PUNCT
iajs-108	4	3	vol	vol	NOUN
iajs-108	4	4	.	.	PROPN
iajs-108	4	5	29	29	NUM
iajs-108	4	6	(	(	PUNCT
iajs-108	4	7	2	2	NUM
iajs-108	4	8	)	)	SYM
iajs-108	4	9	2016	2016	NUM
iajs-108	4	10	measurement	measurement	NOUN
iajs-108	4	11	of	of	ADP
iajs-108	4	12	ferritin	ferritin	ADJ
iajs-108	4	13	and	and	CCONJ
iajs-108	4	14	transforming	transform	VERB
iajs-108	4	15	growth	growth	NOUN
iajs-108	4	16	factor	factor	NOUN
iajs-108	4	17	-	-	PUNCT
iajs-108	4	18	β1	β1	NOUN
iajs-108	4	19	levels	level	NOUN
iajs-108	4	20	in	in	ADP
iajs-108	4	21	iraqi	iraqi	ADJ
iajs-108	4	22	women	woman	NOUN
iajs-108	4	23	with	with	ADP
iajs-108	4	24	polycystic	polycystic	ADJ
iajs-108	4	25	ovary	ovary	ADJ
iajs-108	4	26	syndrome	syndrome	NOUN
iajs-108	4	27	.	.	PUNCT
iajs-108	5	1	qays	qays	PROPN
iajs-108	5	2	a.	a.	PROPN
iajs-108	5	3	mahdi	mahdi	PROPN
iajs-108	5	4	immunologist/	immunologist/	PROPN
iajs-108	5	5	kamal	kamal	PROPN
iajs-108	5	6	al	al	PROPN
iajs-108	5	7	-	-	PUNCT
iajs-108	5	8	samaree	samaree	PROPN
iajs-108	5	9	hospital	hospital	NOUN
iajs-108	5	10	for	for	ADP
iajs-108	5	11	infertility	infertility	NOUN
iajs-108	5	12	and	and	CCONJ
iajs-108	5	13	in	in	ADP
iajs-108	5	14	vitro	vitro	X
iajs-108	5	15	fertilization	fertilization	NOUN
iajs-108	5	16	,	,	PUNCT
iajs-108	5	17	ministry	ministry	NOUN
iajs-108	5	18	of	of	ADP
iajs-108	5	19	health/	health/	NUM
iajs-108	5	20	baghdad	baghdad	PROPN
iajs-108	5	21	shatha	shatha	PROPN
iajs-108	5	22	a.	a.	NOUN
iajs-108	5	23	adbul	adbul	PROPN
iajs-108	5	24	rahman	rahman	PROPN
iajs-108	5	25	fatima	fatima	PROPN
iajs-108	5	26	m.	m.	PROPN
iajs-108	5	27	mohammed	mohammed	PROPN
iajs-108	5	28	dept	dept	PROPN
iajs-108	5	29	.	.	PUNCT
iajs-108	6	1	of	of	ADP
iajs-108	6	2	chemistry/	chemistry/	NUM
iajs-108	6	3	collage	collage	NOUN
iajs-108	6	4	of	of	ADP
iajs-108	6	5	science/	science/	NUM
iajs-108	6	6	university	university	NOUN
iajs-108	6	7	of	of	ADP
iajs-108	6	8	baghdad	baghdad	PROPN
iajs-108	6	9	received	receive	VERB
iajs-108	6	10	in:22	in:22	PROPN
iajs-108	6	11	/	/	SYM
iajs-108	6	12	november/2015,accepted	november/2015,accepted	PROPN
iajs-108	6	13	in:7	in:7	PROPN
iajs-108	6	14	/	/	SYM
iajs-108	6	15	january/2016	january/2016	PROPN
iajs-108	6	16	abstract	abstract	ADJ
iajs-108	6	17	background	background	NOUN
iajs-108	6	18	:	:	PUNCT
iajs-108	6	19	polycystic	polycystic	ADJ
iajs-108	6	20	ovary	ovary	ADJ
iajs-108	6	21	syndrome	syndrome	NOUN
iajs-108	6	22	(	(	PUNCT
iajs-108	6	23	pcos	pcos	PROPN
iajs-108	6	24	)	)	PUNCT
iajs-108	6	25	is	be	AUX
iajs-108	6	26	common	common	ADJ
iajs-108	6	27	heterogeneous	heterogeneous	ADJ
iajs-108	6	28	disorder	disorder	NOUN
iajs-108	6	29	syndrome	syndrome	NOUN
iajs-108	6	30	in	in	ADP
iajs-108	6	31	females	female	NOUN
iajs-108	6	32	,	,	PUNCT
iajs-108	6	33	characterized	characterize	VERB
iajs-108	6	34	by	by	ADP
iajs-108	6	35	chronic	chronic	ADJ
iajs-108	6	36	oligoovulation	oligoovulation	NOUN
iajs-108	6	37	,	,	PUNCT
iajs-108	6	38	polycystic	polycystic	ADJ
iajs-108	6	39	ovary	ovary	NOUN
iajs-108	6	40	,	,	PUNCT
iajs-108	6	41	and	and	CCONJ
iajs-108	6	42	hyperandrogenism	hyperandrogenism	NOUN
iajs-108	6	43	.	.	PUNCT
iajs-108	7	1	this	this	DET
iajs-108	7	2	study	study	NOUN
iajs-108	7	3	aimed	aim	VERB
iajs-108	7	4	to	to	ADP
iajs-108	7	5	the	the	DET
iajs-108	7	6	association	association	NOUN
iajs-108	7	7	of	of	ADP
iajs-108	7	8	ferritin	ferritin	ADJ
iajs-108	7	9	and	and	CCONJ
iajs-108	7	10	transforming	transform	VERB
iajs-108	7	11	growth	growth	NOUN
iajs-108	7	12	factorβ1	factorβ1	NOUN
iajs-108	7	13	(	(	PUNCT
iajs-108	7	14	tgf	tgf	PROPN
iajs-108	7	15	-	-	PUNCT
iajs-108	7	16	β1	β1	PROPN
iajs-108	7	17	)	)	PUNCT
iajs-108	7	18	levels	level	NOUN
iajs-108	7	19	with	with	ADP
iajs-108	7	20	insulin	insulin	NOUN
iajs-108	7	21	resistance	resistance	NOUN
iajs-108	7	22	,	,	PUNCT
iajs-108	7	23	cardiovascular	cardiovascular	ADJ
iajs-108	7	24	and	and	CCONJ
iajs-108	7	25	type	type	NOUN
iajs-108	7	26	2	2	NUM
iajs-108	7	27	diabetes	diabetes	NOUN
iajs-108	7	28	risks	risk	NOUN
iajs-108	7	29	.	.	PUNCT
iajs-108	8	1	patients	patient	NOUN
iajs-108	8	2	and	and	CCONJ
iajs-108	8	3	methods	method	NOUN
iajs-108	8	4	:	:	PUNCT
iajs-108	8	5	(	(	PUNCT
iajs-108	8	6	61	61	NUM
iajs-108	8	7	)	)	PUNCT
iajs-108	8	8	iraqi	iraqi	ADJ
iajs-108	8	9	women	woman	NOUN
iajs-108	8	10	with	with	ADP
iajs-108	8	11	pcos	pcos	PROPN
iajs-108	8	12	patients	patient	NOUN
iajs-108	8	13	diagnosed	diagnose	VERB
iajs-108	8	14	according	accord	VERB
iajs-108	8	15	to	to	ADP
iajs-108	8	16	the	the	DET
iajs-108	8	17	rotterdam	rotterdam	PROPN
iajs-108	8	18	criteria	criterion	NOUN
iajs-108	8	19	,	,	PUNCT
iajs-108	8	20	were	be	AUX
iajs-108	8	21	subdivided	subdivide	VERB
iajs-108	8	22	according	accord	VERB
iajs-108	8	23	to	to	ADP
iajs-108	8	24	their	their	PRON
iajs-108	8	25	body	body	NOUN
iajs-108	8	26	mass	mass	NOUN
iajs-108	8	27	index	index	NOUN
iajs-108	8	28	(	(	PUNCT
iajs-108	8	29	bmi	bmi	PROPN
iajs-108	8	30	)	)	PUNCT
iajs-108	8	31	to	to	PART
iajs-108	8	32	:	:	PUNCT
iajs-108	8	33	(	(	PUNCT
iajs-108	8	34	20	20	X
iajs-108	8	35	)	)	PUNCT
iajs-108	8	36	lean	lean	ADJ
iajs-108	8	37	women	woman	NOUN
iajs-108	8	38	with	with	ADP
iajs-108	8	39	normal	normal	ADJ
iajs-108	8	40	bmi	bmi	NOUN
iajs-108	8	41	:	:	PUNCT
iajs-108	8	42	(	(	PUNCT
iajs-108	8	43	18	18	NUM
iajs-108	8	44	-	-	SYM
iajs-108	8	45	24	24	NUM
iajs-108	8	46	)	)	PUNCT
iajs-108	8	47	,	,	PUNCT
iajs-108	8	48	(	(	PUNCT
iajs-108	8	49	17	17	X
iajs-108	8	50	)	)	PUNCT
iajs-108	8	51	overweight	overweight	ADJ
iajs-108	8	52	women	woman	NOUN
iajs-108	8	53	with	with	ADP
iajs-108	8	54	bmi	bmi	PROPN
iajs-108	8	55	:	:	PUNCT
iajs-108	8	56	(	(	PUNCT
iajs-108	8	57	25	25	NUM
iajs-108	8	58	-	-	SYM
iajs-108	8	59	29	29	NUM
iajs-108	8	60	)	)	PUNCT
iajs-108	8	61	and	and	CCONJ
iajs-108	8	62	(	(	PUNCT
iajs-108	8	63	25	25	NUM
iajs-108	8	64	)	)	PUNCT
iajs-108	8	65	obese	obese	ADJ
iajs-108	8	66	women	woman	NOUN
iajs-108	8	67	with	with	ADP
iajs-108	8	68	bmi	bmi	PROPN
iajs-108	8	69	>	>	X
iajs-108	8	70	30	30	NUM
iajs-108	8	71	.	.	PUNCT
iajs-108	9	1	for	for	ADP
iajs-108	9	2	the	the	DET
iajs-108	9	3	the	the	DET
iajs-108	9	4	purpose	purpose	NOUN
iajs-108	9	5	of	of	ADP
iajs-108	9	6	comparison	comparison	NOUN
iajs-108	9	7	,	,	PUNCT
iajs-108	9	8	(	(	PUNCT
iajs-108	9	9	20	20	X
iajs-108	9	10	)	)	PUNCT
iajs-108	9	11	healthy	healthy	ADJ
iajs-108	9	12	iraqi	iraqi	ADJ
iajs-108	9	13	women	woman	NOUN
iajs-108	9	14	were	be	AUX
iajs-108	9	15	enrolled	enrol	VERB
iajs-108	9	16	as	as	ADP
iajs-108	9	17	controls	control	NOUN
iajs-108	9	18	matched	match	VERB
iajs-108	9	19	for	for	ADP
iajs-108	9	20	age	age	NOUN
iajs-108	9	21	.	.	PUNCT
iajs-108	10	1	fasting	fast	VERB
iajs-108	10	2	serum	serum	NOUN
iajs-108	10	3	glucose	glucose	NOUN
iajs-108	10	4	(	(	PUNCT
iajs-108	10	5	fsg	fsg	PROPN
iajs-108	10	6	)	)	PUNCT
iajs-108	10	7	,	,	PUNCT
iajs-108	10	8	serum	serum	NOUN
iajs-108	10	9	insulin	insulin	NOUN
iajs-108	10	10	,	,	PUNCT
iajs-108	10	11	ferritin	ferritin	ADJ
iajs-108	10	12	and	and	CCONJ
iajs-108	10	13	tgf	tgf	PROPN
iajs-108	10	14	-	-	PUNCT
iajs-108	10	15	β1	β1	PROPN
iajs-108	10	16	was	be	AUX
iajs-108	10	17	quantitatively	quantitatively	ADV
iajs-108	10	18	determine	determine	VERB
iajs-108	10	19	,	,	PUNCT
iajs-108	10	20	homeostatic	homeostatic	ADJ
iajs-108	10	21	model	model	NOUN
iajs-108	10	22	assessment	assessment	NOUN
iajs-108	10	23	(	(	PUNCT
iajs-108	10	24	homa2	homa2	NOUN
iajs-108	10	25	)	)	PUNCT
iajs-108	11	1	parameters	parameter	NOUN
iajs-108	11	2	were	be	AUX
iajs-108	11	3	calculated	calculate	VERB
iajs-108	11	4	.	.	PUNCT
iajs-108	12	1	results	result	NOUN
iajs-108	12	2	:	:	PUNCT
iajs-108	12	3	ferritin	ferritin	ADJ
iajs-108	12	4	levels	level	NOUN
iajs-108	12	5	showed	show	VERB
iajs-108	12	6	a	a	DET
iajs-108	12	7	high	high	ADJ
iajs-108	12	8	significant	significant	ADJ
iajs-108	12	9	increase	increase	NOUN
iajs-108	12	10	in	in	ADP
iajs-108	12	11	the	the	DET
iajs-108	12	12	the	the	DET
iajs-108	12	13	obese	obese	ADJ
iajs-108	12	14	and	and	CCONJ
iajs-108	12	15	overweight	overweight	ADJ
iajs-108	12	16	group	group	NOUN
iajs-108	12	17	when	when	SCONJ
iajs-108	12	18	compared	compare	VERB
iajs-108	12	19	with	with	ADP
iajs-108	12	20	the	the	DET
iajs-108	12	21	lean	lean	ADJ
iajs-108	12	22	group	group	NOUN
iajs-108	12	23	.	.	PUNCT
iajs-108	13	1	tgf	tgf	PROPN
iajs-108	13	2	-	-	PUNCT
iajs-108	13	3	β1	β1	PROPN
iajs-108	13	4	showed	show	VERB
iajs-108	13	5	a	a	DET
iajs-108	13	6	significant	significant	ADJ
iajs-108	13	7	increase	increase	NOUN
iajs-108	13	8	in	in	ADP
iajs-108	13	9	obese	obese	ADJ
iajs-108	13	10	and	and	CCONJ
iajs-108	13	11	overweight	overweight	ADJ
iajs-108	13	12	groups	group	NOUN
iajs-108	13	13	but	but	CCONJ
iajs-108	13	14	not	not	PART
iajs-108	13	15	in	in	ADP
iajs-108	13	16	the	the	DET
iajs-108	13	17	lean	lean	ADJ
iajs-108	13	18	group	group	NOUN
iajs-108	13	19	.	.	PUNCT
iajs-108	14	1	pearson	pearson	PROPN
iajs-108	14	2	correlation	correlation	NOUN
iajs-108	14	3	analysis	analysis	NOUN
iajs-108	14	4	of	of	ADP
iajs-108	14	5	patients	patient	NOUN
iajs-108	14	6	groups	group	NOUN
iajs-108	14	7	revealed	reveal	VERB
iajs-108	14	8	an	an	DET
iajs-108	14	9	a	a	DET
iajs-108	14	10	significant	significant	ADJ
iajs-108	14	11	positive	positive	ADJ
iajs-108	14	12	correlation	correlation	NOUN
iajs-108	14	13	between	between	ADP
iajs-108	14	14	ferritin	ferritin	ADJ
iajs-108	14	15	and	and	CCONJ
iajs-108	14	16	(	(	PUNCT
iajs-108	14	17	insulin	insulin	NOUN
iajs-108	14	18	,	,	PUNCT
iajs-108	14	19	homa	homa	PROPN
iajs-108	14	20	ir	ir	PROPN
iajs-108	14	21	,	,	PUNCT
iajs-108	14	22	and	and	CCONJ
iajs-108	14	23	tgfβ1	tgfβ1	NOUN
iajs-108	14	24	)	)	PUNCT
iajs-108	14	25	and	and	CCONJ
iajs-108	14	26	tgfβ1	tgfβ1	NOUN
iajs-108	14	27	with	with	ADP
iajs-108	14	28	(	(	PUNCT
iajs-108	14	29	fsg	fsg	NOUN
iajs-108	14	30	,	,	PUNCT
iajs-108	14	31	insulin	insulin	NOUN
iajs-108	14	32	,	,	PUNCT
iajs-108	14	33	and	and	CCONJ
iajs-108	14	34	homa	homa	PROPN
iajs-108	14	35	ir	ir	PROPN
iajs-108	14	36	)	)	PUNCT
iajs-108	14	37	while	while	SCONJ
iajs-108	14	38	homa	homa	PROPN
iajs-108	14	39	s	s	X
iajs-108	14	40	(	(	PUNCT
iajs-108	14	41	%	%	INTJ
iajs-108	14	42	)	)	PUNCT
iajs-108	14	43	showed	show	VERB
iajs-108	14	44	significant	significant	ADJ
iajs-108	14	45	negative	negative	ADJ
iajs-108	14	46	correlation	correlation	NOUN
iajs-108	14	47	with	with	ADP
iajs-108	14	48	both	both	CCONJ
iajs-108	14	49	ferritin	ferritin	ADJ
iajs-108	14	50	and	and	CCONJ
iajs-108	14	51	tgfβ1	tgfβ1	PROPN
iajs-108	14	52	.	.	PUNCT
iajs-108	15	1	conclusion	conclusion	NOUN
iajs-108	15	2	:	:	PUNCT
iajs-108	15	3	increase	increase	VERB
iajs-108	15	4	body	body	NOUN
iajs-108	15	5	iron	iron	NOUN
iajs-108	15	6	stores	store	NOUN
iajs-108	15	7	,	,	PUNCT
iajs-108	15	8	as	as	SCONJ
iajs-108	15	9	reflected	reflect	VERB
iajs-108	15	10	by	by	ADP
iajs-108	15	11	serum	serum	NOUN
iajs-108	15	12	ferritin	ferritin	ADJ
iajs-108	15	13	concentrations	concentration	NOUN
iajs-108	15	14	,	,	PUNCT
iajs-108	15	15	and	and	CCONJ
iajs-108	15	16	tgf	tgf	PROPN
iajs-108	15	17	-	-	PUNCT
iajs-108	15	18	β1	β1	PROPN
iajs-108	15	19	in	in	ADP
iajs-108	15	20	pcos	pcos	NOUN
iajs-108	15	21	patients	patient	NOUN
iajs-108	15	22	and	and	CCONJ
iajs-108	15	23	their	their	PRON
iajs-108	15	24	correlation	correlation	NOUN
iajs-108	15	25	with	with	ADP
iajs-108	15	26	insulin	insulin	NOUN
iajs-108	15	27	and	and	CCONJ
iajs-108	15	28	insulin	insulin	NOUN
iajs-108	15	29	resistance	resistance	NOUN
iajs-108	15	30	could	could	AUX
iajs-108	15	31	be	be	AUX
iajs-108	15	32	association	association	NOUN
iajs-108	15	33	with	with	ADP
iajs-108	15	34	the	the	DET
iajs-108	15	35	risk	risk	NOUN
iajs-108	15	36	increased	increase	VERB
iajs-108	15	37	risk	risk	NOUN
iajs-108	15	38	for	for	ADP
iajs-108	15	39	cardiovascular	cardiovascular	ADJ
iajs-108	15	40	and	and	CCONJ
iajs-108	15	41	t2	t2	NOUN
iajs-108	15	42	dm	dm	NUM
iajs-108	15	43	diseases	disease	NOUN
iajs-108	15	44	.	.	PUNCT
iajs-108	16	1	key	key	ADJ
iajs-108	16	2	words	word	NOUN
iajs-108	16	3	:	:	PUNCT
iajs-108	16	4	ferritin	ferritin	ADJ
iajs-108	16	5	,	,	PUNCT
iajs-108	16	6	transforming	transform	VERB
iajs-108	16	7	growth	growth	NOUN
iajs-108	16	8	factor	factor	NOUN
iajs-108	16	9	–	–	PUNCT
iajs-108	16	10	β1	β1	PROPN
iajs-108	16	11	,	,	PUNCT
iajs-108	16	12	pcos	pco	NOUN
iajs-108	16	13	,	,	PUNCT
iajs-108	16	14	hyperinsulinemia	hyperinsulinemia	NOUN
iajs-108	16	15	.	.	PUNCT
iajs-108	17	1	chemistry	chemistry	NOUN
iajs-108	17	2	|	|	ADV
iajs-108	17	3	172	172	NUM
iajs-108	17	4	2016	2016	NUM
iajs-108	17	5	)	)	PUNCT
iajs-108	17	6	عام	عام	ADP
iajs-108	17	7	2العدد	2العدد	NUM
iajs-108	17	8	(	(	PUNCT
iajs-108	17	9	29مجلة	29مجلة	NUM
iajs-108	17	10	إبن	إبن	VERB
iajs-108	17	11	الهيثم	الهيثم	ADJ
iajs-108	17	12	للعلوم	للعلوم	NOUN
iajs-108	17	13	الصرفة	الصرفة	NOUN
iajs-108	18	1	و	و	PRON
iajs-108	18	2	التطبيقية	التطبيقية	ADV
iajs-108	18	3	المجلد	المجلد	VERB
iajs-108	18	4	ibn	ibn	PROPN
iajs-108	18	5	al	al	PROPN
iajs-108	18	6	-	-	PUNCT
iajs-108	18	7	haitham	haitham	PROPN
iajs-108	18	8	jour	jour	X
iajs-108	18	9	.	.	PROPN
iajs-108	19	1	for	for	ADP
iajs-108	19	2	pure	pure	ADJ
iajs-108	19	3	&	&	CCONJ
iajs-108	19	4	appl	appl	PROPN
iajs-108	19	5	.	.	PUNCT
iajs-108	20	1	sci	sci	PROPN
iajs-108	20	2	.	.	PUNCT
iajs-108	20	3	vol	vol	NOUN
iajs-108	20	4	.	.	PROPN
iajs-108	20	5	29	29	NUM
iajs-108	20	6	(	(	PUNCT
iajs-108	20	7	2	2	NUM
iajs-108	20	8	)	)	SYM
iajs-108	20	9	2016	2016	NUM
iajs-108	20	10	introduction	introduction	NOUN
iajs-108	20	11	polycystic	polycystic	ADJ
iajs-108	20	12	ovary	ovary	ADJ
iajs-108	20	13	syndrome	syndrome	NOUN
iajs-108	20	14	(	(	PUNCT
iajs-108	20	15	pcos	pcos	PROPN
iajs-108	20	16	)	)	PUNCT
iajs-108	20	17	is	be	AUX
iajs-108	20	18	a	a	DET
iajs-108	20	19	common	common	ADJ
iajs-108	20	20	heterogeneous	heterogeneous	ADJ
iajs-108	20	21	disorder	disorder	NOUN
iajs-108	20	22	syndrome	syndrome	NOUN
iajs-108	20	23	in	in	ADP
iajs-108	20	24	females	female	NOUN
iajs-108	20	25	,	,	PUNCT
iajs-108	20	26	with	with	ADP
iajs-108	20	27	high	high	ADJ
iajs-108	20	28	prevalence	prevalence	NOUN
iajs-108	20	29	.	.	PUNCT
iajs-108	21	1	it	it	PRON
iajs-108	21	2	is	be	AUX
iajs-108	21	3	a	a	DET
iajs-108	21	4	multifactorial	multifactorial	ADJ
iajs-108	21	5	,	,	PUNCT
iajs-108	21	6	heterogeneous	heterogeneous	ADJ
iajs-108	21	7	,	,	PUNCT
iajs-108	21	8	complex	complex	ADJ
iajs-108	21	9	genetic	genetic	ADJ
iajs-108	21	10	,	,	PUNCT
iajs-108	21	11	endocrine	endocrine	ADJ
iajs-108	21	12	and	and	CCONJ
iajs-108	21	13	metabolic	metabolic	NOUN
iajs-108	21	14	disorder	disorder	NOUN
iajs-108	21	15	,	,	PUNCT
iajs-108	21	16	diagnostically	diagnostically	ADV
iajs-108	21	17	characterized	characterize	VERB
iajs-108	21	18	by	by	ADP
iajs-108	21	19	chronic	chronic	ADJ
iajs-108	21	20	anovulation	anovulation	NOUN
iajs-108	21	21	,	,	PUNCT
iajs-108	21	22	polycystic	polycystic	ADJ
iajs-108	21	23	ovaries	ovary	NOUN
iajs-108	21	24	and	and	CCONJ
iajs-108	21	25	biochemical	biochemical	ADJ
iajs-108	21	26	and	and	CCONJ
iajs-108	21	27	clinical	clinical	ADJ
iajs-108	21	28	manifestations	manifestation	NOUN
iajs-108	21	29	of	of	ADP
iajs-108	21	30	hyperandrogenism	hyperandrogenism	NOUN
iajs-108	21	31	[	[	X
iajs-108	21	32	1	1	NUM
iajs-108	21	33	,	,	PUNCT
iajs-108	21	34	2	2	NUM
iajs-108	21	35	]	]	PUNCT
iajs-108	21	36	.	.	PUNCT
iajs-108	22	1	pcos	pcos	PROPN
iajs-108	22	2	is	be	AUX
iajs-108	22	3	correlation	correlation	NOUN
iajs-108	22	4	with	with	ADP
iajs-108	22	5	insulin	insulin	NOUN
iajs-108	22	6	resistance	resistance	NOUN
iajs-108	22	7	(	(	PUNCT
iajs-108	22	8	ir	ir	NOUN
iajs-108	22	9	)	)	PUNCT
iajs-108	22	10	and	and	CCONJ
iajs-108	22	11	increase	increase	VERB
iajs-108	22	12	the	the	DET
iajs-108	22	13	the	the	DET
iajs-108	22	14	risk	risk	NOUN
iajs-108	22	15	for	for	ADP
iajs-108	22	16	type	type	NOUN
iajs-108	22	17	ii	ii	NOUN
iajs-108	22	18	diabetes	diabetes	NOUN
iajs-108	22	19	and	and	CCONJ
iajs-108	22	20	possibly	possibly	ADV
iajs-108	22	21	cardiovascular	cardiovascular	ADJ
iajs-108	22	22	disease	disease	NOUN
iajs-108	22	23	[	[	X
iajs-108	22	24	3	3	NUM
iajs-108	22	25	,	,	PUNCT
iajs-108	22	26	4	4	NUM
iajs-108	22	27	,	,	PUNCT
iajs-108	22	28	5	5	NUM
iajs-108	22	29	]	]	PUNCT
iajs-108	22	30	.	.	PUNCT
iajs-108	23	1	obesity	obesity	NOUN
iajs-108	23	2	or	or	CCONJ
iajs-108	23	3	overweight	overweight	ADJ
iajs-108	23	4	effect	effect	NOUN
iajs-108	23	5	most	most	ADJ
iajs-108	23	6	of	of	ADP
iajs-108	23	7	the	the	DET
iajs-108	23	8	patients	patient	NOUN
iajs-108	23	9	with	with	ADP
iajs-108	23	10	pcos	pco	NOUN
iajs-108	23	11	,	,	PUNCT
iajs-108	23	12	suggesting	suggest	VERB
iajs-108	23	13	adipose	adipose	ADP
iajs-108	23	14	tissue	tissue	NOUN
iajs-108	23	15	dysfunction	dysfunction	NOUN
iajs-108	23	16	[	[	X
iajs-108	23	17	6	6	NUM
iajs-108	23	18	]	]	PUNCT
iajs-108	23	19	.	.	PUNCT
iajs-108	24	1	transforming	transform	VERB
iajs-108	24	2	growth	growth	NOUN
iajs-108	24	3	factor	factor	NOUN
iajs-108	24	4	β	β	X
iajs-108	24	5	(	(	PUNCT
iajs-108	24	6	tgf	tgf	PROPN
iajs-108	24	7	-	-	PUNCT
iajs-108	24	8	β	β	NOUN
iajs-108	24	9	)	)	PUNCT
iajs-108	24	10	is	be	AUX
iajs-108	24	11	a	a	DET
iajs-108	24	12	highly	highly	ADV
iajs-108	24	13	pleiotropic	pleiotropic	ADJ
iajs-108	24	14	cytokine	cytokine	NOUN
iajs-108	24	15	that	that	SCONJ
iajs-108	24	16	in	in	ADP
iajs-108	24	17	mammals	mammal	NOUN
iajs-108	24	18	exist	exist	VERB
iajs-108	24	19	in	in	ADP
iajs-108	24	20	three	three	NUM
iajs-108	24	21	isoforms	isoform	NOUN
iajs-108	24	22	(	(	PUNCT
iajs-108	24	23	tgf	tgf	NOUN
iajs-108	24	24	-	-	PUNCT
iajs-108	24	25	β1	β1	PROPN
iajs-108	24	26	,	,	PUNCT
iajs-108	24	27	tgf	tgf	PROPN
iajs-108	24	28	-	-	PUNCT
iajs-108	24	29	β2	β2	PROPN
iajs-108	24	30	,	,	PUNCT
iajs-108	24	31	and	and	CCONJ
iajs-108	24	32	tgf	tgf	NOUN
iajs-108	24	33	-	-	PUNCT
iajs-108	24	34	β3	β3	ADJ
iajs-108	24	35	)	)	PUNCT
iajs-108	25	1	[	[	X
iajs-108	25	2	7	7	NUM
iajs-108	25	3	]	]	PUNCT
iajs-108	25	4	.	.	PUNCT
iajs-108	26	1	tgf	tgf	PROPN
iajs-108	26	2	-	-	PUNCT
iajs-108	26	3	β	β	PROPN
iajs-108	26	4	is	be	AUX
iajs-108	26	5	also	also	ADV
iajs-108	26	6	normally	normally	ADV
iajs-108	26	7	found	find	VERB
iajs-108	26	8	in	in	ADP
iajs-108	26	9	the	the	DET
iajs-108	26	10	plasma	plasma	NOUN
iajs-108	26	11	(	(	PUNCT
iajs-108	26	12	tgf	tgf	NOUN
iajs-108	26	13	-	-	PUNCT
iajs-108	26	14	β1	β1	PROPN
iajs-108	26	15	isoform	isoform	NOUN
iajs-108	26	16	)	)	PUNCT
iajs-108	26	17	,	,	PUNCT
iajs-108	26	18	and	and	CCONJ
iajs-108	26	19	bound	bind	VERB
iajs-108	26	20	to	to	ADP
iajs-108	26	21	ecm	ecm	NOUN
iajs-108	26	22	proteins	protein	NOUN
iajs-108	26	23	throughout	throughout	ADP
iajs-108	26	24	the	the	DET
iajs-108	26	25	body	body	NOUN
iajs-108	26	26	[	[	X
iajs-108	26	27	8	8	NUM
iajs-108	26	28	]	]	PUNCT
iajs-108	26	29	.	.	PUNCT
iajs-108	27	1	the	the	DET
iajs-108	27	2	etiology	etiology	NOUN
iajs-108	27	3	of	of	ADP
iajs-108	27	4	pcos	pcos	PROPN
iajs-108	27	5	is	be	AUX
iajs-108	27	6	not	not	PART
iajs-108	27	7	well	well	ADV
iajs-108	27	8	unclear	unclear	ADJ
iajs-108	27	9	;	;	PUNCT
iajs-108	27	10	tgf	tgf	PROPN
iajs-108	27	11	-	-	PUNCT
iajs-108	27	12	β1	β1	PROPN
iajs-108	27	13	is	be	AUX
iajs-108	27	14	expressed	express	VERB
iajs-108	27	15	in	in	ADP
iajs-108	27	16	the	the	DET
iajs-108	27	17	ovary	ovary	NOUN
iajs-108	27	18	and	and	CCONJ
iajs-108	27	19	has	have	AUX
iajs-108	27	20	been	be	AUX
iajs-108	27	21	implicated	implicate	VERB
iajs-108	27	22	in	in	ADP
iajs-108	27	23	the	the	DET
iajs-108	27	24	pathogenesis	pathogenesis	NOUN
iajs-108	27	25	of	of	ADP
iajs-108	27	26	abnormal	abnormal	ADJ
iajs-108	27	27	follicle	follicle	NOUN
iajs-108	27	28	development	development	NOUN
iajs-108	27	29	and	and	CCONJ
iajs-108	27	30	hyperandrogenism	hyperandrogenism	NOUN
iajs-108	27	31	in	in	ADP
iajs-108	27	32	pcos	pcos	PROPN
iajs-108	28	1	[	[	X
iajs-108	28	2	9	9	NUM
iajs-108	28	3	]	]	PUNCT
iajs-108	28	4	.	.	PUNCT
iajs-108	29	1	other	other	ADJ
iajs-108	29	2	factors	factor	NOUN
iajs-108	29	3	,	,	PUNCT
iajs-108	29	4	such	such	ADJ
iajs-108	29	5	as	as	ADP
iajs-108	29	6	endocrine	endocrine	NOUN
iajs-108	29	7	,	,	PUNCT
iajs-108	29	8	environmental	environmental	ADJ
iajs-108	29	9	,	,	PUNCT
iajs-108	29	10	and	and	CCONJ
iajs-108	29	11	metabolic	metabolic	NOUN
iajs-108	29	12	factors	factor	NOUN
iajs-108	29	13	,	,	PUNCT
iajs-108	29	14	might	might	AUX
iajs-108	29	15	also	also	ADV
iajs-108	29	16	play	play	VERB
iajs-108	29	17	a	a	DET
iajs-108	29	18	role	role	NOUN
iajs-108	29	19	in	in	ADP
iajs-108	29	20	dysregulated	dysregulated	ADJ
iajs-108	29	21	tgf	tgf	PROPN
iajs-108	29	22	-	-	PUNCT
iajs-108	29	23	β	β	PROPN
iajs-108	29	24	signaling	signal	VERB
iajs-108	29	25	in	in	ADP
iajs-108	29	26	pcos	pcos	ADJ
iajs-108	29	27	patients	patient	NOUN
iajs-108	29	28	[	[	X
iajs-108	29	29	10	10	NUM
iajs-108	29	30	]	]	PUNCT
iajs-108	29	31	.	.	PUNCT
iajs-108	30	1	iron	iron	NOUN
iajs-108	30	2	stores	store	NOUN
iajs-108	30	3	in	in	ADP
iajs-108	30	4	the	the	DET
iajs-108	30	5	body	body	NOUN
iajs-108	30	6	exist	exist	VERB
iajs-108	30	7	fierstly	fierstly	ADV
iajs-108	30	8	in	in	ADP
iajs-108	30	9	the	the	DET
iajs-108	30	10	form	form	NOUN
iajs-108	30	11	of	of	ADP
iajs-108	30	12	ferritin	ferritin	NOUN
iajs-108	30	13	.	.	PUNCT
iajs-108	31	1	the	the	DET
iajs-108	31	2	ferritin	ferritin	ADJ
iajs-108	31	3	molecule	molecule	NOUN
iajs-108	31	4	is	be	AUX
iajs-108	31	5	an	an	DET
iajs-108	31	6	intracellular	intracellular	ADJ
iajs-108	31	7	protein	protein	NOUN
iajs-108	31	8	and	and	CCONJ
iajs-108	31	9	considered	consider	VERB
iajs-108	31	10	as	as	ADP
iajs-108	31	11	acute	acute	ADJ
iajs-108	31	12	phase	phase	NOUN
iajs-108	31	13	protein	protein	NOUN
iajs-108	31	14	[	[	X
iajs-108	31	15	11	11	NUM
iajs-108	31	16	]	]	PUNCT
iajs-108	31	17	.	.	PUNCT
iajs-108	32	1	oligoovulation	oligoovulation	NOUN
iajs-108	32	2	may	may	AUX
iajs-108	32	3	result	result	VERB
iajs-108	32	4	in	in	ADP
iajs-108	32	5	oligomenorrhea	oligomenorrhea	PROPN
iajs-108	32	6	and/or	and/or	CCONJ
iajs-108	32	7	amenorrhea	amenorrhea	NOUN
iajs-108	32	8	reducing	reduce	VERB
iajs-108	32	9	iron	iron	NOUN
iajs-108	32	10	loss	loss	NOUN
iajs-108	32	11	[	[	X
iajs-108	32	12	12	12	NUM
iajs-108	32	13	]	]	PUNCT
iajs-108	32	14	.	.	PUNCT
iajs-108	33	1	insulin	insulin	NOUN
iajs-108	33	2	resistance	resistance	NOUN
iajs-108	33	3	and	and	CCONJ
iajs-108	33	4	compensatory	compensatory	ADJ
iajs-108	33	5	hyperinsulinemia	hyperinsulinemia	NOUN
iajs-108	33	6	may	may	AUX
iajs-108	33	7	facilitate	facilitate	VERB
iajs-108	33	8	iron	iron	NOUN
iajs-108	33	9	uptake	uptake	NOUN
iajs-108	33	10	by	by	ADP
iajs-108	33	11	different	different	ADJ
iajs-108	33	12	tissues	tissue	NOUN
iajs-108	33	13	[	[	X
iajs-108	33	14	13	13	NUM
iajs-108	33	15	]	]	PUNCT
iajs-108	33	16	.	.	PUNCT
iajs-108	34	1	androgen	androgen	NOUN
iajs-108	34	2	excess	excess	NOUN
iajs-108	34	3	may	may	AUX
iajs-108	34	4	enhance	enhance	VERB
iajs-108	34	5	erythropoiesis	erythropoiesis	NOUN
iajs-108	34	6	and	and	CCONJ
iajs-108	34	7	together	together	ADV
iajs-108	34	8	with	with	ADP
iajs-108	34	9	insulin	insulin	NOUN
iajs-108	34	10	resistance	resistance	NOUN
iajs-108	34	11	,	,	PUNCT
iajs-108	34	12	may	may	AUX
iajs-108	34	13	decrease	decrease	VERB
iajs-108	34	14	hepcidin	hepcidin	ADJ
iajs-108	34	15	secretion	secretion	NOUN
iajs-108	34	16	thereby	thereby	ADV
iajs-108	34	17	increasing	increase	VERB
iajs-108	34	18	iron	iron	NOUN
iajs-108	34	19	absorption	absorption	NOUN
iajs-108	34	20	[	[	X
iajs-108	34	21	14	14	NUM
iajs-108	34	22	,	,	PUNCT
iajs-108	34	23	15	15	NUM
iajs-108	34	24	]	]	PUNCT
iajs-108	34	25	.	.	PUNCT
iajs-108	35	1	of	of	ADP
iajs-108	35	2	these	these	DET
iajs-108	35	3	potential	potential	ADJ
iajs-108	35	4	mechanisms	mechanism	NOUN
iajs-108	35	5	,	,	PUNCT
iajs-108	35	6	data	datum	NOUN
iajs-108	35	7	in	in	ADP
iajs-108	35	8	humans	human	NOUN
iajs-108	35	9	supported	support	VERB
iajs-108	35	10	the	the	DET
iajs-108	35	11	corelation	corelation	NOUN
iajs-108	35	12	of	of	ADP
iajs-108	35	13	reduced	reduce	VERB
iajs-108	35	14	menstrual	menstrual	ADJ
iajs-108	35	15	losses	loss	NOUN
iajs-108	35	16	[	[	X
iajs-108	35	17	16	16	NUM
iajs-108	35	18	]	]	PUNCT
iajs-108	35	19	.	.	PUNCT
iajs-108	36	1	the	the	DET
iajs-108	36	2	aim	aim	NOUN
iajs-108	36	3	of	of	ADP
iajs-108	36	4	the	the	DET
iajs-108	36	5	present	present	ADJ
iajs-108	36	6	study	study	NOUN
iajs-108	36	7	is	be	AUX
iajs-108	36	8	to	to	PART
iajs-108	36	9	explore	explore	VERB
iajs-108	36	10	the	the	DET
iajs-108	36	11	association	association	NOUN
iajs-108	36	12	between	between	ADP
iajs-108	36	13	ferritin	ferritin	ADJ
iajs-108	36	14	and	and	CCONJ
iajs-108	36	15	tgf	tgf	PROPN
iajs-108	36	16	-	-	PUNCT
iajs-108	36	17	β1	β1	PROPN
iajs-108	36	18	levels	level	NOUN
iajs-108	36	19	of	of	ADP
iajs-108	36	20	pcos	pcos	PROPN
iajs-108	36	21	patients	patient	NOUN
iajs-108	36	22	with	with	ADP
iajs-108	36	23	insulin	insulin	NOUN
iajs-108	36	24	resistance	resistance	NOUN
iajs-108	36	25	,	,	PUNCT
iajs-108	36	26	cardiovascular	cardiovascular	ADJ
iajs-108	36	27	and	and	CCONJ
iajs-108	36	28	type	type	NOUN
iajs-108	36	29	2	2	NUM
iajs-108	36	30	diabetes	diabetes	NOUN
iajs-108	36	31	risks	risk	NOUN
iajs-108	36	32	.	.	PUNCT
iajs-108	37	1	experimental	experimental	ADJ
iajs-108	37	2	part	part	NOUN
iajs-108	37	3	subjects	subject	NOUN
iajs-108	37	4	this	this	DET
iajs-108	37	5	study	study	NOUN
iajs-108	37	6	was	be	AUX
iajs-108	37	7	carried	carry	VERB
iajs-108	37	8	out	out	ADP
iajs-108	37	9	in	in	ADP
iajs-108	37	10	baghdad	baghdad	PROPN
iajs-108	37	11	city	city	NOUN
iajs-108	37	12	at	at	ADP
iajs-108	37	13	kamal	kamal	PROPN
iajs-108	37	14	al	al	PROPN
iajs-108	37	15	-	-	PUNCT
iajs-108	37	16	samaree	samaree	PROPN
iajs-108	37	17	hospital	hospital	NOUN
iajs-108	37	18	for	for	ADP
iajs-108	37	19	infertility	infertility	NOUN
iajs-108	37	20	and	and	CCONJ
iajs-108	37	21	in	in	ADP
iajs-108	37	22	vitro	vitro	X
iajs-108	37	23	fertilization	fertilization	NOUN
iajs-108	37	24	,	,	PUNCT
iajs-108	37	25	for	for	ADP
iajs-108	37	26	the	the	DET
iajs-108	37	27	period	period	NOUN
iajs-108	37	28	from	from	ADP
iajs-108	37	29	november	november	PROPN
iajs-108	37	30	2014	2014	NUM
iajs-108	37	31	to	to	ADP
iajs-108	37	32	april	april	PROPN
iajs-108	37	33	2015	2015	NUM
iajs-108	37	34	.	.	PUNCT
iajs-108	38	1	it	it	PRON
iajs-108	38	2	included	include	VERB
iajs-108	38	3	sixty	sixty	NUM
iajs-108	38	4	one	one	NUM
iajs-108	38	5	women	woman	NOUN
iajs-108	38	6	newly	newly	ADV
iajs-108	38	7	diagnosed	diagnose	VERB
iajs-108	38	8	with	with	ADP
iajs-108	38	9	pcos	pco	NOUN
iajs-108	38	10	were	be	AUX
iajs-108	38	11	allocated	allocate	VERB
iajs-108	38	12	into	into	ADP
iajs-108	38	13	three	three	NUM
iajs-108	38	14	groups	group	NOUN
iajs-108	38	15	as	as	SCONJ
iajs-108	38	16	follows	follow	VERB
iajs-108	38	17	:	:	PUNCT
iajs-108	38	18	(	(	PUNCT
iajs-108	38	19	20	20	X
iajs-108	38	20	)	)	PUNCT
iajs-108	38	21	lean	lean	VERB
iajs-108	38	22	with	with	ADP
iajs-108	38	23	bmi	bmi	NOUN
iajs-108	38	24	(	(	PUNCT
iajs-108	38	25	18	18	NUM
iajs-108	38	26	-	-	SYM
iajs-108	38	27	24.9	24.9	NUM
iajs-108	38	28	kg	kg	NOUN
iajs-108	38	29	/	/	SYM
iajs-108	38	30	cm2	cm2	NOUN
iajs-108	38	31	)	)	PUNCT
iajs-108	38	32	,	,	PUNCT
iajs-108	38	33	overweight	overweight	ADJ
iajs-108	38	34	women	woman	NOUN
iajs-108	38	35	with	with	ADP
iajs-108	38	36	bmi	bmi	NOUN
iajs-108	38	37	(	(	PUNCT
iajs-108	38	38	25	25	NUM
iajs-108	38	39	-	-	SYM
iajs-108	38	40	29.9	29.9	NUM
iajs-108	38	41	kg	kg	NOUN
iajs-108	38	42	/	/	SYM
iajs-108	38	43	cm2	cm2	NOUN
iajs-108	38	44	)	)	PUNCT
iajs-108	38	45	,	,	PUNCT
iajs-108	38	46	and	and	CCONJ
iajs-108	38	47	(	(	PUNCT
iajs-108	38	48	24	24	NUM
iajs-108	38	49	)	)	PUNCT
iajs-108	38	50	obese	obese	ADJ
iajs-108	38	51	women	woman	NOUN
iajs-108	38	52	with	with	ADP
iajs-108	38	53	bmi	bmi	PROPN
iajs-108	38	54	over	over	ADP
iajs-108	38	55	30	30	NUM
iajs-108	38	56	kg	kg	NOUN
iajs-108	38	57	/	/	SYM
iajs-108	38	58	cm2	cm2	NOUN
iajs-108	38	59	.	.	PROPN
iajs-108	38	60	additionally	additionally	ADV
iajs-108	38	61	,	,	PUNCT
iajs-108	38	62	twenty	twenty	NUM
iajs-108	38	63	apparently	apparently	ADV
iajs-108	38	64	healthy	healthy	ADJ
iajs-108	38	65	women	woman	NOUN
iajs-108	38	66	were	be	AUX
iajs-108	38	67	selected	select	VERB
iajs-108	38	68	to	to	PART
iajs-108	38	69	serve	serve	VERB
iajs-108	38	70	as	as	ADP
iajs-108	38	71	controls	control	NOUN
iajs-108	38	72	.	.	PUNCT
iajs-108	39	1	the	the	DET
iajs-108	39	2	controls	control	NOUN
iajs-108	39	3	have	have	VERB
iajs-108	39	4	a	a	DET
iajs-108	39	5	regular	regular	ADJ
iajs-108	39	6	menstrual	menstrual	ADJ
iajs-108	39	7	cycle	cycle	NOUN
iajs-108	39	8	with	with	ADP
iajs-108	39	9	bmi	bmi	PROPN
iajs-108	39	10	range	range	NOUN
iajs-108	39	11	(	(	PUNCT
iajs-108	39	12	18	18	NUM
iajs-108	39	13	-	-	SYM
iajs-108	39	14	25	25	NUM
iajs-108	39	15	kg	kg	PROPN
iajs-108	39	16	/	/	SYM
iajs-108	39	17	cm2	cm2	NOUN
iajs-108	39	18	)	)	PUNCT
iajs-108	39	19	,	,	PUNCT
iajs-108	39	20	and	and	CCONJ
iajs-108	39	21	with	with	ADP
iajs-108	39	22	the	the	DET
iajs-108	39	23	comparable	comparable	ADJ
iajs-108	39	24	age	age	NOUN
iajs-108	39	25	of	of	ADP
iajs-108	39	26	selected	select	VERB
iajs-108	39	27	patients	patient	NOUN
iajs-108	39	28	.	.	PUNCT
iajs-108	40	1	the	the	DET
iajs-108	40	2	diagnosis	diagnosis	NOUN
iajs-108	40	3	of	of	ADP
iajs-108	40	4	pcos	pcos	PROPN
iajs-108	40	5	depende	depende	PROPN
iajs-108	40	6	on	on	ADP
iajs-108	40	7	the	the	DET
iajs-108	40	8	definition	definition	NOUN
iajs-108	40	9	generated	generate	VERB
iajs-108	40	10	at	at	ADP
iajs-108	40	11	to	to	ADP
iajs-108	40	12	criteria	criterion	NOUN
iajs-108	40	13	of	of	ADP
iajs-108	40	14	the	the	DET
iajs-108	40	15	rotterdam	rotterdam	NOUN
iajs-108	40	16	,	,	PUNCT
iajs-108	40	17	when	when	SCONJ
iajs-108	40	18	at	at	ADV
iajs-108	40	19	least	least	ADV
iajs-108	40	20	two	two	NUM
iajs-108	40	21	of	of	ADP
iajs-108	40	22	the	the	DET
iajs-108	40	23	following	follow	VERB
iajs-108	40	24	features	feature	NOUN
iajs-108	40	25	were	be	AUX
iajs-108	40	26	present	present	ADJ
iajs-108	40	27	:	:	PUNCT
iajs-108	40	28	oligoor	oligoor	ADJ
iajs-108	40	29	anovulation	anovulation	NOUN
iajs-108	40	30	;	;	PUNCT
iajs-108	40	31	clinical	clinical	ADJ
iajs-108	40	32	and/or	and/or	CCONJ
iajs-108	40	33	biochemical	biochemical	ADJ
iajs-108	40	34	signs	sign	NOUN
iajs-108	40	35	of	of	ADP
iajs-108	40	36	hyperandrogenism	hyperandrogenism	NOUN
iajs-108	40	37	;	;	PUNCT
iajs-108	40	38	and	and	CCONJ
iajs-108	40	39	polycystic	polycystic	ADJ
iajs-108	40	40	ovaries	ovary	NOUN
iajs-108	40	41	(	(	PUNCT
iajs-108	40	42	presence	presence	NOUN
iajs-108	40	43	of	of	ADP
iajs-108	40	44	12	12	NUM
iajs-108	40	45	or	or	CCONJ
iajs-108	40	46	more	more	ADJ
iajs-108	40	47	follicles	follicle	NOUN
iajs-108	40	48	in	in	ADP
iajs-108	40	49	each	each	DET
iajs-108	40	50	ovary	ovary	NOUN
iajs-108	40	51	measuring	measure	VERB
iajs-108	40	52	2	2	NUM
iajs-108	40	53	–	–	SYM
iajs-108	40	54	9	9	NUM
iajs-108	40	55	mm	mm	NOUN
iajs-108	40	56	in	in	ADP
iajs-108	40	57	diameter	diameter	NOUN
iajs-108	40	58	and/or	and/or	CCONJ
iajs-108	40	59	increased	increase	VERB
iajs-108	40	60	ovarian	ovarian	ADJ
iajs-108	40	61	volume	volume	NOUN
iajs-108	40	62	(	(	PUNCT
iajs-108	40	63	>	>	X
iajs-108	40	64	10	10	NUM
iajs-108	40	65	cm3	cm3	NOUN
iajs-108	40	66	)	)	PUNCT
iajs-108	40	67	(	(	PUNCT
iajs-108	40	68	17	17	NUM
iajs-108	40	69	)	)	PUNCT
iajs-108	40	70	.	.	PUNCT
iajs-108	41	1	exclusion	exclusion	NOUN
iajs-108	41	2	criteria	criterion	NOUN
iajs-108	41	3	for	for	ADP
iajs-108	41	4	women	woman	NOUN
iajs-108	41	5	included	include	VERB
iajs-108	41	6	in	in	ADP
iajs-108	41	7	the	the	DET
iajs-108	41	8	study	study	NOUN
iajs-108	41	9	:	:	PUNCT
iajs-108	42	1	pregnancy	pregnancy	NOUN
iajs-108	42	2	,	,	PUNCT
iajs-108	42	3	current	current	ADJ
iajs-108	42	4	or	or	CCONJ
iajs-108	42	5	previous	previous	ADJ
iajs-108	42	6	(	(	PUNCT
iajs-108	42	7	within	within	ADP
iajs-108	42	8	six	six	NUM
iajs-108	42	9	months	month	NOUN
iajs-108	42	10	)	)	PUNCT
iajs-108	42	11	use	use	NOUN
iajs-108	42	12	of	of	ADP
iajs-108	42	13	oral	oral	ADJ
iajs-108	42	14	contraceptives	contraceptive	NOUN
iajs-108	42	15	,	,	PUNCT
iajs-108	42	16	antiandrogens	antiandrogen	NOUN
iajs-108	42	17	or	or	CCONJ
iajs-108	42	18	other	other	ADJ
iajs-108	42	19	hormonal	hormonal	ADJ
iajs-108	42	20	drugs	drug	NOUN
iajs-108	42	21	,	,	PUNCT
iajs-108	42	22	known	know	VERB
iajs-108	42	23	cardiovascular	cardiovascular	ADJ
iajs-108	42	24	,	,	PUNCT
iajs-108	42	25	renal	renal	ADJ
iajs-108	42	26	,	,	PUNCT
iajs-108	42	27	liver	liver	NOUN
iajs-108	42	28	,	,	PUNCT
iajs-108	42	29	lung	lung	NOUN
iajs-108	42	30	diseases	disease	NOUN
iajs-108	42	31	and	and	CCONJ
iajs-108	42	32	diabetes	diabetes	NOUN
iajs-108	42	33	mellitus	mellitus	NOUN
iajs-108	42	34	,	,	PUNCT
iajs-108	42	35	and	and	CCONJ
iajs-108	42	36	cigarette	cigarette	NOUN
iajs-108	42	37	smoking	smoking	NOUN
iajs-108	42	38	.	.	PUNCT
iajs-108	43	1	sample	sample	NOUN
iajs-108	43	2	collection	collection	NOUN
iajs-108	43	3	a	a	DET
iajs-108	43	4	venous	venous	ADJ
iajs-108	43	5	blood	blood	NOUN
iajs-108	43	6	specimen	speciman	NOUN
iajs-108	43	7	was	be	AUX
iajs-108	43	8	withdrawn	withdraw	VERB
iajs-108	43	9	on	on	ADP
iajs-108	43	10	day	day	NOUN
iajs-108	43	11	2	2	NUM
iajs-108	43	12	-	-	SYM
iajs-108	43	13	5	5	NUM
iajs-108	43	14	of	of	ADP
iajs-108	43	15	the	the	DET
iajs-108	43	16	menstrual	menstrual	ADJ
iajs-108	43	17	cycle	cycle	NOUN
iajs-108	43	18	about	about	ADP
iajs-108	43	19	(	(	PUNCT
iajs-108	43	20	5	5	NUM
iajs-108	43	21	ml	ml	NOUN
iajs-108	43	22	)	)	PUNCT
iajs-108	43	23	by	by	ADP
iajs-108	43	24	disposable	disposable	ADJ
iajs-108	43	25	syringe	syringe	NOUN
iajs-108	43	26	from	from	ADP
iajs-108	43	27	each	each	DET
iajs-108	43	28	woman	woman	NOUN
iajs-108	43	29	between	between	ADP
iajs-108	43	30	08:00	08:00	NUM
iajs-108	43	31	and	and	CCONJ
iajs-108	43	32	12:00	12:00	NUM
iajs-108	43	33	a.m	a.m	PROPN
iajs-108	43	34	,	,	PUNCT
iajs-108	43	35	after	after	ADP
iajs-108	43	36	an	an	DET
iajs-108	43	37	overnight	overnight	ADJ
iajs-108	43	38	fasting	fasting	NOUN
iajs-108	43	39	to	to	PART
iajs-108	43	40	be	be	AUX
iajs-108	43	41	placed	place	VERB
iajs-108	43	42	in	in	ADP
iajs-108	43	43	gel	gel	NOUN
iajs-108	43	44	-	-	PUNCT
iajs-108	43	45	containing	contain	VERB
iajs-108	43	46	tubes	tube	NOUN
iajs-108	43	47	.	.	PUNCT
iajs-108	44	1	after	after	ADP
iajs-108	44	2	clotting	clot	VERB
iajs-108	44	3	,	,	PUNCT
iajs-108	44	4	the	the	DET
iajs-108	44	5	specimens	specimen	NOUN
iajs-108	44	6	were	be	AUX
iajs-108	44	7	centrifuged	centrifuge	VERB
iajs-108	44	8	at	at	ADP
iajs-108	44	9	3000	3000	NUM
iajs-108	44	10	rpm	rpm	NOUN
iajs-108	44	11	for	for	ADP
iajs-108	44	12	10	10	NUM
iajs-108	44	13	minutes	minute	NOUN
iajs-108	44	14	to	to	PART
iajs-108	44	15	collect	collect	VERB
iajs-108	44	16	serum	serum	NOUN
iajs-108	44	17	that	that	PRON
iajs-108	44	18	was	be	AUX
iajs-108	44	19	divide	divide	ADJ
iajs-108	44	20	into	into	ADP
iajs-108	44	21	aliquots	aliquot	NOUN
iajs-108	44	22	(	(	PUNCT
iajs-108	44	23	300	300	NUM
iajs-108	44	24	µl	µl	NOUN
iajs-108	44	25	)	)	PUNCT
iajs-108	44	26	in	in	ADP
iajs-108	44	27	eppendorff	eppendorff	PROPN
iajs-108	44	28	tube	tube	NOUN
iajs-108	44	29	,	,	PUNCT
iajs-108	44	30	to	to	PART
iajs-108	44	31	be	be	AUX
iajs-108	44	32	useing	use	VERB
iajs-108	44	33	in	in	ADP
iajs-108	44	34	the	the	DET
iajs-108	44	35	estimation	estimation	NOUN
iajs-108	44	36	of	of	ADP
iajs-108	44	37	fsg	fsg	PROPN
iajs-108	44	38	,	,	PUNCT
iajs-108	44	39	on	on	ADP
iajs-108	44	40	the	the	DET
iajs-108	44	41	same	same	ADJ
iajs-108	44	42	day	day	NOUN
iajs-108	44	43	;	;	PUNCT
iajs-108	44	44	other	other	ADJ
iajs-108	44	45	aliquots	aliquot	NOUN
iajs-108	44	46	were	be	AUX
iajs-108	44	47	keep	keep	VERB
iajs-108	44	48	frozen	frozen	ADJ
iajs-108	44	49	at	at	ADP
iajs-108	44	50	-20	-20	NUM
iajs-108	44	51	c	c	NOUN
iajs-108	44	52	°	°	NOUN
iajs-108	44	53	until	until	SCONJ
iajs-108	44	54	used	use	VERB
iajs-108	44	55	.	.	PUNCT
iajs-108	45	1	chemistry	chemistry	NOUN
iajs-108	46	1	|	|	ADV
iajs-108	46	2	173	173	NUM
iajs-108	46	3	2016	2016	NUM
iajs-108	46	4	)	)	PUNCT
iajs-108	47	1	عام	عام	ADP
iajs-108	47	2	2العدد	2العدد	NUM
iajs-108	47	3	(	(	PUNCT
iajs-108	47	4	29مجلة	29مجلة	NUM
iajs-108	47	5	إبن	إبن	VERB
iajs-108	47	6	الهيثم	الهيثم	ADJ
iajs-108	47	7	للعلوم	للعلوم	NOUN
iajs-108	47	8	الصرفة	الصرفة	NOUN
iajs-108	48	1	و	و	PRON
iajs-108	48	2	التطبيقية	التطبيقية	ADV
iajs-108	48	3	المجلد	المجلد	VERB
iajs-108	48	4	ibn	ibn	PROPN
iajs-108	48	5	al	al	PROPN
iajs-108	48	6	-	-	PUNCT
iajs-108	48	7	haitham	haitham	PROPN
iajs-108	48	8	jour	jour	X
iajs-108	48	9	.	.	PROPN
iajs-108	49	1	for	for	ADP
iajs-108	49	2	pure	pure	ADJ
iajs-108	49	3	&	&	CCONJ
iajs-108	49	4	appl	appl	PROPN
iajs-108	49	5	.	.	PUNCT
iajs-108	50	1	sci	sci	PROPN
iajs-108	50	2	.	.	PUNCT
iajs-108	50	3	vol	vol	NOUN
iajs-108	50	4	.	.	PROPN
iajs-108	50	5	29	29	NUM
iajs-108	50	6	(	(	PUNCT
iajs-108	50	7	2	2	NUM
iajs-108	50	8	)	)	PUNCT
iajs-108	50	9	2016	2016	NUM
iajs-108	50	10	anthropometric	anthropometric	ADJ
iajs-108	50	11	indices	index	NOUN
iajs-108	50	12	measurements	measurement	NOUN
iajs-108	50	13	determination	determination	NOUN
iajs-108	50	14	of	of	ADP
iajs-108	50	15	body	body	NOUN
iajs-108	50	16	mass	mass	NOUN
iajs-108	50	17	index	index	NOUN
iajs-108	50	18	(	(	PUNCT
iajs-108	50	19	bmi	bmi	PROPN
iajs-108	50	20	)	)	PUNCT
iajs-108	50	21	body	body	NOUN
iajs-108	50	22	mass	mass	NOUN
iajs-108	50	23	index	index	NOUN
iajs-108	50	24	was	be	AUX
iajs-108	50	25	determine	determine	NOUN
iajs-108	50	26	by	by	ADP
iajs-108	50	27	dividing	divide	VERB
iajs-108	50	28	body	body	NOUN
iajs-108	50	29	weight	weight	NOUN
iajs-108	50	30	in	in	ADP
iajs-108	50	31	kilogram	kilogram	PROPN
iajs-108	50	32	by	by	ADP
iajs-108	50	33	the	the	DET
iajs-108	50	34	square	square	NOUN
iajs-108	50	35	of	of	ADP
iajs-108	50	36	her	her	PRON
iajs-108	50	37	height	height	NOUN
iajs-108	50	38	in	in	ADP
iajs-108	50	39	meter	meter	NOUN
iajs-108	50	40	.	.	PUNCT
iajs-108	51	1	the	the	DET
iajs-108	51	2	equation	equation	NOUN
iajs-108	51	3	used	use	VERB
iajs-108	51	4	in	in	ADP
iajs-108	51	5	medicine	medicine	NOUN
iajs-108	51	6	produce	produce	VERB
iajs-108	51	7	a	a	DET
iajs-108	51	8	unit	unit	NOUN
iajs-108	51	9	of	of	ADP
iajs-108	51	10	measure	measure	NOUN
iajs-108	51	11	of	of	ADP
iajs-108	51	12	kg	kg	PROPN
iajs-108	51	13	/	/	SYM
iajs-108	51	14	m2	m2	PROPN
iajs-108	52	1	[	[	X
iajs-108	52	2	18	18	NUM
iajs-108	52	3	]	]	PUNCT
iajs-108	52	4	.	.	PUNCT
iajs-108	53	1	laboratory	laboratory	NOUN
iajs-108	53	2	methods	method	NOUN
iajs-108	53	3	measurement	measurement	NOUN
iajs-108	53	4	of	of	ADP
iajs-108	53	5	glycemic	glycemic	ADJ
iajs-108	53	6	indices	index	NOUN
iajs-108	53	7	:	:	PUNCT
iajs-108	53	8	serum	serum	NOUN
iajs-108	53	9	glucose	glucose	NOUN
iajs-108	53	10	level	level	NOUN
iajs-108	53	11	was	be	AUX
iajs-108	53	12	measure	measure	NOUN
iajs-108	53	13	by	by	ADP
iajs-108	53	14	the	the	DET
iajs-108	53	15	glucose	glucose	NOUN
iajs-108	53	16	oxidase	oxidase	NOUN
iajs-108	53	17	method	method	NOUN
iajs-108	53	18	0f	0f	NOUN
iajs-108	53	19	trinder	trinder	NOUN
iajs-108	53	20	1969	1969	NUM
iajs-108	53	21	(	(	PUNCT
iajs-108	53	22	linear	linear	PROPN
iajs-108	53	23	,	,	PUNCT
iajs-108	53	24	spain	spain	PROPN
iajs-108	53	25	)	)	PUNCT
iajs-108	54	1	[	[	X
iajs-108	54	2	19	19	NUM
iajs-108	54	3	]	]	PUNCT
iajs-108	54	4	.	.	PUNCT
iajs-108	55	1	serum	serum	PROPN
iajs-108	55	2	insulin	insulin	NOUN
iajs-108	55	3	levels	level	NOUN
iajs-108	55	4	were	be	AUX
iajs-108	55	5	determined	determine	VERB
iajs-108	55	6	using	use	VERB
iajs-108	55	7	elisa	elisa	NOUN
iajs-108	55	8	kit	kit	NOUN
iajs-108	56	1	[	[	X
iajs-108	56	2	20	20	NUM
iajs-108	56	3	]	]	PUNCT
iajs-108	56	4	(	(	PUNCT
iajs-108	56	5	drg	drg	PROPN
iajs-108	56	6	,	,	PUNCT
iajs-108	56	7	diagnostic	diagnostic	ADJ
iajs-108	56	8	company	company	NOUN
iajs-108	56	9	,	,	PUNCT
iajs-108	56	10	germany	germany	PROPN
iajs-108	56	11	)	)	PUNCT
iajs-108	56	12	as	as	SCONJ
iajs-108	56	13	described	describe	VERB
iajs-108	56	14	by	by	ADP
iajs-108	56	15	the	the	DET
iajs-108	56	16	manufacture	manufacture	NOUN
iajs-108	56	17	.	.	PUNCT
iajs-108	57	1	the	the	DET
iajs-108	57	2	drg	drg	PROPN
iajs-108	57	3	insulin	insulin	NOUN
iajs-108	57	4	elisa	elisa	NOUN
iajs-108	57	5	kit	kit	NOUN
iajs-108	57	6	is	be	AUX
iajs-108	57	7	a	a	DET
iajs-108	57	8	solid	solid	ADJ
iajs-108	57	9	phase	phase	NOUN
iajs-108	57	10	enzymelinked	enzymelinke	VERB
iajs-108	57	11	immunosorbent	immunosorbent	NOUN
iajs-108	57	12	assay	assay	PROPN
iajs-108	57	13	(	(	PUNCT
iajs-108	57	14	elisa	elisa	NOUN
iajs-108	57	15	)	)	PUNCT
iajs-108	57	16	based	base	VERB
iajs-108	57	17	on	on	ADP
iajs-108	57	18	the	the	DET
iajs-108	57	19	sandwich	sandwich	NOUN
iajs-108	57	20	principle	principle	NOUN
iajs-108	57	21	.	.	PUNCT
iajs-108	58	1	homa2	homa2	NOUN
iajs-108	58	2	parameters	parameter	NOUN
iajs-108	58	3	:	:	PUNCT
iajs-108	58	4	homa2	homa2	PROPN
iajs-108	58	5	-	-	PUNCT
iajs-108	58	6	ir	ir	PROPN
iajs-108	58	7	,	,	PUNCT
iajs-108	58	8	β	β	NOUN
iajs-108	58	9	-	-	NOUN
iajs-108	58	10	cell	cell	NOUN
iajs-108	58	11	percentage	percentage	NOUN
iajs-108	58	12	(	(	PUNCT
iajs-108	58	13	homa2β	homa2β	ADJ
iajs-108	58	14	%	%	NOUN
iajs-108	58	15	)	)	PUNCT
iajs-108	58	16	and	and	CCONJ
iajs-108	58	17	sensitivity	sensitivity	NOUN
iajs-108	58	18	percentage	percentage	NOUN
iajs-108	58	19	(	(	PUNCT
iajs-108	58	20	homa2	homa2	NOUN
iajs-108	58	21	-	-	PUNCT
iajs-108	58	22	s	s	PRON
iajs-108	58	23	%	%	NOUN
iajs-108	58	24	)	)	PUNCT
iajs-108	58	25	were	be	AUX
iajs-108	58	26	calculated	calculate	VERB
iajs-108	58	27	using	use	VERB
iajs-108	58	28	an	an	DET
iajs-108	58	29	homa2	homa2	NOUN
iajs-108	58	30	calculator	calculator	NOUN
iajs-108	58	31	[	[	X
iajs-108	58	32	21	21	NUM
iajs-108	58	33	]	]	PUNCT
iajs-108	58	34	.	.	PUNCT
iajs-108	59	1	determination	determination	NOUN
iajs-108	59	2	of	of	ADP
iajs-108	59	3	serum	serum	NOUN
iajs-108	59	4	ferritin	ferritin	ADJ
iajs-108	59	5	and	and	CCONJ
iajs-108	59	6	transforming	transform	VERB
iajs-108	59	7	growth	growth	NOUN
iajs-108	59	8	factor	factor	NOUN
iajs-108	59	9	beta-1(tgf	beta-1(tgf	PROPN
iajs-108	59	10	-	-	PUNCT
iajs-108	59	11	β1	β1	PROPN
iajs-108	59	12	)	)	PUNCT
iajs-108	59	13	levels	level	NOUN
iajs-108	59	14	serum	serum	VERB
iajs-108	59	15	ferritin	ferritin	ADJ
iajs-108	59	16	level	level	NOUN
iajs-108	59	17	was	be	AUX
iajs-108	59	18	quantitatively	quantitatively	ADV
iajs-108	59	19	determine	determine	VERB
iajs-108	59	20	in	in	ADP
iajs-108	59	21	patients	patient	NOUN
iajs-108	59	22	and	and	CCONJ
iajs-108	59	23	control	control	NOUN
iajs-108	59	24	groups	group	NOUN
iajs-108	59	25	using	use	VERB
iajs-108	59	26	the	the	DET
iajs-108	59	27	indirect	indirect	ADJ
iajs-108	59	28	enzyme	enzyme	NOUN
iajs-108	59	29	immune	immune	ADJ
iajs-108	59	30	assay	assay	NOUN
iajs-108	59	31	(	(	PUNCT
iajs-108	59	32	elisa	elisa	NOUN
iajs-108	59	33	)	)	PUNCT
iajs-108	59	34	method	method	NOUN
iajs-108	59	35	,	,	PUNCT
iajs-108	59	36	and	and	CCONJ
iajs-108	59	37	serum	serum	PROPN
iajs-108	59	38	tgf	tgf	PROPN
iajs-108	59	39	-	-	PUNCT
iajs-108	59	40	β1	β1	PROPN
iajs-108	59	41	level	level	NOUN
iajs-108	59	42	was	be	AUX
iajs-108	59	43	quantitatively	quantitatively	ADV
iajs-108	59	44	determined	determined	ADJ
iajs-108	59	45	using	use	VERB
iajs-108	59	46	sandwich	sandwich	NOUN
iajs-108	59	47	elisa	elisa	NOUN
iajs-108	59	48	method	method	NOUN
iajs-108	59	49	,	,	PUNCT
iajs-108	59	50	using	use	VERB
iajs-108	59	51	(	(	PUNCT
iajs-108	59	52	demeditec	demeditec	PROPN
iajs-108	59	53	germany	germany	PROPN
iajs-108	59	54	)	)	PUNCT
iajs-108	59	55	kits	kit	NOUN
iajs-108	60	1	[	[	X
iajs-108	60	2	22	22	NUM
iajs-108	60	3	,	,	PUNCT
iajs-108	60	4	23	23	NUM
iajs-108	60	5	]	]	PUNCT
iajs-108	60	6	.	.	PUNCT
iajs-108	61	1	statistical	statistical	ADJ
iajs-108	61	2	analysis	analysis	NOUN
iajs-108	61	3	statistical	statistical	ADJ
iajs-108	61	4	package	package	NOUN
iajs-108	61	5	for	for	ADP
iajs-108	61	6	the	the	DET
iajs-108	61	7	social	social	ADJ
iajs-108	61	8	sciences	science	NOUN
iajs-108	61	9	,	,	PUNCT
iajs-108	61	10	(	(	PUNCT
iajs-108	61	11	spss	spss	ADJ
iajs-108	61	12	)	)	PUNCT
iajs-108	61	13	version	version	NOUN
iajs-108	61	14	20.0	20.0	NUM
iajs-108	61	15	for	for	ADP
iajs-108	61	16	windows	window	NOUN
iajs-108	61	17	software	software	NOUN
iajs-108	61	18	(	(	PUNCT
iajs-108	61	19	spss	spss	PROPN
iajs-108	61	20	inc	inc	PROPN
iajs-108	61	21	.	.	PROPN
iajs-108	61	22	,	,	PUNCT
iajs-108	61	23	chicago	chicago	PROPN
iajs-108	61	24	,	,	PUNCT
iajs-108	61	25	iii	iii	PROPN
iajs-108	61	26	,	,	PUNCT
iajs-108	61	27	usa	usa	PROPN
iajs-108	61	28	)	)	PUNCT
iajs-108	61	29	was	be	AUX
iajs-108	61	30	useing	use	VERB
iajs-108	61	31	for	for	ADP
iajs-108	61	32	statistical	statistical	ADJ
iajs-108	61	33	analysis	analysis	NOUN
iajs-108	61	34	.	.	PUNCT
iajs-108	62	1	the	the	DET
iajs-108	62	2	data	datum	NOUN
iajs-108	62	3	were	be	AUX
iajs-108	62	4	normally	normally	ADV
iajs-108	62	5	distribute	distribute	ADJ
iajs-108	62	6	and	and	CCONJ
iajs-108	62	7	were	be	AUX
iajs-108	62	8	expresse	expresse	ADJ
iajs-108	62	9	as	as	ADP
iajs-108	62	10	mean	mean	NOUN
iajs-108	62	11	±	±	NUM
iajs-108	62	12	standard	standard	ADJ
iajs-108	62	13	deviation	deviation	NOUN
iajs-108	62	14	(	(	PUNCT
iajs-108	62	15	sd	sd	NOUN
iajs-108	62	16	)	)	PUNCT
iajs-108	62	17	.	.	PUNCT
iajs-108	63	1	one	one	NUM
iajs-108	63	2	-	-	PUNCT
iajs-108	63	3	way	way	NOUN
iajs-108	63	4	analysis	analysis	NOUN
iajs-108	63	5	of	of	ADP
iajs-108	63	6	variance	variance	NOUN
iajs-108	63	7	(	(	PUNCT
iajs-108	63	8	anova	anova	PROPN
iajs-108	63	9	)	)	PUNCT
iajs-108	63	10	was	be	AUX
iajs-108	63	11	used	use	VERB
iajs-108	63	12	to	to	PART
iajs-108	63	13	compare	compare	VERB
iajs-108	63	14	the	the	DET
iajs-108	63	15	parameters	parameter	NOUN
iajs-108	63	16	among	among	ADP
iajs-108	63	17	groups	group	NOUN
iajs-108	63	18	(	(	PUNCT
iajs-108	63	19	control	control	NOUN
iajs-108	63	20	,	,	PUNCT
iajs-108	63	21	lean	lean	ADJ
iajs-108	63	22	,	,	PUNCT
iajs-108	63	23	overweight	overweight	ADJ
iajs-108	63	24	and	and	CCONJ
iajs-108	63	25	obese	obese	ADJ
iajs-108	63	26	)	)	PUNCT
iajs-108	63	27	followed	follow	VERB
iajs-108	63	28	by	by	ADP
iajs-108	63	29	post	post	X
iajs-108	63	30	hoc	hoc	X
iajs-108	63	31	test	test	NOUN
iajs-108	63	32	.	.	PUNCT
iajs-108	64	1	differences	difference	NOUN
iajs-108	64	2	among	among	ADP
iajs-108	64	3	groups	group	NOUN
iajs-108	64	4	were	be	AUX
iajs-108	64	5	defined	define	VERB
iajs-108	64	6	to	to	PART
iajs-108	64	7	be	be	AUX
iajs-108	64	8	statistically	statistically	ADV
iajs-108	64	9	significant	significant	ADJ
iajs-108	64	10	if	if	SCONJ
iajs-108	64	11	the	the	DET
iajs-108	64	12	corresponding	correspond	VERB
iajs-108	64	13	pvalue	pvalue	NOUN
iajs-108	64	14	was	be	AUX
iajs-108	64	15	equal	equal	ADJ
iajs-108	64	16	and	and	CCONJ
iajs-108	64	17	less	less	ADJ
iajs-108	64	18	than	than	ADP
iajs-108	64	19	0.05	0.05	NUM
iajs-108	64	20	.	.	PUNCT
iajs-108	65	1	correlation	correlation	NOUN
iajs-108	65	2	between	between	ADP
iajs-108	65	3	variables	variable	NOUN
iajs-108	65	4	was	be	AUX
iajs-108	65	5	determine	determine	NOUN
iajs-108	65	6	by	by	ADP
iajs-108	65	7	pearson	pearson	NOUN
iajs-108	65	8	correlation	correlation	NOUN
iajs-108	65	9	coefficients	coefficient	NOUN
iajs-108	65	10	(	(	PUNCT
iajs-108	65	11	rvalues	rvalue	NOUN
iajs-108	65	12	)	)	PUNCT
iajs-108	65	13	.	.	PUNCT
iajs-108	66	1	results	result	VERB
iajs-108	66	2	a	a	DET
iajs-108	66	3	significant	significant	ADJ
iajs-108	66	4	increase	increase	NOUN
iajs-108	66	5	in	in	ADP
iajs-108	66	6	mean	mean	ADJ
iajs-108	66	7	level	level	NOUN
iajs-108	66	8	of	of	ADP
iajs-108	66	9	bmi	bmi	NOUN
iajs-108	66	10	was	be	AUX
iajs-108	66	11	observed	observe	VERB
iajs-108	66	12	in	in	ADP
iajs-108	66	13	overweight	overweight	ADJ
iajs-108	66	14	and	and	CCONJ
iajs-108	66	15	obese	obese	ADJ
iajs-108	66	16	groups	group	NOUN
iajs-108	66	17	in	in	ADP
iajs-108	66	18	comparison	comparison	NOUN
iajs-108	66	19	with	with	ADP
iajs-108	66	20	that	that	PRON
iajs-108	66	21	of	of	ADP
iajs-108	66	22	control	control	NOUN
iajs-108	66	23	group	group	NOUN
iajs-108	66	24	(	(	PUNCT
iajs-108	66	25	26.84	26.84	NUM
iajs-108	66	26	and	and	CCONJ
iajs-108	66	27	35.04	35.04	NUM
iajs-108	66	28	vs.	vs.	ADP
iajs-108	66	29	22.7	22.7	NUM
iajs-108	66	30	kg	kg	NOUN
iajs-108	66	31	/	/	SYM
iajs-108	66	32	cm2	cm2	NOUN
iajs-108	66	33	)	)	PUNCT
iajs-108	66	34	respectively	respectively	ADV
iajs-108	66	35	,	,	PUNCT
iajs-108	66	36	and	and	CCONJ
iajs-108	66	37	no	no	DET
iajs-108	66	38	significant	significant	ADJ
iajs-108	66	39	difference	difference	NOUN
iajs-108	66	40	is	be	AUX
iajs-108	66	41	found	find	VERB
iajs-108	66	42	between	between	ADP
iajs-108	66	43	lean	lean	ADJ
iajs-108	66	44	group	group	NOUN
iajs-108	66	45	and	and	CCONJ
iajs-108	66	46	control	control	NOUN
iajs-108	66	47	group	group	NOUN
iajs-108	66	48	(	(	PUNCT
iajs-108	66	49	table	table	NOUN
iajs-108	66	50	1	1	NUM
iajs-108	66	51	)	)	PUNCT
iajs-108	66	52	a	a	DET
iajs-108	66	53	significant	significant	ADJ
iajs-108	66	54	increase	increase	NOUN
iajs-108	66	55	in	in	ADP
iajs-108	66	56	the	the	DET
iajs-108	66	57	mean	mean	ADJ
iajs-108	66	58	level	level	NOUN
iajs-108	66	59	of	of	ADP
iajs-108	66	60	fsg	fsg	PROPN
iajs-108	66	61	was	be	AUX
iajs-108	66	62	observe	observe	VERB
iajs-108	66	63	in	in	ADP
iajs-108	66	64	lean	lean	ADJ
iajs-108	66	65	,	,	PUNCT
iajs-108	66	66	overweight	overweight	ADJ
iajs-108	66	67	and	and	CCONJ
iajs-108	66	68	obese	obese	ADJ
iajs-108	66	69	groups	group	NOUN
iajs-108	66	70	in	in	ADP
iajs-108	66	71	comparison	comparison	NOUN
iajs-108	66	72	with	with	ADP
iajs-108	66	73	that	that	PRON
iajs-108	66	74	of	of	ADP
iajs-108	66	75	the	the	DET
iajs-108	66	76	control	control	NOUN
iajs-108	66	77	group	group	NOUN
iajs-108	66	78	(	(	PUNCT
iajs-108	66	79	93.96	93.96	NUM
iajs-108	66	80	,	,	PUNCT
iajs-108	66	81	98.3and	98.3and	NUM
iajs-108	66	82	99.96	99.96	NUM
iajs-108	66	83	vs.	vs.	ADP
iajs-108	66	84	82.32mg	82.32mg	PROPN
iajs-108	66	85	/	/	SYM
iajs-108	66	86	dl	dl	NOUN
iajs-108	66	87	)	)	PUNCT
iajs-108	66	88	.	.	PUNCT
iajs-108	67	1	and	and	CCONJ
iajs-108	67	2	no	no	DET
iajs-108	67	3	significant	significant	ADJ
iajs-108	67	4	difference	difference	NOUN
iajs-108	67	5	was	be	AUX
iajs-108	67	6	found	find	VERB
iajs-108	67	7	between	between	ADP
iajs-108	67	8	patients	patient	NOUN
iajs-108	67	9	groups	group	NOUN
iajs-108	67	10	(	(	PUNCT
iajs-108	67	11	table	table	NOUN
iajs-108	67	12	1	1	NUM
iajs-108	67	13	)	)	PUNCT
iajs-108	67	14	.	.	PUNCT
iajs-108	68	1	a	a	DET
iajs-108	68	2	significant	significant	ADJ
iajs-108	68	3	increase	increase	NOUN
iajs-108	68	4	in	in	ADP
iajs-108	68	5	the	the	DET
iajs-108	68	6	mean	mean	ADJ
iajs-108	68	7	level	level	NOUN
iajs-108	68	8	of	of	ADP
iajs-108	68	9	insulin	insulin	NOUN
iajs-108	68	10	was	be	AUX
iajs-108	68	11	observe	observe	VERB
iajs-108	68	12	in	in	ADP
iajs-108	68	13	groups	group	NOUN
iajs-108	68	14	(	(	PUNCT
iajs-108	68	15	lean	lean	ADJ
iajs-108	68	16	,	,	PUNCT
iajs-108	68	17	overweight	overweight	ADJ
iajs-108	68	18	and	and	CCONJ
iajs-108	68	19	obese	obese	ADJ
iajs-108	68	20	)	)	PUNCT
iajs-108	68	21	in	in	ADP
iajs-108	68	22	comparison	comparison	NOUN
iajs-108	68	23	with	with	ADP
iajs-108	68	24	that	that	PRON
iajs-108	68	25	of	of	ADP
iajs-108	68	26	the	the	DET
iajs-108	68	27	control	control	NOUN
iajs-108	68	28	group	group	NOUN
iajs-108	68	29	(	(	PUNCT
iajs-108	68	30	14.65	14.65	NUM
iajs-108	68	31	,	,	PUNCT
iajs-108	68	32	21.25	21.25	NUM
iajs-108	68	33	and	and	CCONJ
iajs-108	68	34	21.6	21.6	NUM
iajs-108	68	35	vs.	vs.	ADP
iajs-108	68	36	09.99	09.99	NUM
iajs-108	68	37	µlu	µlu	VERB
iajs-108	68	38	/	/	SYM
iajs-108	68	39	ml	ml	NOUN
iajs-108	68	40	)	)	PUNCT
iajs-108	68	41	.	.	PUNCT
iajs-108	69	1	insulin	insulin	NOUN
iajs-108	69	2	showed	show	VERB
iajs-108	69	3	a	a	DET
iajs-108	69	4	decrease	decrease	NOUN
iajs-108	69	5	in	in	ADP
iajs-108	69	6	the	the	DET
iajs-108	69	7	mean	mean	NOUN
iajs-108	69	8	of	of	ADP
iajs-108	69	9	the	the	DET
iajs-108	69	10	lean	lean	ADJ
iajs-108	69	11	group	group	NOUN
iajs-108	69	12	in	in	ADP
iajs-108	69	13	comparison	comparison	NOUN
iajs-108	69	14	with	with	ADP
iajs-108	69	15	an	an	DET
iajs-108	69	16	obese	obese	ADJ
iajs-108	69	17	group	group	NOUN
iajs-108	69	18	(	(	PUNCT
iajs-108	69	19	14.65	14.65	NUM
iajs-108	69	20	vs.	vs.	ADP
iajs-108	69	21	21.6µlu	21.6µlu	PROPN
iajs-108	69	22	/	/	SYM
iajs-108	69	23	ml	ml	NOUN
iajs-108	69	24	)	)	PUNCT
iajs-108	69	25	and	and	CCONJ
iajs-108	69	26	the	the	DET
iajs-108	69	27	difference	difference	NOUN
iajs-108	69	28	was	be	AUX
iajs-108	69	29	significant	significant	ADJ
iajs-108	69	30	(	(	PUNCT
iajs-108	69	31	p<0.05	p<0.05	NOUN
iajs-108	69	32	)	)	PUNCT
iajs-108	69	33	.	.	PUNCT
iajs-108	70	1	also	also	ADV
iajs-108	70	2	,	,	PUNCT
iajs-108	70	3	between	between	ADP
iajs-108	70	4	lean	lean	ADJ
iajs-108	70	5	and	and	CCONJ
iajs-108	70	6	overweight	overweight	ADJ
iajs-108	70	7	groups	group	NOUN
iajs-108	70	8	(	(	PUNCT
iajs-108	70	9	14.65	14.65	NUM
iajs-108	70	10	vs.	vs.	ADP
iajs-108	70	11	21.25	21.25	NUM
iajs-108	70	12	µlu	µlu	VERB
iajs-108	70	13	/	/	SYM
iajs-108	70	14	ml	ml	NOUN
iajs-108	70	15	)	)	PUNCT
iajs-108	70	16	and	and	CCONJ
iajs-108	70	17	the	the	DET
iajs-108	70	18	difference	difference	NOUN
iajs-108	70	19	was	be	AUX
iajs-108	70	20	significant	significant	ADJ
iajs-108	70	21	,	,	PUNCT
iajs-108	70	22	(	(	PUNCT
iajs-108	70	23	table	table	NOUN
iajs-108	70	24	1	1	NUM
iajs-108	70	25	)	)	PUNCT
iajs-108	70	26	.	.	PUNCT
iajs-108	71	1	a	a	DET
iajs-108	71	2	significant	significant	ADJ
iajs-108	71	3	increase	increase	NOUN
iajs-108	71	4	in	in	ADP
iajs-108	71	5	mean	mean	ADJ
iajs-108	71	6	level	level	NOUN
iajs-108	71	7	of	of	ADP
iajs-108	71	8	homa2	homa2	NOUN
iajs-108	71	9	-	-	PUNCT
iajs-108	71	10	b	b	PROPN
iajs-108	71	11	(	(	PUNCT
iajs-108	71	12	%	%	INTJ
iajs-108	71	13	)	)	PUNCT
iajs-108	71	14	was	be	AUX
iajs-108	71	15	observe	observe	VERB
iajs-108	71	16	in	in	ADP
iajs-108	71	17	overweight	overweight	ADJ
iajs-108	71	18	and	and	CCONJ
iajs-108	71	19	obese	obese	ADJ
iajs-108	71	20	groups	group	NOUN
iajs-108	71	21	in	in	ADP
iajs-108	71	22	comparison	comparison	NOUN
iajs-108	71	23	with	with	ADP
iajs-108	71	24	that	that	PRON
iajs-108	71	25	of	of	ADP
iajs-108	71	26	control	control	NOUN
iajs-108	71	27	group	group	NOUN
iajs-108	71	28	(	(	PUNCT
iajs-108	71	29	165.29	165.29	NUM
iajs-108	71	30	and	and	CCONJ
iajs-108	71	31	157.71	157.71	NUM
iajs-108	71	32	vs.	vs.	ADP
iajs-108	71	33	136.4	136.4	NUM
iajs-108	71	34	)	)	PUNCT
iajs-108	71	35	.	.	PUNCT
iajs-108	72	1	also	also	ADV
iajs-108	72	2	,	,	PUNCT
iajs-108	72	3	a	a	DET
iajs-108	72	4	significant	significant	ADJ
iajs-108	72	5	increase	increase	NOUN
iajs-108	72	6	was	be	AUX
iajs-108	72	7	observed	observe	VERB
iajs-108	72	8	in	in	ADP
iajs-108	72	9	overweight	overweight	ADJ
iajs-108	72	10	and	and	CCONJ
iajs-108	72	11	obese	obese	ADJ
iajs-108	72	12	groups	group	NOUN
iajs-108	72	13	in	in	ADP
iajs-108	72	14	comparison	comparison	NOUN
iajs-108	72	15	with	with	ADP
iajs-108	72	16	lean	lean	ADJ
iajs-108	72	17	group	group	NOUN
iajs-108	72	18	(	(	PUNCT
iajs-108	72	19	165.29	165.29	NUM
iajs-108	72	20	and	and	CCONJ
iajs-108	72	21	chemistry	chemistry	NOUN
iajs-108	72	22	|	|	ADV
iajs-108	72	23	174	174	NUM
iajs-108	72	24	2016	2016	NUM
iajs-108	72	25	)	)	PUNCT
iajs-108	72	26	عام	عام	ADP
iajs-108	72	27	2العدد	2العدد	NUM
iajs-108	72	28	(	(	PUNCT
iajs-108	72	29	29مجلة	29مجلة	NUM
iajs-108	72	30	إبن	إبن	VERB
iajs-108	72	31	الهيثم	الهيثم	ADJ
iajs-108	72	32	للعلوم	للعلوم	NOUN
iajs-108	72	33	الصرفة	الصرفة	NOUN
iajs-108	73	1	و	و	PRON
iajs-108	73	2	التطبيقية	التطبيقية	ADV
iajs-108	73	3	المجلد	المجلد	VERB
iajs-108	73	4	ibn	ibn	PROPN
iajs-108	73	5	al	al	PROPN
iajs-108	73	6	-	-	PUNCT
iajs-108	73	7	haitham	haitham	PROPN
iajs-108	73	8	jour	jour	X
iajs-108	73	9	.	.	PROPN
iajs-108	74	1	for	for	ADP
iajs-108	74	2	pure	pure	ADJ
iajs-108	74	3	&	&	CCONJ
iajs-108	74	4	appl	appl	PROPN
iajs-108	74	5	.	.	PUNCT
iajs-108	75	1	sci	sci	PROPN
iajs-108	75	2	.	.	PUNCT
iajs-108	75	3	vol	vol	NOUN
iajs-108	75	4	.	.	PROPN
iajs-108	75	5	29	29	NUM
iajs-108	75	6	(	(	PUNCT
iajs-108	75	7	2	2	NUM
iajs-108	75	8	)	)	PUNCT
iajs-108	75	9	2016	2016	NUM
iajs-108	75	10	157.71	157.71	NUM
iajs-108	75	11	vs.	vs.	ADP
iajs-108	75	12	134.7	134.7	NUM
iajs-108	75	13	)	)	PUNCT
iajs-108	75	14	.	.	PUNCT
iajs-108	76	1	however	however	ADV
iajs-108	76	2	,	,	PUNCT
iajs-108	76	3	no	no	DET
iajs-108	76	4	significant	significant	ADJ
iajs-108	76	5	difference	difference	NOUN
iajs-108	76	6	was	be	AUX
iajs-108	76	7	found	find	VERB
iajs-108	76	8	in	in	ADP
iajs-108	76	9	homa2	homa2	PROPN
iajs-108	77	1	b	b	ADP
iajs-108	78	1	cell	cell	NOUN
iajs-108	78	2	(	(	PUNCT
iajs-108	78	3	%	%	INTJ
iajs-108	78	4	)	)	PUNCT
iajs-108	78	5	between	between	ADP
iajs-108	78	6	control	control	NOUN
iajs-108	78	7	and	and	CCONJ
iajs-108	78	8	lean	lean	ADJ
iajs-108	78	9	groups	group	NOUN
iajs-108	78	10	,	,	PUNCT
iajs-108	78	11	(	(	PUNCT
iajs-108	78	12	table	table	NOUN
iajs-108	78	13	1	1	NUM
iajs-108	78	14	)	)	PUNCT
iajs-108	78	15	.	.	PUNCT
iajs-108	79	1	a	a	DET
iajs-108	79	2	significant	significant	ADJ
iajs-108	79	3	decrease	decrease	NOUN
iajs-108	79	4	in	in	ADP
iajs-108	79	5	mean	mean	ADJ
iajs-108	79	6	levels	level	NOUN
iajs-108	79	7	of	of	ADP
iajs-108	79	8	homa2	homa2	NOUN
iajs-108	79	9	-	-	PUNCT
iajs-108	79	10	s	s	X
iajs-108	79	11	(	(	PUNCT
iajs-108	79	12	%	%	INTJ
iajs-108	79	13	)	)	PUNCT
iajs-108	79	14	was	be	AUX
iajs-108	79	15	observe	observe	VERB
iajs-108	79	16	in	in	ADP
iajs-108	79	17	lean	lean	ADJ
iajs-108	79	18	,	,	PUNCT
iajs-108	79	19	overweight	overweight	ADJ
iajs-108	79	20	and	and	CCONJ
iajs-108	79	21	obese	obese	ADJ
iajs-108	79	22	groups	group	NOUN
iajs-108	79	23	in	in	ADP
iajs-108	79	24	comparison	comparison	NOUN
iajs-108	79	25	with	with	ADP
iajs-108	79	26	that	that	PRON
iajs-108	79	27	of	of	ADP
iajs-108	79	28	the	the	DET
iajs-108	79	29	control	control	NOUN
iajs-108	79	30	group	group	NOUN
iajs-108	79	31	(	(	PUNCT
iajs-108	79	32	59.95	59.95	NUM
iajs-108	79	33	,	,	PUNCT
iajs-108	79	34	40.98	40.98	NUM
iajs-108	79	35	and	and	CCONJ
iajs-108	79	36	38.1	38.1	NUM
iajs-108	79	37	vs.	vs.	ADP
iajs-108	79	38	82.26	82.26	NUM
iajs-108	79	39	)	)	PUNCT
iajs-108	79	40	.	.	PUNCT
iajs-108	80	1	homa2	homa2	NOUN
iajs-108	80	2	-	-	PUNCT
iajs-108	80	3	s	s	X
iajs-108	80	4	(	(	PUNCT
iajs-108	80	5	%	%	NOUN
iajs-108	80	6	)	)	PUNCT
iajs-108	80	7	also	also	ADV
iajs-108	80	8	showed	show	VERB
iajs-108	80	9	a	a	DET
iajs-108	80	10	significant	significant	ADJ
iajs-108	80	11	decrease	decrease	NOUN
iajs-108	80	12	in	in	ADP
iajs-108	80	13	mean	mean	ADJ
iajs-108	80	14	levels	level	NOUN
iajs-108	80	15	of	of	ADP
iajs-108	80	16	the	the	DET
iajs-108	80	17	obese	obese	ADJ
iajs-108	80	18	group	group	NOUN
iajs-108	80	19	in	in	ADP
iajs-108	80	20	comparison	comparison	NOUN
iajs-108	80	21	with	with	ADP
iajs-108	80	22	that	that	PRON
iajs-108	80	23	of	of	ADP
iajs-108	80	24	the	the	DET
iajs-108	80	25	lean	lean	ADJ
iajs-108	80	26	group	group	NOUN
iajs-108	80	27	(	(	PUNCT
iajs-108	80	28	38.1	38.1	NUM
iajs-108	80	29	vs.	vs.	ADP
iajs-108	80	30	59.95	59.95	NUM
iajs-108	80	31	)	)	PUNCT
iajs-108	80	32	and	and	CCONJ
iajs-108	80	33	between	between	ADP
iajs-108	80	34	overweight	overweight	ADJ
iajs-108	80	35	and	and	CCONJ
iajs-108	80	36	lean	lean	ADJ
iajs-108	80	37	groups	group	NOUN
iajs-108	80	38	(	(	PUNCT
iajs-108	80	39	40.98	40.98	NUM
iajs-108	80	40	vs.	vs.	ADP
iajs-108	80	41	59.95	59.95	NUM
iajs-108	80	42	)	)	PUNCT
iajs-108	80	43	.	.	PUNCT
iajs-108	81	1	a	a	DET
iajs-108	81	2	significant	significant	ADJ
iajs-108	81	3	increase	increase	NOUN
iajs-108	81	4	in	in	ADP
iajs-108	81	5	mean	mean	ADJ
iajs-108	81	6	levels	level	NOUN
iajs-108	81	7	of	of	ADP
iajs-108	81	8	homa2	homa2	NOUN
iajs-108	81	9	-	-	PUNCT
iajs-108	81	10	ir	ir	PROPN
iajs-108	81	11	was	be	AUX
iajs-108	81	12	observe	observe	VERB
iajs-108	81	13	in	in	ADP
iajs-108	81	14	lean	lean	ADJ
iajs-108	81	15	,	,	PUNCT
iajs-108	81	16	overweight	overweight	ADJ
iajs-108	81	17	and	and	CCONJ
iajs-108	81	18	obese	obese	ADJ
iajs-108	81	19	groups	group	NOUN
iajs-108	81	20	in	in	ADP
iajs-108	81	21	comparison	comparison	NOUN
iajs-108	81	22	with	with	ADP
iajs-108	81	23	that	that	PRON
iajs-108	81	24	of	of	ADP
iajs-108	81	25	the	the	DET
iajs-108	81	26	control	control	NOUN
iajs-108	81	27	group	group	NOUN
iajs-108	81	28	(	(	PUNCT
iajs-108	81	29	1.9	1.9	NUM
iajs-108	81	30	,	,	PUNCT
iajs-108	81	31	2.73	2.73	NUM
iajs-108	81	32	and	and	CCONJ
iajs-108	81	33	2.8	2.8	NUM
iajs-108	81	34	vs.	vs.	ADP
iajs-108	81	35	1.27	1.27	NUM
iajs-108	81	36	)	)	PUNCT
iajs-108	81	37	.	.	PUNCT
iajs-108	82	1	also	also	ADV
iajs-108	82	2	,	,	PUNCT
iajs-108	82	3	significant	significant	ADJ
iajs-108	82	4	increase	increase	NOUN
iajs-108	82	5	in	in	ADP
iajs-108	82	6	the	the	DET
iajs-108	82	7	mean	mean	ADJ
iajs-108	82	8	level	level	NOUN
iajs-108	82	9	of	of	ADP
iajs-108	82	10	homa2	homa2	NOUN
iajs-108	82	11	-	-	PUNCT
iajs-108	82	12	ir	ir	PROPN
iajs-108	82	13	was	be	AUX
iajs-108	82	14	observed	observe	VERB
iajs-108	82	15	in	in	ADP
iajs-108	82	16	overweight	overweight	ADJ
iajs-108	82	17	and	and	CCONJ
iajs-108	82	18	obese	obese	ADJ
iajs-108	82	19	groups	group	NOUN
iajs-108	82	20	in	in	ADP
iajs-108	82	21	comparison	comparison	NOUN
iajs-108	82	22	with	with	ADP
iajs-108	82	23	that	that	PRON
iajs-108	82	24	of	of	ADP
iajs-108	82	25	the	the	DET
iajs-108	82	26	lean	lean	ADJ
iajs-108	82	27	group	group	NOUN
iajs-108	82	28	(	(	PUNCT
iajs-108	82	29	2.73	2.73	NUM
iajs-108	82	30	and	and	CCONJ
iajs-108	82	31	2.8	2.8	NUM
iajs-108	82	32	vs.1.9	vs.1.9	NOUN
iajs-108	82	33	)	)	PUNCT
iajs-108	82	34	as	as	SCONJ
iajs-108	82	35	shown	show	VERB
iajs-108	82	36	in	in	ADP
iajs-108	82	37	the	the	DET
iajs-108	82	38	table	table	NOUN
iajs-108	82	39	(	(	PUNCT
iajs-108	82	40	2	2	NUM
iajs-108	82	41	)	)	PUNCT
iajs-108	82	42	.	.	PUNCT
iajs-108	83	1	the	the	DET
iajs-108	83	2	mean	mean	ADJ
iajs-108	83	3	level	level	NOUN
iajs-108	83	4	of	of	ADP
iajs-108	83	5	ferritin	ferritin	NOUN
iajs-108	83	6	showed	show	VERB
iajs-108	83	7	a	a	DET
iajs-108	83	8	significant	significant	ADJ
iajs-108	83	9	increase	increase	NOUN
iajs-108	83	10	in	in	ADP
iajs-108	83	11	lean	lean	ADJ
iajs-108	83	12	,	,	PUNCT
iajs-108	83	13	overweight	overweight	ADJ
iajs-108	83	14	and	and	CCONJ
iajs-108	83	15	obese	obese	ADJ
iajs-108	83	16	groups	group	NOUN
iajs-108	83	17	in	in	ADP
iajs-108	83	18	comparison	comparison	NOUN
iajs-108	83	19	with	with	ADP
iajs-108	83	20	that	that	PRON
iajs-108	83	21	of	of	ADP
iajs-108	83	22	the	the	DET
iajs-108	83	23	control	control	NOUN
iajs-108	83	24	group	group	NOUN
iajs-108	83	25	(	(	PUNCT
iajs-108	83	26	57.87	57.87	NUM
iajs-108	83	27	,	,	PUNCT
iajs-108	83	28	60.7	60.7	NUM
iajs-108	83	29	and	and	CCONJ
iajs-108	83	30	67.3	67.3	NUM
iajs-108	83	31	vs.	vs.	ADP
iajs-108	83	32	45.14ng	45.14ng	NUM
iajs-108	83	33	/	/	SYM
iajs-108	83	34	ml	ml	NOUN
iajs-108	83	35	)	)	PUNCT
iajs-108	83	36	.	.	PUNCT
iajs-108	84	1	the	the	DET
iajs-108	84	2	mean	mean	ADJ
iajs-108	84	3	level	level	NOUN
iajs-108	84	4	of	of	ADP
iajs-108	84	5	tgf	tgf	PROPN
iajs-108	84	6	-	-	PUNCT
iajs-108	84	7	β1	β1	PROPN
iajs-108	84	8	showed	show	VERB
iajs-108	84	9	a	a	DET
iajs-108	84	10	significant	significant	ADJ
iajs-108	84	11	increase	increase	NOUN
iajs-108	84	12	in	in	ADP
iajs-108	84	13	overweight	overweight	ADJ
iajs-108	84	14	and	and	CCONJ
iajs-108	84	15	obese	obese	ADJ
iajs-108	84	16	groups	group	NOUN
iajs-108	84	17	in	in	ADP
iajs-108	84	18	comparison	comparison	NOUN
iajs-108	84	19	with	with	ADP
iajs-108	84	20	that	that	PRON
iajs-108	84	21	of	of	ADP
iajs-108	84	22	the	the	DET
iajs-108	84	23	control	control	NOUN
iajs-108	84	24	group	group	NOUN
iajs-108	84	25	(	(	PUNCT
iajs-108	84	26	21.12	21.12	NUM
iajs-108	84	27	and	and	CCONJ
iajs-108	84	28	22.1	22.1	NUM
iajs-108	84	29	vs.	vs.	ADP
iajs-108	84	30	16.76	16.76	NUM
iajs-108	84	31	pg	pg	NOUN
iajs-108	84	32	/	/	SYM
iajs-108	84	33	ml	ml	NOUN
iajs-108	84	34	)	)	PUNCT
iajs-108	84	35	,	,	PUNCT
iajs-108	84	36	and	and	CCONJ
iajs-108	84	37	no	no	DET
iajs-108	84	38	significant	significant	ADJ
iajs-108	84	39	difference	difference	NOUN
iajs-108	84	40	was	be	AUX
iajs-108	84	41	observe	observe	VERB
iajs-108	84	42	between	between	ADP
iajs-108	84	43	control	control	NOUN
iajs-108	84	44	and	and	CCONJ
iajs-108	84	45	lean	lean	ADJ
iajs-108	84	46	groups	group	NOUN
iajs-108	84	47	(	(	PUNCT
iajs-108	84	48	table	table	NOUN
iajs-108	84	49	2	2	NUM
iajs-108	84	50	)	)	PUNCT
iajs-108	84	51	.	.	PUNCT
iajs-108	85	1	person	person	NOUN
iajs-108	85	2	correlation	correlation	NOUN
iajs-108	85	3	analysis	analysis	NOUN
iajs-108	85	4	of	of	ADP
iajs-108	85	5	ferritin	ferritin	ADJ
iajs-108	85	6	and	and	CCONJ
iajs-108	85	7	tgf	tgf	PROPN
iajs-108	85	8	-	-	PUNCT
iajs-108	85	9	β1	β1	PROPN
iajs-108	85	10	as	as	SCONJ
iajs-108	85	11	shown	show	VERB
iajs-108	85	12	in	in	ADP
iajs-108	85	13	the	the	DET
iajs-108	85	14	table	table	NOUN
iajs-108	85	15	(	(	PUNCT
iajs-108	85	16	2	2	NUM
iajs-108	85	17	)	)	PUNCT
iajs-108	85	18	,	,	PUNCT
iajs-108	85	19	ferritin	ferritin	ADJ
iajs-108	85	20	level	level	NOUN
iajs-108	85	21	of	of	ADP
iajs-108	85	22	the	the	DET
iajs-108	85	23	lean	lean	ADJ
iajs-108	85	24	group	group	NOUN
iajs-108	85	25	showed	show	VERB
iajs-108	85	26	significant	significant	ADJ
iajs-108	85	27	positive	positive	ADJ
iajs-108	85	28	correlation	correlation	NOUN
iajs-108	85	29	with	with	ADP
iajs-108	85	30	insulin	insulin	NOUN
iajs-108	85	31	,	,	PUNCT
iajs-108	85	32	homa2	homa2	PROPN
iajs-108	85	33	ir	ir	PROPN
iajs-108	85	34	and	and	CCONJ
iajs-108	85	35	significant	significant	ADJ
iajs-108	85	36	negative	negative	ADJ
iajs-108	85	37	correlation	correlation	NOUN
iajs-108	85	38	with	with	ADP
iajs-108	85	39	homa2	homa2	NOUN
iajs-108	85	40	s	s	PART
iajs-108	85	41	%	%	NOUN
iajs-108	85	42	(	(	PUNCT
iajs-108	85	43	figure1	figure1	PROPN
iajs-108	85	44	)	)	PUNCT
iajs-108	85	45	.	.	PUNCT
iajs-108	86	1	a	a	DET
iajs-108	86	2	ferritin	ferritin	ADJ
iajs-108	86	3	level	level	NOUN
iajs-108	86	4	of	of	ADP
iajs-108	86	5	the	the	DET
iajs-108	86	6	overweight	overweight	ADJ
iajs-108	86	7	group	group	NOUN
iajs-108	86	8	showed	show	VERB
iajs-108	86	9	significant	significant	ADJ
iajs-108	86	10	positive	positive	ADJ
iajs-108	86	11	correlation	correlation	NOUN
iajs-108	86	12	with	with	ADP
iajs-108	86	13	insulin	insulin	NOUN
iajs-108	86	14	,	,	PUNCT
iajs-108	86	15	homa2	homa2	PROPN
iajs-108	86	16	ir	ir	PROPN
iajs-108	86	17	,	,	PUNCT
iajs-108	86	18	and	and	CCONJ
iajs-108	86	19	tgf	tgf	PROPN
iajs-108	86	20	-	-	PUNCT
iajs-108	86	21	β1	β1	PROPN
iajs-108	86	22	,	,	PUNCT
iajs-108	86	23	and	and	CCONJ
iajs-108	86	24	significant	significant	ADJ
iajs-108	86	25	negative	negative	ADJ
iajs-108	86	26	correlation	correlation	NOUN
iajs-108	86	27	with	with	ADP
iajs-108	86	28	homa2	homa2	NOUN
iajs-108	86	29	s	s	PART
iajs-108	86	30	(	(	PUNCT
iajs-108	86	31	%	%	INTJ
iajs-108	86	32	,	,	PUNCT
iajs-108	86	33	(	(	PUNCT
iajs-108	86	34	figure	figure	NOUN
iajs-108	86	35	2	2	NUM
iajs-108	86	36	)	)	PUNCT
iajs-108	86	37	.	.	PUNCT
iajs-108	87	1	a	a	DET
iajs-108	87	2	ferritin	ferritin	NOUN
iajs-108	87	3	of	of	ADP
iajs-108	87	4	the	the	DET
iajs-108	87	5	obese	obese	ADJ
iajs-108	87	6	group	group	NOUN
iajs-108	87	7	showed	show	VERB
iajs-108	87	8	significant	significant	ADJ
iajs-108	87	9	positive	positive	ADJ
iajs-108	87	10	correlation	correlation	NOUN
iajs-108	87	11	with	with	ADP
iajs-108	87	12	insulin	insulin	NOUN
iajs-108	87	13	,	,	PUNCT
iajs-108	87	14	homa2	homa2	PROPN
iajs-108	87	15	ir	ir	PROPN
iajs-108	87	16	and	and	CCONJ
iajs-108	87	17	tgf	tgf	PROPN
iajs-108	87	18	-	-	PUNCT
iajs-108	87	19	β1	β1	PROPN
iajs-108	87	20	and	and	CCONJ
iajs-108	87	21	significant	significant	ADJ
iajs-108	87	22	negative	negative	ADJ
iajs-108	87	23	correlation	correlation	NOUN
iajs-108	87	24	with	with	ADP
iajs-108	87	25	homa2	homa2	NOUN
iajs-108	87	26	s	s	PART
iajs-108	87	27	%	%	NOUN
iajs-108	87	28	(	(	PUNCT
iajs-108	87	29	figure	figure	NOUN
iajs-108	87	30	3	3	NUM
iajs-108	87	31	)	)	PUNCT
iajs-108	87	32	.	.	PUNCT
iajs-108	88	1	as	as	SCONJ
iajs-108	88	2	shown	show	VERB
iajs-108	88	3	in	in	ADP
iajs-108	88	4	table	table	NOUN
iajs-108	88	5	(	(	PUNCT
iajs-108	88	6	4	4	NUM
iajs-108	88	7	)	)	PUNCT
iajs-108	88	8	,	,	PUNCT
iajs-108	88	9	tgf	tgf	PROPN
iajs-108	88	10	-	-	PUNCT
iajs-108	88	11	β1	β1	PROPN
iajs-108	88	12	of	of	ADP
iajs-108	88	13	the	the	DET
iajs-108	88	14	lean	lean	ADJ
iajs-108	88	15	group	group	NOUN
iajs-108	88	16	showed	show	VERB
iajs-108	88	17	significant	significant	ADJ
iajs-108	88	18	positive	positive	ADJ
iajs-108	88	19	correlation	correlation	NOUN
iajs-108	88	20	with	with	ADP
iajs-108	88	21	insulin	insulin	NOUN
iajs-108	88	22	and	and	CCONJ
iajs-108	88	23	homa2	homa2	NOUN
iajs-108	88	24	ir	ir	PROPN
iajs-108	88	25	(	(	PUNCT
iajs-108	88	26	figure	figure	VERB
iajs-108	88	27	4	4	NUM
iajs-108	88	28	)	)	PUNCT
iajs-108	88	29	.	.	PUNCT
iajs-108	89	1	tgf	tgf	PROPN
iajs-108	89	2	-	-	PUNCT
iajs-108	89	3	β1	β1	PROPN
iajs-108	89	4	of	of	ADP
iajs-108	89	5	the	the	DET
iajs-108	89	6	overweight	overweight	ADJ
iajs-108	89	7	group	group	NOUN
iajs-108	89	8	showed	show	VERB
iajs-108	89	9	significant	significant	ADJ
iajs-108	89	10	positive	positive	ADJ
iajs-108	89	11	correlation	correlation	NOUN
iajs-108	89	12	with	with	ADP
iajs-108	89	13	insulin	insulin	NOUN
iajs-108	89	14	,	,	PUNCT
iajs-108	89	15	homa2	homa2	PROPN
iajs-108	89	16	ir	ir	PROPN
iajs-108	89	17	,	,	PUNCT
iajs-108	89	18	and	and	CCONJ
iajs-108	89	19	ferritin	ferritin	ADJ
iajs-108	89	20	(	(	PUNCT
iajs-108	89	21	figure	figure	NOUN
iajs-108	89	22	2	2	NUM
iajs-108	89	23	,	,	PUNCT
iajs-108	89	24	d	d	NOUN
iajs-108	89	25	)	)	PUNCT
iajs-108	89	26	and	and	CCONJ
iajs-108	89	27	(	(	PUNCT
iajs-108	89	28	figure	figure	NOUN
iajs-108	89	29	5	5	NUM
iajs-108	89	30	)	)	PUNCT
iajs-108	89	31	.	.	PUNCT
iajs-108	90	1	tgf	tgf	PROPN
iajs-108	90	2	-	-	PUNCT
iajs-108	90	3	β1of	β1of	ADJ
iajs-108	90	4	obese	obese	PROPN
iajs-108	90	5	group	group	NOUN
iajs-108	90	6	showed	show	VERB
iajs-108	90	7	significant	significant	ADJ
iajs-108	90	8	positive	positive	ADJ
iajs-108	90	9	correlation	correlation	NOUN
iajs-108	90	10	with	with	ADP
iajs-108	90	11	(	(	PUNCT
iajs-108	90	12	fsg	fsg	NOUN
iajs-108	90	13	,	,	PUNCT
iajs-108	90	14	insulin	insulin	PROPN
iajs-108	90	15	,	,	PUNCT
iajs-108	90	16	homa2	homa2	PROPN
iajs-108	90	17	ir	ir	NOUN
iajs-108	90	18	,	,	PUNCT
iajs-108	90	19	and	and	CCONJ
iajs-108	90	20	ferritin	ferritin	ADJ
iajs-108	90	21	(	(	PUNCT
iajs-108	90	22	figure	figure	NOUN
iajs-108	90	23	3	3	NUM
iajs-108	90	24	,	,	PUNCT
iajs-108	90	25	d	d	NOUN
iajs-108	90	26	)	)	PUNCT
iajs-108	90	27	,	,	PUNCT
iajs-108	90	28	while	while	SCONJ
iajs-108	90	29	significant	significant	ADJ
iajs-108	90	30	negative	negative	ADJ
iajs-108	90	31	correlation	correlation	NOUN
iajs-108	90	32	with	with	ADP
iajs-108	90	33	homa2	homa2	NOUN
iajs-108	90	34	s	s	PART
iajs-108	90	35	(	(	PUNCT
iajs-108	90	36	%	%	INTJ
iajs-108	90	37	)	)	PUNCT
iajs-108	90	38	was	be	AUX
iajs-108	90	39	found	find	VERB
iajs-108	90	40	,	,	PUNCT
iajs-108	90	41	(	(	PUNCT
iajs-108	90	42	figure	figure	NOUN
iajs-108	90	43	6	6	NUM
iajs-108	90	44	)	)	PUNCT
iajs-108	90	45	.	.	PUNCT
iajs-108	91	1	discussion	discussion	NOUN
iajs-108	91	2	ferritin	ferritin	ADJ
iajs-108	91	3	levels	level	NOUN
iajs-108	91	4	in	in	ADP
iajs-108	91	5	this	this	DET
iajs-108	91	6	study	study	NOUN
iajs-108	91	7	showed	show	VERB
iajs-108	91	8	a	a	DET
iajs-108	91	9	higher	high	ADJ
iajs-108	91	10	significant	significant	ADJ
iajs-108	91	11	increase	increase	NOUN
iajs-108	91	12	of	of	ADP
iajs-108	91	13	overweight	overweight	NOUN
iajs-108	91	14	and	and	CCONJ
iajs-108	91	15	obese	obese	ADJ
iajs-108	91	16	groups	group	NOUN
iajs-108	91	17	.	.	PUNCT
iajs-108	92	1	also	also	ADV
iajs-108	92	2	lean	lean	ADJ
iajs-108	92	3	group	group	NOUN
iajs-108	92	4	showed	show	VERB
iajs-108	92	5	a	a	DET
iajs-108	92	6	significant	significant	ADJ
iajs-108	92	7	increase	increase	NOUN
iajs-108	92	8	in	in	ADP
iajs-108	92	9	comparison	comparison	NOUN
iajs-108	92	10	with	with	ADP
iajs-108	92	11	control	control	NOUN
iajs-108	92	12	group	group	NOUN
iajs-108	92	13	(	(	PUNCT
iajs-108	92	14	table	table	NOUN
iajs-108	92	15	1).these	1).these	NUM
iajs-108	92	16	results	result	NOUN
iajs-108	92	17	in	in	ADP
iajs-108	92	18	agreement	agreement	NOUN
iajs-108	92	19	with	with	ADP
iajs-108	92	20	faranak	faranak	NOUN
iajs-108	92	21	(	(	PUNCT
iajs-108	92	22	et	et	NOUN
iajs-108	92	23	al	al	PROPN
iajs-108	92	24	.	.	PROPN
iajs-108	92	25	,	,	PUNCT
iajs-108	92	26	2011	2011	NUM
iajs-108	92	27	)	)	PUNCT
iajs-108	93	1	[	[	X
iajs-108	93	2	24	24	NUM
iajs-108	93	3	]	]	PUNCT
iajs-108	93	4	who	who	PRON
iajs-108	93	5	found	find	VERB
iajs-108	93	6	that	that	SCONJ
iajs-108	93	7	serum	serum	NOUN
iajs-108	93	8	ferritin	ferritin	ADJ
iajs-108	93	9	levels	level	NOUN
iajs-108	93	10	increased	increase	VERB
iajs-108	93	11	in	in	ADP
iajs-108	93	12	women	woman	NOUN
iajs-108	93	13	with	with	ADP
iajs-108	93	14	pcos	pcos	PROPN
iajs-108	93	15	irrespective	irrespective	ADV
iajs-108	93	16	of	of	ADP
iajs-108	93	17	their	their	PRON
iajs-108	93	18	bmi	bmi	NOUN
iajs-108	93	19	,	,	PUNCT
iajs-108	93	20	crp	crp	PROPN
iajs-108	93	21	,	,	PUNCT
iajs-108	93	22	and	and	CCONJ
iajs-108	93	23	ir	ir	INTJ
iajs-108	93	24	,	,	PUNCT
iajs-108	93	25	they	they	PRON
iajs-108	93	26	due	due	ADJ
iajs-108	93	27	there	there	PRON
iajs-108	93	28	results	result	VERB
iajs-108	93	29	to	to	ADP
iajs-108	93	30	oligomenorrhea	oligomenorrhea	NOUN
iajs-108	93	31	and	and	CCONJ
iajs-108	93	32	less	less	ADJ
iajs-108	93	33	blood	blood	NOUN
iajs-108	93	34	loss	loss	NOUN
iajs-108	93	35	.	.	PUNCT
iajs-108	94	1	in	in	ADP
iajs-108	94	2	another	another	DET
iajs-108	94	3	study	study	NOUN
iajs-108	94	4	,	,	PUNCT
iajs-108	94	5	higher	high	ADJ
iajs-108	94	6	levels	level	NOUN
iajs-108	94	7	of	of	ADP
iajs-108	94	8	ferritin	ferritin	ADJ
iajs-108	94	9	only	only	ADV
iajs-108	94	10	in	in	ADP
iajs-108	94	11	overweight	overweight	ADJ
iajs-108	94	12	and	and	CCONJ
iajs-108	94	13	obese	obese	ADJ
iajs-108	94	14	women	woman	NOUN
iajs-108	94	15	with	with	ADP
iajs-108	94	16	pcos	pcos	PROPN
iajs-108	94	17	and	and	CCONJ
iajs-108	94	18	not	not	PART
iajs-108	94	19	in	in	ADP
iajs-108	94	20	lean	lean	ADJ
iajs-108	94	21	subjects	subject	NOUN
iajs-108	94	22	and	and	CCONJ
iajs-108	94	23	concluded	conclude	VERB
iajs-108	94	24	that	that	SCONJ
iajs-108	94	25	increase	increase	NOUN
iajs-108	94	26	iron	iron	NOUN
iajs-108	94	27	stores	store	NOUN
iajs-108	94	28	might	might	AUX
iajs-108	94	29	contribute	contribute	VERB
iajs-108	94	30	to	to	ADP
iajs-108	94	31	ir	ir	PROPN
iajs-108	94	32	and	and	CCONJ
iajs-108	94	33	β	β	NOUN
iajs-108	94	34	-	-	NOUN
iajs-108	94	35	cell	cell	NOUN
iajs-108	94	36	dysfunction	dysfunction	NOUN
iajs-108	94	37	in	in	ADP
iajs-108	94	38	pcos	pcos	PROPN
iajs-108	94	39	patients	patient	NOUN
iajs-108	94	40	,	,	PUNCT
iajs-108	94	41	however	however	ADV
iajs-108	94	42	,	,	PUNCT
iajs-108	94	43	the	the	DET
iajs-108	94	44	elevation	elevation	NOUN
iajs-108	94	45	in	in	ADP
iajs-108	94	46	serum	serum	NOUN
iajs-108	94	47	ferritin	ferritin	ADJ
iajs-108	94	48	levels	level	NOUN
iajs-108	94	49	in	in	ADP
iajs-108	94	50	pcos	pcos	PROPN
iajs-108	94	51	may	may	AUX
iajs-108	94	52	be	be	AUX
iajs-108	94	53	a	a	DET
iajs-108	94	54	secondary	secondary	ADJ
iajs-108	94	55	,	,	PUNCT
iajs-108	94	56	not	not	PART
iajs-108	94	57	a	a	DET
iajs-108	94	58	pathogenic	pathogenic	ADJ
iajs-108	94	59	[	[	X
iajs-108	94	60	25	25	NUM
iajs-108	94	61	]	]	PUNCT
iajs-108	94	62	.	.	PUNCT
iajs-108	95	1	serum	serum	PROPN
iajs-108	95	2	ferritin	ferritin	ADJ
iajs-108	95	3	levels	level	NOUN
iajs-108	95	4	were	be	AUX
iajs-108	95	5	elevated	elevate	VERB
iajs-108	95	6	in	in	ADP
iajs-108	95	7	amenorrhea	amenorrhea	ADJ
iajs-108	95	8	patients	patient	NOUN
iajs-108	95	9	in	in	ADP
iajs-108	95	10	compared	compare	VERB
iajs-108	95	11	with	with	ADP
iajs-108	95	12	regularly	regularly	ADV
iajs-108	95	13	menstruating	menstruate	VERB
iajs-108	95	14	women	woman	NOUN
iajs-108	95	15	,	,	PUNCT
iajs-108	95	16	so	so	SCONJ
iajs-108	95	17	the	the	DET
iajs-108	95	18	absence	absence	NOUN
iajs-108	95	19	of	of	ADP
iajs-108	95	20	regular	regular	ADJ
iajs-108	95	21	menstrual	menstrual	ADJ
iajs-108	95	22	blood	blood	NOUN
iajs-108	95	23	loss	loss	NOUN
iajs-108	95	24	in	in	ADP
iajs-108	95	25	pcos	pcos	NOUN
iajs-108	95	26	patients	patient	NOUN
iajs-108	95	27	might	might	AUX
iajs-108	95	28	contribute	contribute	VERB
iajs-108	95	29	to	to	ADP
iajs-108	95	30	iron	iron	NOUN
iajs-108	95	31	overload	overload	NOUN
iajs-108	95	32	[	[	X
iajs-108	95	33	24	24	NUM
iajs-108	95	34	]	]	PUNCT
iajs-108	95	35	.	.	PUNCT
iajs-108	96	1	also	also	ADV
iajs-108	96	2	similar	similar	ADJ
iajs-108	96	3	result	result	NOUN
iajs-108	96	4	was	be	AUX
iajs-108	96	5	found	find	VERB
iajs-108	96	6	by	by	ADP
iajs-108	96	7	luqueramírez	luqueramírez	NOUN
iajs-108	96	8	and	and	CCONJ
iajs-108	96	9	his	his	PRON
iajs-108	96	10	colleagues	colleague	NOUN
iajs-108	96	11	[	[	X
iajs-108	96	12	26	26	NUM
iajs-108	96	13	]	]	PUNCT
iajs-108	96	14	.	.	PUNCT
iajs-108	97	1	it	it	PRON
iajs-108	97	2	was	be	AUX
iajs-108	97	3	hypothesized	hypothesize	VERB
iajs-108	97	4	that	that	SCONJ
iajs-108	97	5	the	the	DET
iajs-108	97	6	absence	absence	NOUN
iajs-108	97	7	of	of	ADP
iajs-108	97	8	a	a	DET
iajs-108	97	9	regular	regular	ADJ
iajs-108	97	10	menstrual	menstrual	ADJ
iajs-108	97	11	blood	blood	NOUN
iajs-108	97	12	loss	loss	NOUN
iajs-108	97	13	,	,	PUNCT
iajs-108	97	14	genetic	genetic	ADJ
iajs-108	97	15	factors	factor	NOUN
iajs-108	97	16	or	or	CCONJ
iajs-108	97	17	hyperinsulinemia	hyperinsulinemia	NOUN
iajs-108	97	18	resulting	result	VERB
iajs-108	97	19	from	from	ADP
iajs-108	97	20	ir	ir	PROPN
iajs-108	97	21	.	.	PUNCT
iajs-108	98	1	considering	consider	VERB
iajs-108	98	2	that	that	SCONJ
iajs-108	98	3	insulin	insulin	NOUN
iajs-108	98	4	might	might	AUX
iajs-108	98	5	induce	induce	VERB
iajs-108	98	6	intestinal	intestinal	ADJ
iajs-108	98	7	iron	iron	NOUN
iajs-108	98	8	absorption	absorption	NOUN
iajs-108	98	9	by	by	ADP
iajs-108	98	10	up	up	ADP
iajs-108	98	11	regulating	regulate	VERB
iajs-108	98	12	the	the	DET
iajs-108	98	13	activity	activity	NOUN
iajs-108	98	14	of	of	ADP
iajs-108	98	15	hypoxia	hypoxia	NOUN
iajs-108	98	16	inducible	inducible	ADJ
iajs-108	98	17	factor	factor	NOUN
iajs-108	98	18	1alpha	1alpha	NUM
iajs-108	98	19	and	and	CCONJ
iajs-108	98	20	down	down	ADV
iajs-108	98	21	regulating	regulate	VERB
iajs-108	98	22	hepcidin	hepcidin	ADJ
iajs-108	98	23	expression	expression	NOUN
iajs-108	98	24	[	[	X
iajs-108	98	25	27	27	NUM
iajs-108	98	26	,	,	PUNCT
iajs-108	98	27	28	28	NUM
iajs-108	98	28	]	]	PUNCT
iajs-108	98	29	.	.	PUNCT
iajs-108	99	1	that	that	PRON
iajs-108	99	2	may	may	AUX
iajs-108	99	3	have	have	AUX
iajs-108	99	4	contributed	contribute	VERB
iajs-108	99	5	to	to	ADP
iajs-108	99	6	the	the	DET
iajs-108	99	7	elevation	elevation	NOUN
iajs-108	99	8	body	body	NOUN
iajs-108	99	9	iron	iron	NOUN
iajs-108	99	10	stores	store	NOUN
iajs-108	99	11	and	and	CCONJ
iajs-108	99	12	serum	serum	NOUN
iajs-108	99	13	ferritin	ferritin	ADJ
iajs-108	99	14	levels	level	NOUN
iajs-108	99	15	observed	observe	VERB
iajs-108	99	16	in	in	ADP
iajs-108	99	17	pcos	pcos	NOUN
iajs-108	99	18	patients	patient	NOUN
iajs-108	99	19	,	,	PUNCT
iajs-108	99	20	and	and	CCONJ
iajs-108	99	21	not	not	PART
iajs-108	99	22	the	the	DET
iajs-108	99	23	decrease	decrease	NOUN
iajs-108	99	24	menstrual	menstrual	ADJ
iajs-108	99	25	losses	loss	NOUN
iajs-108	99	26	secondary	secondary	ADJ
iajs-108	99	27	to	to	ADP
iajs-108	99	28	from	from	ADP
iajs-108	99	29	oligo	oligo	ADJ
iajs-108	99	30	or	or	CCONJ
iajs-108	99	31	amenorrhea	amenorrhea	NOUN
iajs-108	99	32	.	.	PUNCT
iajs-108	100	1	in	in	ADP
iajs-108	100	2	this	this	DET
iajs-108	100	3	study	study	NOUN
iajs-108	100	4	,	,	PUNCT
iajs-108	100	5	we	we	PRON
iajs-108	100	6	find	find	VERB
iajs-108	100	7	a	a	DET
iajs-108	100	8	higher	high	ADJ
iajs-108	100	9	positive	positive	ADJ
iajs-108	100	10	correlation	correlation	NOUN
iajs-108	100	11	between	between	ADP
iajs-108	100	12	insulin	insulin	NOUN
iajs-108	100	13	,	,	PUNCT
iajs-108	100	14	homa2	homa2	PROPN
iajs-108	100	15	ir	ir	PROPN
iajs-108	100	16	with	with	ADP
iajs-108	100	17	ferritin	ferritin	ADJ
iajs-108	100	18	;	;	PUNCT
iajs-108	100	19	also	also	ADV
iajs-108	100	20	a	a	DET
iajs-108	100	21	higher	high	ADJ
iajs-108	100	22	negative	negative	ADJ
iajs-108	100	23	correlation	correlation	NOUN
iajs-108	100	24	between	between	ADP
iajs-108	100	25	ferritin	ferritin	ADJ
iajs-108	100	26	and	and	CCONJ
iajs-108	100	27	homa2	homa2	NOUN
iajs-108	100	28	s	s	PART
iajs-108	100	29	(	(	PUNCT
iajs-108	100	30	%	%	INTJ
iajs-108	100	31	)	)	PUNCT
iajs-108	100	32	of	of	ADP
iajs-108	100	33	lean	lean	ADJ
iajs-108	100	34	,	,	PUNCT
iajs-108	100	35	overweight	overweight	ADJ
iajs-108	100	36	and	and	CCONJ
iajs-108	100	37	obese	obese	ADJ
iajs-108	100	38	groups	group	NOUN
iajs-108	100	39	table	table	NOUN
iajs-108	100	40	(	(	PUNCT
iajs-108	100	41	2	2	NUM
iajs-108	100	42	)	)	PUNCT
iajs-108	100	43	figure	figure	NOUN
iajs-108	100	44	(	(	PUNCT
iajs-108	100	45	1	1	NUM
iajs-108	100	46	)	)	PUNCT
iajs-108	100	47	,	,	PUNCT
iajs-108	100	48	these	these	DET
iajs-108	100	49	results	result	NOUN
iajs-108	100	50	agree	agree	VERB
iajs-108	100	51	with	with	ADP
iajs-108	100	52	[	[	X
iajs-108	100	53	26	26	NUM
iajs-108	100	54	]	]	PUNCT
iajs-108	100	55	.	.	PUNCT
iajs-108	101	1	recent	recent	ADJ
iajs-108	101	2	data	datum	NOUN
iajs-108	101	3	support	support	VERB
iajs-108	101	4	this	this	DET
iajs-108	101	5	hypothesis	hypothesis	NOUN
iajs-108	101	6	and	and	CCONJ
iajs-108	101	7	chemistry	chemistry	NOUN
iajs-108	101	8	|	|	ADV
iajs-108	101	9	175	175	NUM
iajs-108	101	10	2016	2016	NUM
iajs-108	101	11	)	)	PUNCT
iajs-108	101	12	عام	عام	ADP
iajs-108	101	13	2العدد	2العدد	NUM
iajs-108	101	14	(	(	PUNCT
iajs-108	101	15	29مجلة	29مجلة	NUM
iajs-108	101	16	إبن	إبن	VERB
iajs-108	101	17	الهيثم	الهيثم	ADJ
iajs-108	101	18	للعلوم	للعلوم	NOUN
iajs-108	101	19	الصرفة	الصرفة	NOUN
iajs-108	102	1	و	و	PRON
iajs-108	102	2	التطبيقية	التطبيقية	ADV
iajs-108	102	3	المجلد	المجلد	VERB
iajs-108	102	4	ibn	ibn	PROPN
iajs-108	102	5	al	al	PROPN
iajs-108	102	6	-	-	PUNCT
iajs-108	102	7	haitham	haitham	PROPN
iajs-108	102	8	jour	jour	X
iajs-108	102	9	.	.	PROPN
iajs-108	103	1	for	for	ADP
iajs-108	103	2	pure	pure	ADJ
iajs-108	103	3	&	&	CCONJ
iajs-108	103	4	appl	appl	PROPN
iajs-108	103	5	.	.	PUNCT
iajs-108	104	1	sci	sci	PROPN
iajs-108	104	2	.	.	PUNCT
iajs-108	104	3	vol	vol	NOUN
iajs-108	104	4	.	.	PROPN
iajs-108	104	5	29	29	NUM
iajs-108	104	6	(	(	PUNCT
iajs-108	104	7	2	2	NUM
iajs-108	104	8	)	)	PUNCT
iajs-108	104	9	2016	2016	NUM
iajs-108	104	10	show	show	VERB
iajs-108	104	11	that	that	SCONJ
iajs-108	104	12	insulin	insulin	NOUN
iajs-108	104	13	sensitivity	sensitivity	NOUN
iajs-108	104	14	is	be	AUX
iajs-108	104	15	inversely	inversely	ADV
iajs-108	104	16	relate	relate	VERB
iajs-108	104	17	to	to	ADP
iajs-108	104	18	ferritin	ferritin	ADJ
iajs-108	104	19	concentrations	concentration	NOUN
iajs-108	104	20	in	in	ADP
iajs-108	104	21	premenopausal	premenopausal	ADJ
iajs-108	104	22	women	woman	NOUN
iajs-108	104	23	and	and	CCONJ
iajs-108	104	24	that	that	SCONJ
iajs-108	104	25	women	woman	NOUN
iajs-108	104	26	with	with	ADP
iajs-108	104	27	abnormal	abnormal	ADJ
iajs-108	104	28	glucose	glucose	NOUN
iajs-108	104	29	tolerance	tolerance	NOUN
iajs-108	104	30	have	have	AUX
iajs-108	104	31	increased	increase	VERB
iajs-108	104	32	ferritin	ferritin	ADJ
iajs-108	104	33	levels	level	NOUN
iajs-108	104	34	[	[	X
iajs-108	104	35	16	16	NUM
iajs-108	104	36	,	,	PUNCT
iajs-108	104	37	30	30	NUM
iajs-108	104	38	]	]	PUNCT
iajs-108	104	39	.	.	PUNCT
iajs-108	105	1	elevated	elevate	VERB
iajs-108	105	2	ferritin	ferritin	ADJ
iajs-108	105	3	levels	level	NOUN
iajs-108	105	4	were	be	AUX
iajs-108	105	5	positively	positively	ADV
iajs-108	105	6	correlated	correlate	VERB
iajs-108	105	7	with	with	ADP
iajs-108	105	8	the	the	DET
iajs-108	105	9	prevalence	prevalence	NOUN
iajs-108	105	10	of	of	ADP
iajs-108	105	11	the	the	DET
iajs-108	105	12	metabolic	metabolic	NOUN
iajs-108	105	13	syndrome	syndrome	NOUN
iajs-108	105	14	and	and	CCONJ
iajs-108	105	15	with	with	ADP
iajs-108	105	16	insulin	insulin	NOUN
iajs-108	105	17	resistance	resistance	NOUN
iajs-108	105	18	and	and	CCONJ
iajs-108	105	19	an	an	DET
iajs-108	105	20	increased	increase	VERB
iajs-108	105	21	risk	risk	NOUN
iajs-108	105	22	of	of	ADP
iajs-108	105	23	t2	t2	NOUN
iajs-108	105	24	dm	dm	PROPN
iajs-108	106	1	[	[	X
iajs-108	106	2	31	31	NUM
iajs-108	106	3	,	,	PUNCT
iajs-108	106	4	32	32	NUM
iajs-108	106	5	,	,	PUNCT
iajs-108	106	6	and	and	CCONJ
iajs-108	106	7	33	33	NUM
iajs-108	106	8	]	]	PUNCT
iajs-108	106	9	.	.	PUNCT
iajs-108	107	1	the	the	DET
iajs-108	107	2	increased	increase	VERB
iajs-108	107	3	ferritin	ferritin	ADJ
iajs-108	107	4	level	level	NOUN
iajs-108	107	5	,	,	PUNCT
iajs-108	107	6	occurred	occur	VERB
iajs-108	107	7	independent	independent	ADJ
iajs-108	107	8	of	of	ADP
iajs-108	107	9	changes	change	NOUN
iajs-108	107	10	in	in	ADP
iajs-108	107	11	serum	serum	NOUN
iajs-108	107	12	inflammatory	inflammatory	ADJ
iajs-108	107	13	markers	marker	NOUN
iajs-108	107	14	,	,	PUNCT
iajs-108	107	15	indicates	indicate	VERB
iajs-108	107	16	that	that	SCONJ
iajs-108	107	17	body	body	NOUN
iajs-108	107	18	iron	iron	NOUN
iajs-108	107	19	stores	store	NOUN
iajs-108	107	20	are	be	AUX
iajs-108	107	21	increase	increase	NOUN
iajs-108	107	22	in	in	ADP
iajs-108	107	23	these	these	DET
iajs-108	107	24	women	woman	NOUN
iajs-108	107	25	and	and	CCONJ
iajs-108	107	26	do	do	AUX
iajs-108	107	27	not	not	PART
iajs-108	107	28	result	result	VERB
iajs-108	107	29	from	from	ADP
iajs-108	107	30	the	the	DET
iajs-108	107	31	secondary	secondary	ADJ
iajs-108	107	32	role	role	NOUN
iajs-108	107	33	of	of	ADP
iajs-108	107	34	ferritin	ferritin	ADJ
iajs-108	107	35	as	as	ADP
iajs-108	107	36	an	an	DET
iajs-108	107	37	acute	acute	ADJ
iajs-108	107	38	phase	phase	NOUN
iajs-108	107	39	marker	marker	NOUN
iajs-108	108	1	[	[	X
iajs-108	108	2	12	12	NUM
iajs-108	108	3	]	]	PUNCT
iajs-108	108	4	.	.	PUNCT
iajs-108	109	1	therefore	therefore	ADV
iajs-108	109	2	,	,	PUNCT
iajs-108	109	3	both	both	DET
iajs-108	109	4	androgen	androgen	NOUN
iajs-108	109	5	excess	excess	ADJ
iajs-108	109	6	and	and	CCONJ
iajs-108	109	7	insulin	insulin	NOUN
iajs-108	109	8	resistance	resistance	NOUN
iajs-108	109	9	might	might	AUX
iajs-108	109	10	be	be	AUX
iajs-108	109	11	the	the	DET
iajs-108	109	12	cause	cause	NOUN
iajs-108	109	13	for	for	ADP
iajs-108	109	14	increased	increase	VERB
iajs-108	109	15	serum	serum	NOUN
iajs-108	109	16	ferritin	ferritin	ADJ
iajs-108	109	17	levels	level	NOUN
iajs-108	109	18	.	.	PUNCT
iajs-108	110	1	however	however	ADV
iajs-108	110	2	,	,	PUNCT
iajs-108	110	3	other	other	ADJ
iajs-108	110	4	study	study	NOUN
iajs-108	110	5	hypothesized	hypothesize	VERB
iajs-108	110	6	that	that	SCONJ
iajs-108	110	7	the	the	DET
iajs-108	110	8	reduced	reduce	VERB
iajs-108	110	9	menstrual	menstrual	ADJ
iajs-108	110	10	losses	loss	NOUN
iajs-108	110	11	due	due	ADP
iajs-108	110	12	to	to	ADP
iajs-108	110	13	the	the	DET
iajs-108	110	14	oligomenorrhea	oligomenorrhea	ADJ
iajs-108	110	15	present	present	NOUN
iajs-108	110	16	in	in	ADP
iajs-108	110	17	most	most	ADJ
iajs-108	110	18	women	woman	NOUN
iajs-108	110	19	with	with	ADP
iajs-108	110	20	pcos	pcos	PROPN
iajs-108	110	21	could	could	AUX
iajs-108	110	22	contribute	contribute	VERB
iajs-108	110	23	to	to	ADP
iajs-108	110	24	their	their	PRON
iajs-108	110	25	increased	increase	VERB
iajs-108	110	26	iron	iron	NOUN
iajs-108	110	27	stores	store	NOUN
iajs-108	110	28	.	.	PUNCT
iajs-108	111	1	recent	recent	ADJ
iajs-108	111	2	data	datum	NOUN
iajs-108	111	3	suggest	suggest	VERB
iajs-108	111	4	that	that	SCONJ
iajs-108	111	5	insulin	insulin	NOUN
iajs-108	111	6	resistance	resistance	NOUN
iajs-108	111	7	is	be	AUX
iajs-108	111	8	one	one	NUM
iajs-108	111	9	of	of	ADP
iajs-108	111	10	the	the	DET
iajs-108	111	11	major	major	ADJ
iajs-108	111	12	players	player	NOUN
iajs-108	111	13	explaining	explain	VERB
iajs-108	111	14	their	their	PRON
iajs-108	111	15	increased	increase	VERB
iajs-108	111	16	serum	serum	NOUN
iajs-108	111	17	ferritin	ferritin	ADJ
iajs-108	111	18	levels	level	NOUN
iajs-108	111	19	,	,	PUNCT
iajs-108	111	20	whereas	whereas	SCONJ
iajs-108	111	21	serum	serum	NOUN
iajs-108	111	22	ferritin	ferritin	ADJ
iajs-108	111	23	levels	level	NOUN
iajs-108	111	24	did	do	AUX
iajs-108	111	25	not	not	PART
iajs-108	111	26	change	change	VERB
iajs-108	111	27	after	after	ADP
iajs-108	111	28	restoring	restore	VERB
iajs-108	111	29	regular	regular	ADJ
iajs-108	111	30	menses	mense	NOUN
iajs-108	111	31	by	by	ADP
iajs-108	111	32	using	use	VERB
iajs-108	111	33	an	an	DET
iajs-108	111	34	oral	oral	ADJ
iajs-108	111	35	contraceptive	contraceptive	NOUN
iajs-108	111	36	for	for	ADP
iajs-108	111	37	six	six	NUM
iajs-108	111	38	months	month	NOUN
iajs-108	111	39	,	,	PUNCT
iajs-108	111	40	these	these	DET
iajs-108	111	41	levels	level	NOUN
iajs-108	111	42	decreased	decrease	VERB
iajs-108	111	43	markedly	markedly	ADV
iajs-108	111	44	after	after	ADP
iajs-108	111	45	insulin	insulin	NOUN
iajs-108	111	46	sensitization	sensitization	NOUN
iajs-108	111	47	with	with	ADP
iajs-108	111	48	metformin	metformin	NOUN
iajs-108	111	49	[	[	X
iajs-108	111	50	24	24	NUM
iajs-108	111	51	]	]	PUNCT
iajs-108	111	52	.	.	PUNCT
iajs-108	112	1	in	in	ADP
iajs-108	112	2	this	this	DET
iajs-108	112	3	study	study	NOUN
iajs-108	112	4	,	,	PUNCT
iajs-108	112	5	high	high	ADJ
iajs-108	112	6	significant	significant	ADJ
iajs-108	112	7	increase	increase	NOUN
iajs-108	112	8	in	in	ADP
iajs-108	112	9	tgf	tgf	PROPN
iajs-108	112	10	-	-	PUNCT
iajs-108	112	11	β1	β1	PROPN
iajs-108	112	12	level	level	NOUN
iajs-108	112	13	was	be	AUX
iajs-108	112	14	found	find	VERB
iajs-108	112	15	only	only	ADV
iajs-108	112	16	in	in	ADP
iajs-108	112	17	obese	obese	ADJ
iajs-108	112	18	group	group	NOUN
iajs-108	112	19	and	and	CCONJ
iajs-108	112	20	significant	significant	ADJ
iajs-108	112	21	increase	increase	NOUN
iajs-108	112	22	in	in	ADP
iajs-108	112	23	overweight	overweight	ADJ
iajs-108	112	24	group	group	NOUN
iajs-108	112	25	,	,	PUNCT
iajs-108	112	26	while	while	SCONJ
iajs-108	112	27	no	no	DET
iajs-108	112	28	significant	significant	ADJ
iajs-108	112	29	difference	difference	NOUN
iajs-108	112	30	in	in	ADP
iajs-108	112	31	lean	lean	ADJ
iajs-108	112	32	group	group	NOUN
iajs-108	112	33	in	in	ADP
iajs-108	112	34	comparison	comparison	NOUN
iajs-108	112	35	with	with	ADP
iajs-108	112	36	control	control	NOUN
iajs-108	112	37	group	group	NOUN
iajs-108	112	38	was	be	AUX
iajs-108	112	39	noted	note	VERB
iajs-108	112	40	(	(	PUNCT
iajs-108	112	41	table	table	NOUN
iajs-108	112	42	1	1	NUM
iajs-108	112	43	)	)	PUNCT
iajs-108	112	44	.	.	PUNCT
iajs-108	113	1	this	this	DET
iajs-108	113	2	data	datum	NOUN
iajs-108	113	3	are	be	AUX
iajs-108	113	4	in	in	ADP
iajs-108	113	5	agreement	agreement	NOUN
iajs-108	113	6	with	with	ADP
iajs-108	113	7	the	the	DET
iajs-108	113	8	previous	previous	ADJ
iajs-108	113	9	findings	finding	NOUN
iajs-108	113	10	of	of	ADP
iajs-108	113	11	two	two	NUM
iajs-108	113	12	studies	study	NOUN
iajs-108	113	13	by	by	ADP
iajs-108	113	14	[	[	X
iajs-108	113	15	34,35	34,35	NOUN
iajs-108	113	16	]	]	PUNCT
iajs-108	113	17	showing	show	VERB
iajs-108	113	18	increased	increase	VERB
iajs-108	113	19	serum	serum	PROPN
iajs-108	113	20	tgf	tgf	PROPN
iajs-108	113	21	-	-	PUNCT
iajs-108	113	22	b1	b1	NOUN
iajs-108	113	23	levels	level	NOUN
iajs-108	113	24	in	in	ADP
iajs-108	113	25	patients	patient	NOUN
iajs-108	113	26	with	with	ADP
iajs-108	113	27	pcos	pco	NOUN
iajs-108	113	28	.	.	PUNCT
iajs-108	114	1	it	it	PRON
iajs-108	114	2	is	be	AUX
iajs-108	114	3	now	now	ADV
iajs-108	114	4	clear	clear	ADJ
iajs-108	114	5	that	that	SCONJ
iajs-108	114	6	pcos	pcos	PROPN
iajs-108	114	7	is	be	AUX
iajs-108	114	8	a	a	DET
iajs-108	114	9	pro	pro	ADJ
iajs-108	114	10	-	-	ADJ
iajs-108	114	11	inflammatory	inflammatory	ADJ
iajs-108	114	12	state	state	NOUN
iajs-108	114	13	,	,	PUNCT
iajs-108	114	14	as	as	SCONJ
iajs-108	114	15	stated	state	VERB
iajs-108	114	16	by	by	ADP
iajs-108	114	17	gonzales	gonzales	PROPN
iajs-108	114	18	(	(	PUNCT
iajs-108	114	19	et	et	X
iajs-108	114	20	.	.	PUNCT
iajs-108	115	1	al	al	PROPN
iajs-108	115	2	.	.	PROPN
iajs-108	115	3	,	,	PUNCT
iajs-108	115	4	2006	2006	NUM
iajs-108	115	5	)	)	PUNCT
iajs-108	116	1	[	[	X
iajs-108	116	2	31	31	NUM
iajs-108	116	3	]	]	PUNCT
iajs-108	116	4	.	.	PUNCT
iajs-108	117	1	a	a	DET
iajs-108	117	2	low	low	ADJ
iajs-108	117	3	chronic	chronic	ADJ
iajs-108	117	4	inflammatory	inflammatory	ADJ
iajs-108	117	5	state	state	NOUN
iajs-108	117	6	,	,	PUNCT
iajs-108	117	7	characterized	characterize	VERB
iajs-108	117	8	by	by	ADP
iajs-108	117	9	elevation	elevation	NOUN
iajs-108	117	10	levels	level	NOUN
iajs-108	117	11	of	of	ADP
iajs-108	117	12	proinflammatory	proinflammatory	ADJ
iajs-108	117	13	molecules	molecule	NOUN
iajs-108	117	14	and	and	CCONJ
iajs-108	117	15	acute	acute	ADJ
iajs-108	117	16	phase	phase	NOUN
iajs-108	117	17	proteins	protein	NOUN
iajs-108	117	18	,	,	PUNCT
iajs-108	117	19	can	can	AUX
iajs-108	117	20	be	be	AUX
iajs-108	117	21	present	present	ADJ
iajs-108	117	22	in	in	ADP
iajs-108	117	23	obesity	obesity	NOUN
iajs-108	117	24	and	and	CCONJ
iajs-108	117	25	insulin	insulin	NOUN
iajs-108	117	26	resistance	resistance	NOUN
iajs-108	117	27	[	[	X
iajs-108	117	28	36	36	NUM
iajs-108	117	29	,	,	PUNCT
iajs-108	117	30	37	37	NUM
iajs-108	117	31	]	]	PUNCT
iajs-108	117	32	.	.	PUNCT
iajs-108	118	1	we	we	PRON
iajs-108	118	2	found	find	VERB
iajs-108	118	3	that	that	SCONJ
iajs-108	118	4	tgf	tgf	PROPN
iajs-108	118	5	-	-	PUNCT
iajs-108	118	6	β1	β1	PROPN
iajs-108	118	7	of	of	ADP
iajs-108	118	8	overweight	overweight	NOUN
iajs-108	118	9	and	and	CCONJ
iajs-108	118	10	obese	obese	ADJ
iajs-108	118	11	groups	group	NOUN
iajs-108	118	12	showed	show	VERB
iajs-108	118	13	a	a	DET
iajs-108	118	14	higher	high	ADJ
iajs-108	118	15	significant	significant	ADJ
iajs-108	118	16	positive	positive	ADJ
iajs-108	118	17	correlation	correlation	NOUN
iajs-108	118	18	with	with	ADP
iajs-108	118	19	insulin	insulin	NOUN
iajs-108	118	20	resistance	resistance	NOUN
iajs-108	118	21	,	,	PUNCT
iajs-108	118	22	insulin	insulin	NOUN
iajs-108	118	23	,	,	PUNCT
iajs-108	118	24	and	and	CCONJ
iajs-108	118	25	significant	significant	ADJ
iajs-108	118	26	negative	negative	ADJ
iajs-108	118	27	correlation	correlation	NOUN
iajs-108	118	28	with	with	ADP
iajs-108	118	29	homa2	homa2	NOUN
iajs-108	118	30	s	s	PART
iajs-108	118	31	%	%	NOUN
iajs-108	118	32	(	(	PUNCT
iajs-108	118	33	table	table	NOUN
iajs-108	118	34	3	3	NUM
iajs-108	118	35	)	)	PUNCT
iajs-108	118	36	(	(	PUNCT
iajs-108	118	37	figure	figure	NOUN
iajs-108	118	38	2	2	NUM
iajs-108	118	39	)	)	PUNCT
iajs-108	118	40	.	.	PUNCT
iajs-108	119	1	in	in	ADP
iajs-108	119	2	other	other	ADJ
iajs-108	119	3	studies	study	NOUN
iajs-108	119	4	,	,	PUNCT
iajs-108	119	5	increased	increase	VERB
iajs-108	119	6	circulating	circulate	VERB
iajs-108	119	7	tgf	tgf	PROPN
iajs-108	119	8	-	-	PUNCT
iajs-108	119	9	β1	β1	PROPN
iajs-108	119	10	levels	level	NOUN
iajs-108	119	11	in	in	ADP
iajs-108	119	12	various	various	ADJ
iajs-108	119	13	cardio	cardio	NOUN
iajs-108	119	14	metabolic	metabolic	NOUN
iajs-108	119	15	complications	complication	NOUN
iajs-108	119	16	,	,	PUNCT
iajs-108	119	17	hypertension	hypertension	NOUN
iajs-108	119	18	,	,	PUNCT
iajs-108	119	19	obesity	obesity	NOUN
iajs-108	119	20	,	,	PUNCT
iajs-108	119	21	insulin	insulin	NOUN
iajs-108	119	22	resistance	resistance	NOUN
iajs-108	119	23	,	,	PUNCT
iajs-108	119	24	diabetes	diabetes	NOUN
iajs-108	119	25	,	,	PUNCT
iajs-108	119	26	and	and	CCONJ
iajs-108	119	27	coronary	coronary	ADJ
iajs-108	119	28	artery	artery	NOUN
iajs-108	119	29	disease	disease	NOUN
iajs-108	119	30	were	be	AUX
iajs-108	119	31	found	find	VERB
iajs-108	119	32	[	[	X
iajs-108	119	33	38	38	NUM
iajs-108	119	34	,	,	PUNCT
iajs-108	119	35	39	39	NUM
iajs-108	119	36	,	,	PUNCT
iajs-108	119	37	36	36	NUM
iajs-108	119	38	and	and	CCONJ
iajs-108	119	39	40	40	NUM
iajs-108	119	40	]	]	PUNCT
iajs-108	119	41	.	.	PUNCT
iajs-108	120	1	these	these	DET
iajs-108	120	2	findings	finding	NOUN
iajs-108	120	3	of	of	ADP
iajs-108	120	4	increased	increase	VERB
iajs-108	120	5	tgf	tgf	PROPN
iajs-108	120	6	-	-	PUNCT
iajs-108	120	7	β1	β1	NOUN
iajs-108	120	8	reveal	reveal	VERB
iajs-108	120	9	the	the	DET
iajs-108	120	10	bioavailability	bioavailability	NOUN
iajs-108	120	11	in	in	ADP
iajs-108	120	12	pcos	pcos	PROPN
iajs-108	120	13	is	be	AUX
iajs-108	120	14	consistent	consistent	ADJ
iajs-108	120	15	with	with	ADP
iajs-108	120	16	an	an	DET
iajs-108	120	17	important	important	ADJ
iajs-108	120	18	role	role	NOUN
iajs-108	120	19	for	for	ADP
iajs-108	120	20	tgf	tgf	PROPN
iajs-108	120	21	-	-	PUNCT
iajs-108	120	22	β1	β1	PROPN
iajs-108	120	23	in	in	ADP
iajs-108	120	24	the	the	DET
iajs-108	120	25	pathogenesis	pathogenesis	NOUN
iajs-108	120	26	of	of	ADP
iajs-108	120	27	the	the	DET
iajs-108	120	28	cardio	cardio	NOUN
iajs-108	120	29	-	-	PUNCT
iajs-108	120	30	metabolic	metabolic	NOUN
iajs-108	120	31	complications	complication	NOUN
iajs-108	120	32	seen	see	VERB
iajs-108	120	33	in	in	ADP
iajs-108	120	34	iraqi	iraqi	ADJ
iajs-108	120	35	women	woman	NOUN
iajs-108	120	36	with	with	ADP
iajs-108	120	37	pcos	pcos	PROPN
iajs-108	120	38	.	.	PUNCT
iajs-108	121	1	targeting	target	VERB
iajs-108	121	2	tgf	tgf	PROPN
iajs-108	121	3	-	-	PUNCT
iajs-108	121	4	β1	β1	PROPN
iajs-108	121	5	dysregulation	dysregulation	NOUN
iajs-108	121	6	may	may	AUX
iajs-108	121	7	be	be	AUX
iajs-108	121	8	particularly	particularly	ADV
iajs-108	121	9	important	important	ADJ
iajs-108	121	10	in	in	ADP
iajs-108	121	11	pcos	pcos	PROPN
iajs-108	121	12	as	as	SCONJ
iajs-108	121	13	women	woman	NOUN
iajs-108	121	14	with	with	ADP
iajs-108	121	15	pcos	pco	NOUN
iajs-108	121	16	are	be	AUX
iajs-108	121	17	at	at	ADP
iajs-108	121	18	increased	increase	VERB
iajs-108	121	19	risk	risk	NOUN
iajs-108	121	20	of	of	ADP
iajs-108	121	21	impaired	impaired	ADJ
iajs-108	121	22	glucose	glucose	NOUN
iajs-108	121	23	tolerance	tolerance	NOUN
iajs-108	121	24	and	and	CCONJ
iajs-108	121	25	type	type	NOUN
iajs-108	121	26	2	2	NUM
iajs-108	121	27	diabetes	diabetes	NOUN
iajs-108	121	28	due	due	ADJ
iajs-108	121	29	to	to	ADP
iajs-108	121	30	underlying	underlie	VERB
iajs-108	121	31	insulin	insulin	NOUN
iajs-108	121	32	resistance	resistance	NOUN
iajs-108	121	33	.	.	PUNCT
iajs-108	122	1	excessive	excessive	PROPN
iajs-108	122	2	tgf	tgf	PROPN
iajs-108	122	3	-	-	PUNCT
iajs-108	122	4	β1	β1	NOUN
iajs-108	122	5	activity	activity	NOUN
iajs-108	122	6	has	have	AUX
iajs-108	122	7	been	be	AUX
iajs-108	122	8	implicate	implicate	ADJ
iajs-108	122	9	in	in	ADP
iajs-108	122	10	the	the	DET
iajs-108	122	11	pathogenesis	pathogenesis	NOUN
iajs-108	122	12	of	of	ADP
iajs-108	122	13	arterial	arterial	ADJ
iajs-108	122	14	disease	disease	NOUN
iajs-108	122	15	in	in	ADP
iajs-108	122	16	patients	patient	NOUN
iajs-108	122	17	with	with	ADP
iajs-108	122	18	altered	alter	VERB
iajs-108	122	19	glucose	glucose	NOUN
iajs-108	122	20	metabolism	metabolism	NOUN
iajs-108	123	1	[	[	X
iajs-108	123	2	41	41	NUM
iajs-108	123	3	]	]	PUNCT
iajs-108	123	4	.	.	PUNCT
iajs-108	124	1	cells	cell	NOUN
iajs-108	124	2	in	in	ADP
iajs-108	124	3	the	the	DET
iajs-108	124	4	vessel	vessel	NOUN
iajs-108	124	5	wall	wall	NOUN
iajs-108	124	6	express	express	VERB
iajs-108	124	7	the	the	DET
iajs-108	124	8	isoforms	isoform	NOUN
iajs-108	124	9	tgf	tgf	PROPN
iajs-108	124	10	-	-	PUNCT
iajs-108	124	11	β1	β1	PROPN
iajs-108	124	12	,	,	PUNCT
iajs-108	124	13	tgf	tgf	PROPN
iajs-108	124	14	-	-	PUNCT
iajs-108	124	15	β2	β2	PROPN
iajs-108	124	16	,	,	PUNCT
iajs-108	124	17	and	and	CCONJ
iajs-108	124	18	tgf	tgf	PROPN
iajs-108	124	19	-	-	PUNCT
iajs-108	124	20	β3	β3	ADJ
iajs-108	124	21	,	,	PUNCT
iajs-108	124	22	which	which	PRON
iajs-108	124	23	regulate	regulate	VERB
iajs-108	124	24	cell	cell	NOUN
iajs-108	124	25	differentiation	differentiation	NOUN
iajs-108	124	26	,	,	PUNCT
iajs-108	124	27	cell	cell	NOUN
iajs-108	124	28	proliferation	proliferation	NOUN
iajs-108	124	29	,	,	PUNCT
iajs-108	124	30	cell	cell	NOUN
iajs-108	124	31	migration	migration	NOUN
iajs-108	124	32	,	,	PUNCT
iajs-108	124	33	production	production	NOUN
iajs-108	124	34	of	of	ADP
iajs-108	124	35	the	the	DET
iajs-108	124	36	extracellular	extracellular	ADJ
iajs-108	124	37	matrix	matrix	NOUN
iajs-108	124	38	,	,	PUNCT
iajs-108	124	39	and	and	CCONJ
iajs-108	124	40	immune	immune	ADJ
iajs-108	124	41	cell	cell	NOUN
iajs-108	124	42	functions	function	NOUN
iajs-108	124	43	.	.	PUNCT
iajs-108	125	1	as	as	ADP
iajs-108	125	2	a	a	DET
iajs-108	125	3	potent	potent	ADJ
iajs-108	125	4	regulator	regulator	NOUN
iajs-108	125	5	of	of	ADP
iajs-108	125	6	vascular	vascular	ADJ
iajs-108	125	7	cell	cell	NOUN
iajs-108	125	8	responses	response	NOUN
iajs-108	125	9	,	,	PUNCT
iajs-108	125	10	tgf	tgf	PROPN
iajs-108	125	11	-	-	PUNCT
iajs-108	125	12	β1	β1	PROPN
iajs-108	125	13	plays	play	VERB
iajs-108	125	14	an	an	DET
iajs-108	125	15	important	important	ADJ
iajs-108	125	16	role	role	NOUN
iajs-108	125	17	in	in	ADP
iajs-108	125	18	atherosclerosis	atherosclerosis	NOUN
iajs-108	125	19	and	and	CCONJ
iajs-108	125	20	vascular	vascular	ADJ
iajs-108	125	21	remodeling	remodeling	NOUN
iajs-108	126	1	[	[	X
iajs-108	126	2	42	42	NUM
iajs-108	126	3	]	]	PUNCT
iajs-108	126	4	.	.	PUNCT
iajs-108	127	1	dysregulated	dysregulated	PROPN
iajs-108	127	2	tgf	tgf	PROPN
iajs-108	127	3	-	-	PUNCT
iajs-108	127	4	β1	β1	NOUN
iajs-108	127	5	activity	activity	NOUN
iajs-108	127	6	may	may	AUX
iajs-108	127	7	contribute	contribute	VERB
iajs-108	127	8	to	to	ADP
iajs-108	127	9	atherosclerosis	atherosclerosis	NOUN
iajs-108	127	10	by	by	ADP
iajs-108	127	11	stimulating	stimulate	VERB
iajs-108	127	12	smooth	smooth	ADJ
iajs-108	127	13	muscle	muscle	NOUN
iajs-108	127	14	cells	cell	NOUN
iajs-108	127	15	in	in	ADP
iajs-108	127	16	the	the	DET
iajs-108	127	17	vasculature	vasculature	NOUN
iajs-108	127	18	to	to	PART
iajs-108	127	19	proliferate	proliferate	VERB
iajs-108	127	20	and	and	CCONJ
iajs-108	127	21	synthesize	synthesize	VERB
iajs-108	127	22	collagen	collagen	NOUN
iajs-108	127	23	.	.	PUNCT
iajs-108	128	1	tgf	tgf	PROPN
iajs-108	128	2	-	-	PUNCT
iajs-108	128	3	β1	β1	PROPN
iajs-108	128	4	also	also	ADV
iajs-108	128	5	regulates	regulate	VERB
iajs-108	128	6	endothelial	endothelial	ADJ
iajs-108	128	7	cells	cell	NOUN
iajs-108	128	8	,	,	PUNCT
iajs-108	128	9	macrophages	macrophage	NOUN
iajs-108	128	10	,	,	PUNCT
iajs-108	128	11	and	and	CCONJ
iajs-108	128	12	t	t	NOUN
iajs-108	128	13	cell	cell	NOUN
iajs-108	128	14	responses	response	NOUN
iajs-108	128	15	in	in	ADP
iajs-108	128	16	the	the	DET
iajs-108	128	17	vasculature	vasculature	NOUN
iajs-108	128	18	.	.	PUNCT
iajs-108	129	1	in	in	ADP
iajs-108	129	2	endothelial	endothelial	ADJ
iajs-108	129	3	cells	cell	NOUN
iajs-108	129	4	,	,	PUNCT
iajs-108	129	5	tgf	tgf	PROPN
iajs-108	129	6	-	-	PUNCT
iajs-108	129	7	β1	β1	PROPN
iajs-108	129	8	regulates	regulate	VERB
iajs-108	129	9	the	the	DET
iajs-108	129	10	expression	expression	NOUN
iajs-108	129	11	of	of	ADP
iajs-108	129	12	genes	gene	NOUN
iajs-108	129	13	that	that	PRON
iajs-108	129	14	promote	promote	VERB
iajs-108	129	15	inflammation	inflammation	NOUN
iajs-108	129	16	,	,	PUNCT
iajs-108	129	17	such	such	ADJ
iajs-108	129	18	as	as	ADP
iajs-108	129	19	interleukin	interleukin	NOUN
iajs-108	129	20	6	6	NUM
iajs-108	129	21	.	.	PUNCT
iajs-108	130	1	circulating	circulate	VERB
iajs-108	130	2	and	and	CCONJ
iajs-108	130	3	molecular	molecular	ADJ
iajs-108	130	4	markers	marker	NOUN
iajs-108	130	5	of	of	ADP
iajs-108	130	6	oxidative	oxidative	ADJ
iajs-108	130	7	stress	stress	NOUN
iajs-108	130	8	and	and	CCONJ
iajs-108	130	9	inflammation	inflammation	NOUN
iajs-108	130	10	are	be	AUX
iajs-108	130	11	highly	highly	ADV
iajs-108	130	12	correlate	correlate	ADJ
iajs-108	130	13	with	with	ADP
iajs-108	130	14	circulating	circulate	VERB
iajs-108	130	15	androgens	androgen	NOUN
iajs-108	130	16	[	[	X
iajs-108	130	17	43	43	NUM
iajs-108	130	18	,	,	PUNCT
iajs-108	130	19	44	44	NUM
iajs-108	130	20	,	,	PUNCT
iajs-108	130	21	45	45	NUM
iajs-108	130	22	]	]	PUNCT
iajs-108	130	23	.	.	PUNCT
iajs-108	131	1	these	these	DET
iajs-108	131	2	findings	finding	NOUN
iajs-108	131	3	raise	raise	VERB
iajs-108	131	4	the	the	DET
iajs-108	131	5	possibility	possibility	NOUN
iajs-108	131	6	that	that	SCONJ
iajs-108	131	7	in	in	ADP
iajs-108	131	8	pcos	pcos	PROPN
iajs-108	131	9	,	,	PUNCT
iajs-108	131	10	either	either	CCONJ
iajs-108	131	11	hyperandrogenemia	hyperandrogenemia	PROPN
iajs-108	131	12	pre	pre	ADJ
iajs-108	131	13	-	-	ADJ
iajs-108	131	14	activate	activate	VERB
iajs-108	131	15	mononuclear	mononuclear	ADJ
iajs-108	131	16	cells	cell	NOUN
iajs-108	131	17	(	(	PUNCT
iajs-108	131	18	mnc	mnc	PROPN
iajs-108	131	19	)	)	PUNCT
iajs-108	131	20	to	to	PART
iajs-108	131	21	account	account	VERB
iajs-108	131	22	for	for	ADP
iajs-108	131	23	the	the	DET
iajs-108	131	24	hyperglycemia	hyperglycemia	NOUN
iajs-108	131	25	induced	induce	VERB
iajs-108	131	26	inflammation	inflammation	NOUN
iajs-108	131	27	,	,	PUNCT
iajs-108	131	28	or	or	CCONJ
iajs-108	131	29	conversely	conversely	ADV
iajs-108	131	30	that	that	SCONJ
iajs-108	131	31	glucose	glucose	NOUN
iajs-108	131	32	-	-	PUNCT
iajs-108	131	33	stimulated	stimulate	VERB
iajs-108	131	34	inflammation	inflammation	NOUN
iajs-108	131	35	promotes	promote	VERB
iajs-108	131	36	ovarian	ovarian	ADJ
iajs-108	131	37	androgen	androgen	NOUN
iajs-108	131	38	production	production	NOUN
iajs-108	131	39	in	in	ADP
iajs-108	131	40	pcos	pcos	PROPN
iajs-108	131	41	.	.	PUNCT
iajs-108	132	1	there	there	PRON
iajs-108	132	2	is	be	VERB
iajs-108	132	3	data	datum	NOUN
iajs-108	132	4	to	to	PART
iajs-108	132	5	support	support	VERB
iajs-108	132	6	that	that	SCONJ
iajs-108	132	7	both	both	DET
iajs-108	132	8	mechanisms	mechanism	NOUN
iajs-108	132	9	may	may	AUX
iajs-108	132	10	occur	occur	VERB
iajs-108	132	11	[	[	X
iajs-108	132	12	46	46	NUM
iajs-108	132	13	,	,	PUNCT
iajs-108	132	14	47	47	NUM
iajs-108	132	15	]	]	PUNCT
iajs-108	132	16	.	.	PUNCT
iajs-108	133	1	conclusions	conclusion	NOUN
iajs-108	133	2	1.hyperinsulinemia	1.hyperinsulinemia	NUM
iajs-108	133	3	and	and	CCONJ
iajs-108	133	4	insulin	insulin	NOUN
iajs-108	133	5	resistance	resistance	NOUN
iajs-108	133	6	in	in	ADP
iajs-108	133	7	iraqi	iraqi	ADJ
iajs-108	133	8	women	woman	NOUN
iajs-108	133	9	with	with	ADP
iajs-108	133	10	pcos	pcos	PROPN
iajs-108	133	11	have	have	VERB
iajs-108	133	12	an	an	DET
iajs-108	133	13	increased	increase	VERB
iajs-108	133	14	risk	risk	NOUN
iajs-108	133	15	for	for	ADP
iajs-108	133	16	t2	t2	NOUN
iajs-108	133	17	dm	dm	NUM
iajs-108	133	18	disease	disease	NOUN
iajs-108	133	19	.	.	PUNCT
iajs-108	134	1	2.increased	2.increased	NUM
iajs-108	134	2	serum	serum	NOUN
iajs-108	134	3	ferritin	ferritin	ADJ
iajs-108	134	4	levels	level	NOUN
iajs-108	134	5	in	in	ADP
iajs-108	134	6	pcos	pcos	NOUN
iajs-108	134	7	patients	patient	NOUN
iajs-108	134	8	and	and	CCONJ
iajs-108	134	9	its	its	PRON
iajs-108	134	10	correlation	correlation	NOUN
iajs-108	134	11	with	with	ADP
iajs-108	134	12	insulin	insulin	NOUN
iajs-108	134	13	and	and	CCONJ
iajs-108	134	14	ir	ir	PROPN
iajs-108	134	15	support	support	VERB
iajs-108	134	16	the	the	DET
iajs-108	134	17	hypothesis	hypothesis	NOUN
iajs-108	134	18	that	that	PRON
iajs-108	134	19	insulin	insulin	NOUN
iajs-108	134	20	resistance	resistance	NOUN
iajs-108	134	21	is	be	AUX
iajs-108	134	22	the	the	DET
iajs-108	134	23	cause	cause	NOUN
iajs-108	134	24	of	of	ADP
iajs-108	134	25	this	this	DET
iajs-108	134	26	increase	increase	NOUN
iajs-108	134	27	.	.	PUNCT
iajs-108	135	1	chemistry	chemistry	NOUN
iajs-108	135	2	|	|	ADV
iajs-108	135	3	176	176	NUM
iajs-108	135	4	2016	2016	NUM
iajs-108	135	5	)	)	PUNCT
iajs-108	135	6	عام	عام	ADP
iajs-108	135	7	2العدد	2العدد	NUM
iajs-108	135	8	(	(	PUNCT
iajs-108	135	9	29مجلة	29مجلة	NUM
iajs-108	135	10	إبن	إبن	VERB
iajs-108	135	11	الهيثم	الهيثم	ADJ
iajs-108	135	12	للعلوم	للعلوم	NOUN
iajs-108	135	13	الصرفة	الصرفة	NOUN
iajs-108	136	1	و	و	PRON
iajs-108	136	2	التطبيقية	التطبيقية	ADV
iajs-108	136	3	المجلد	المجلد	VERB
iajs-108	136	4	ibn	ibn	PROPN
iajs-108	136	5	al	al	PROPN
iajs-108	136	6	-	-	PUNCT
iajs-108	136	7	haitham	haitham	PROPN
iajs-108	136	8	jour	jour	X
iajs-108	136	9	.	.	PROPN
iajs-108	137	1	for	for	ADP
iajs-108	137	2	pure	pure	ADJ
iajs-108	137	3	&	&	CCONJ
iajs-108	137	4	appl	appl	PROPN
iajs-108	137	5	.	.	PUNCT
iajs-108	138	1	sci	sci	PROPN
iajs-108	138	2	.	.	PUNCT
iajs-108	138	3	vol	vol	NOUN
iajs-108	138	4	.	.	PROPN
iajs-108	138	5	29	29	NUM
iajs-108	138	6	(	(	PUNCT
iajs-108	138	7	2	2	NUM
iajs-108	138	8	)	)	PUNCT
iajs-108	138	9	2016	2016	NUM
iajs-108	138	10	3	3	NUM
iajs-108	138	11	.	.	PUNCT
iajs-108	138	12	increased	increase	VERB
iajs-108	138	13	tgf	tgf	PROPN
iajs-108	138	14	-	-	PUNCT
iajs-108	138	15	β1	β1	PROPN
iajs-108	138	16	level	level	NOUN
iajs-108	138	17	in	in	ADP
iajs-108	138	18	overweight	overweight	NOUN
iajs-108	138	19	and	and	CCONJ
iajs-108	138	20	obese	obese	ADJ
iajs-108	138	21	iraqi	iraqi	ADJ
iajs-108	138	22	women	woman	NOUN
iajs-108	138	23	with	with	ADP
iajs-108	138	24	pcos	pcos	PROPN
iajs-108	138	25	,	,	PUNCT
iajs-108	138	26	but	but	CCONJ
iajs-108	138	27	not	not	PART
iajs-108	138	28	in	in	ADP
iajs-108	138	29	lean	lean	ADJ
iajs-108	138	30	pcos	pcos	NOUN
iajs-108	138	31	patients	patient	NOUN
iajs-108	138	32	increase	increase	VERB
iajs-108	138	33	their	their	PRON
iajs-108	138	34	risk	risk	NOUN
iajs-108	138	35	for	for	ADP
iajs-108	138	36	cvd	cvd	PROPN
iajs-108	138	37	diseases	disease	NOUN
iajs-108	138	38	.	.	PUNCT
iajs-108	139	1	4	4	X
iajs-108	139	2	.	.	X
iajs-108	139	3	the	the	DET
iajs-108	139	4	tgf	tgf	PROPN
iajs-108	139	5	-	-	PUNCT
iajs-108	139	6	β1	β1	PROPN
iajs-108	139	7	regulatory	regulatory	ADJ
iajs-108	139	8	pathway	pathway	NOUN
iajs-108	139	9	appears	appear	VERB
iajs-108	139	10	to	to	PART
iajs-108	139	11	play	play	VERB
iajs-108	139	12	a	a	DET
iajs-108	139	13	critical	critical	ADJ
iajs-108	139	14	role	role	NOUN
iajs-108	139	15	in	in	ADP
iajs-108	139	16	the	the	DET
iajs-108	139	17	development	development	NOUN
iajs-108	139	18	of	of	ADP
iajs-108	139	19	pcos	pcos	PROPN
iajs-108	139	20	and	and	CCONJ
iajs-108	139	21	may	may	AUX
iajs-108	139	22	be	be	AUX
iajs-108	139	23	an	an	DET
iajs-108	139	24	important	important	ADJ
iajs-108	139	25	therapeutic	therapeutic	ADJ
iajs-108	139	26	target	target	NOUN
iajs-108	139	27	for	for	ADP
iajs-108	139	28	pcos	pco	NOUN
iajs-108	139	29	.	.	PUNCT
iajs-108	140	1	references	reference	NOUN
iajs-108	140	2	1	1	NUM
iajs-108	140	3	.	.	PUNCT
iajs-108	141	1	knochenhauser	knochenhauser	ADJ
iajs-108	141	2	,	,	PUNCT
iajs-108	141	3	es	es	NOUN
iajs-108	141	4	.	.	PROPN
iajs-108	141	5	;	;	PUNCT
iajs-108	141	6	key	key	ADJ
iajs-108	141	7	,	,	PUNCT
iajs-108	141	8	tj	tj	PROPN
iajs-108	141	9	.	.	PROPN
iajs-108	141	10	;	;	PUNCT
iajs-108	141	11	kahsar	kahsar	PROPN
iajs-108	141	12	-	-	PUNCT
iajs-108	141	13	miller	miller	PROPN
iajs-108	141	14	,	,	PUNCT
iajs-108	141	15	m.	m.	NOUN
iajs-108	141	16	;	;	PUNCT
iajs-108	141	17	waggoner	waggoner	PROPN
iajs-108	141	18	,	,	PUNCT
iajs-108	141	19	w.	w.	PROPN
iajs-108	141	20	;	;	PUNCT
iajs-108	141	21	boots	boot	NOUN
iajs-108	141	22	,	,	PUNCT
iajs-108	141	23	lr	lr	PROPN
iajs-108	141	24	.	.	PROPN
iajs-108	141	25	;	;	PUNCT
iajs-108	141	26	and	and	CCONJ
iajs-108	141	27	azziz	azziz	PROPN
iajs-108	141	28	r.	r.	PROPN
iajs-108	141	29	,	,	PUNCT
iajs-108	141	30	(	(	PUNCT
iajs-108	141	31	1998	1998	NUM
iajs-108	141	32	)	)	PUNCT
iajs-108	141	33	prevalence	prevalence	NOUN
iajs-108	141	34	of	of	ADP
iajs-108	141	35	the	the	DET
iajs-108	141	36	polycystic	polycystic	ADJ
iajs-108	141	37	ovary	ovary	ADJ
iajs-108	141	38	syndrome	syndrome	NOUN
iajs-108	141	39	in	in	ADP
iajs-108	141	40	unselected	unselected	ADJ
iajs-108	141	41	black	black	ADJ
iajs-108	141	42	and	and	CCONJ
iajs-108	141	43	white	white	ADJ
iajs-108	141	44	women	woman	NOUN
iajs-108	141	45	of	of	ADP
iajs-108	141	46	southeastern	southeastern	ADJ
iajs-108	141	47	united	united	PROPN
iajs-108	141	48	states	states	PROPN
iajs-108	141	49	:	:	PUNCT
iajs-108	141	50	a	a	DET
iajs-108	141	51	prospective	prospective	ADJ
iajs-108	141	52	study	study	NOUN
iajs-108	141	53	.	.	PUNCT
iajs-108	142	1	j	j	PROPN
iajs-108	142	2	clin	clin	PROPN
iajs-108	142	3	.	.	PUNCT
iajs-108	143	1	endocrinol	endocrinol	PROPN
iajs-108	143	2	metab	metab	NOUN
iajs-108	143	3	.	.	PUNCT
iajs-108	144	1	83	83	NUM
iajs-108	144	2	:	:	PUNCT
iajs-108	144	3	3070	3070	NUM
iajs-108	144	4	-	-	SYM
iajs-108	144	5	3078	3078	NUM
iajs-108	144	6	.	.	PUNCT
iajs-108	145	1	2	2	X
iajs-108	145	2	.	.	X
iajs-108	145	3	the	the	DET
iajs-108	145	4	rotterdam	rotterdam	PROPN
iajs-108	145	5	eshre	eshre	PROPN
iajs-108	145	6	/	/	SYM
iajs-108	145	7	asrm	asrm	NOUN
iajs-108	145	8	-	-	PUNCT
iajs-108	145	9	sponsored	sponsor	VERB
iajs-108	145	10	pcos	pcos	PROPN
iajs-108	145	11	consensus	consensus	NOUN
iajs-108	145	12	workshop	workshop	NOUN
iajs-108	145	13	group	group	NOUN
iajs-108	145	14	.	.	PUNCT
iajs-108	146	1	(	(	PUNCT
iajs-108	146	2	2004	2004	NUM
iajs-108	146	3	)	)	PUNCT
iajs-108	146	4	revised	revise	VERB
iajs-108	146	5	2003	2003	NUM
iajs-108	146	6	consensus	consensus	NOUN
iajs-108	146	7	on	on	ADP
iajs-108	146	8	diagnostic	diagnostic	ADJ
iajs-108	146	9	criteria	criterion	NOUN
iajs-108	146	10	and	and	CCONJ
iajs-108	146	11	long	long	ADJ
iajs-108	146	12	-	-	PUNCT
iajs-108	146	13	term	term	NOUN
iajs-108	146	14	health	health	NOUN
iajs-108	146	15	risks	risk	NOUN
iajs-108	146	16	related	relate	VERB
iajs-108	146	17	to	to	ADP
iajs-108	146	18	polycystic	polycystic	ADJ
iajs-108	146	19	ovary	ovary	ADJ
iajs-108	146	20	syndrome	syndrome	NOUN
iajs-108	146	21	(	(	PUNCT
iajs-108	146	22	pcos	pcos	PROPN
iajs-108	146	23	)	)	PUNCT
iajs-108	146	24	.	.	PUNCT
iajs-108	147	1	fertil	fertil	PROPN
iajs-108	147	2	steril	steril	PROPN
iajs-108	147	3	.	.	PROPN
iajs-108	148	1	81(1	81(1	NUM
iajs-108	148	2	):	):	PUNCT
iajs-108	148	3	19	19	NUM
iajs-108	148	4	-	-	SYM
iajs-108	148	5	25	25	NUM
iajs-108	148	6	.	.	PUNCT
iajs-108	149	1	3	3	X
iajs-108	149	2	.	.	X
iajs-108	149	3	tabassum	tabassum	PROPN
iajs-108	149	4	,	,	PUNCT
iajs-108	149	5	r.	r.	PROPN
iajs-108	149	6	;	;	PUNCT
iajs-108	149	7	imtiaz	imtiaz	PROPN
iajs-108	149	8	,	,	PUNCT
iajs-108	149	9	f.	f.	PROPN
iajs-108	149	10	;	;	PUNCT
iajs-108	149	11	sharafat	sharafat	PROPN
iajs-108	149	12	,	,	PUNCT
iajs-108	149	13	s.	s.	PROPN
iajs-108	149	14	;	;	PUNCT
iajs-108	149	15	shukar	shukar	PROPN
iajs-108	149	16	-	-	PUNCT
iajs-108	149	17	ud	ud	ADP
iajs-108	149	18	-	-	PUNCT
iajs-108	149	19	din	din	NOUN
iajs-108	149	20	,	,	PUNCT
iajs-108	149	21	s.	s.	PROPN
iajs-108	149	22	;	;	PUNCT
iajs-108	149	23	and	and	CCONJ
iajs-108	149	24	nusrat	nusrat	PROPN
iajs-108	149	25	,	,	PUNCT
iajs-108	149	26	u.	u.	PROPN
iajs-108	149	27	(	(	PUNCT
iajs-108	149	28	2013	2013	NUM
iajs-108	149	29	)	)	PUNCT
iajs-108	149	30	prevalence	prevalence	NOUN
iajs-108	149	31	and	and	CCONJ
iajs-108	149	32	clinical	clinical	ADJ
iajs-108	149	33	profile	profile	NOUN
iajs-108	149	34	of	of	ADP
iajs-108	149	35	insulin	insulin	NOUN
iajs-108	149	36	resistance	resistance	NOUN
iajs-108	149	37	in	in	ADP
iajs-108	149	38	young	young	ADJ
iajs-108	149	39	women	woman	NOUN
iajs-108	149	40	of	of	ADP
iajs-108	149	41	poly	poly	ADJ
iajs-108	149	42	cystic	cystic	ADJ
iajs-108	149	43	ovary	ovary	ADJ
iajs-108	149	44	syndrome	syndrome	NOUN
iajs-108	149	45	:	:	PUNCT
iajs-108	149	46	a	a	DET
iajs-108	149	47	study	study	NOUN
iajs-108	149	48	from	from	ADP
iajs-108	149	49	pakistan	pakistan	PROPN
iajs-108	149	50	.	.	PUNCT
iajs-108	150	1	j	j	PROPN
iajs-108	150	2	med	med	PROPN
iajs-108	150	3	sci	sci	PROPN
iajs-108	150	4	.	.	PUNCT
iajs-108	151	1	29(2):593	29(2):593	NOUN
iajs-108	151	2	-	-	SYM
iajs-108	151	3	596	596	NUM
iajs-108	151	4	.	.	NOUN
iajs-108	151	5	4	4	NUM
iajs-108	151	6	.	.	X
iajs-108	151	7	legro	legro	NOUN
iajs-108	151	8	,	,	PUNCT
iajs-108	151	9	rs	rs	NOUN
iajs-108	151	10	.	.	PUNCT
iajs-108	151	11	;	;	PUNCT
iajs-108	151	12	kunselman	kunselman	NOUN
iajs-108	151	13	,	,	PUNCT
iajs-108	151	14	ar	ar	PROPN
iajs-108	151	15	.	.	PROPN
iajs-108	151	16	;	;	PUNCT
iajs-108	151	17	dodson	dodson	PROPN
iajs-108	151	18	,	,	PUNCT
iajs-108	151	19	wc	wc	PROPN
iajs-108	151	20	.	.	PROPN
iajs-108	151	21	;	;	PUNCT
iajs-108	151	22	and	and	CCONJ
iajs-108	151	23	  	  	SPACE
iajs-108	151	24	dunaif	dunaif	NOUN
iajs-108	151	25	,	,	PUNCT
iajs-108	151	26	a.	a.	NOUN
iajs-108	151	27	(	(	PUNCT
iajs-108	151	28	1999)prevalence	1999)prevalence	NUM
iajs-108	151	29	and	and	CCONJ
iajs-108	151	30	predictors	predictor	NOUN
iajs-108	151	31	of	of	ADP
iajs-108	151	32	risk	risk	NOUN
iajs-108	151	33	for	for	ADP
iajs-108	151	34	type	type	NOUN
iajs-108	151	35	2	2	NUM
iajs-108	151	36	diabetes	diabetes	NOUN
iajs-108	151	37	mellitus	mellitus	NOUN
iajs-108	151	38	and	and	CCONJ
iajs-108	151	39	impaired	impaired	ADJ
iajs-108	151	40	glucose	glucose	NOUN
iajs-108	151	41	tolerance	tolerance	NOUN
iajs-108	151	42	in	in	ADP
iajs-108	151	43	polycystic	polycystic	ADJ
iajs-108	151	44	ovary	ovary	ADJ
iajs-108	151	45	syndrome	syndrome	NOUN
iajs-108	151	46	:	:	PUNCT
iajs-108	151	47	a	a	DET
iajs-108	151	48	prospective	prospective	ADJ
iajs-108	151	49	,	,	PUNCT
iajs-108	151	50	controlled	control	VERB
iajs-108	151	51	study	study	NOUN
iajs-108	151	52	in	in	ADP
iajs-108	151	53	254	254	NUM
iajs-108	151	54	affected	affected	ADJ
iajs-108	151	55	women	woman	NOUN
iajs-108	151	56	.	.	PUNCT
iajs-108	152	1	j	j	PROPN
iajs-108	152	2	clin	clin	PROPN
iajs-108	152	3	endocrinol	endocrinol	PROPN
iajs-108	152	4	metab	metab	NOUN
iajs-108	152	5	.	.	PUNCT
iajs-108	153	1	84	84	NUM
iajs-108	153	2	:	:	PUNCT
iajs-108	153	3	165–169	165–169	NUM
iajs-108	153	4	.	.	NOUN
iajs-108	153	5	5	5	NUM
iajs-108	153	6	.	.	X
iajs-108	153	7	azevedo	azevedo	PROPN
iajs-108	153	8	,	,	PUNCT
iajs-108	153	9	gd	gd	PROPN
iajs-108	153	10	.	.	PUNCT
iajs-108	153	11	;	;	PUNCT
iajs-108	153	12	duarte	duarte	PROPN
iajs-108	153	13	,	,	PUNCT
iajs-108	153	14	jm	jm	PROPN
iajs-108	153	15	.	.	PROPN
iajs-108	153	16	;	;	PUNCT
iajs-108	153	17	souza	souza	PROPN
iajs-108	153	18	,	,	PUNCT
iajs-108	153	19	mo	mo	PROPN
iajs-108	153	20	.	.	PROPN
iajs-108	153	21	;	;	PUNCT
iajs-108	153	22	costa	costa	PROPN
iajs-108	153	23	-	-	PUNCT
iajs-108	153	24	e	e	NOUN
iajs-108	153	25	-	-	NOUN
iajs-108	153	26	silva	silva	NOUN
iajs-108	153	27	,	,	PUNCT
iajs-108	153	28	td	td	PROPN
iajs-108	153	29	.	.	PUNCT
iajs-108	153	30	;	;	PUNCT
iajs-108	153	31	soares	soare	NOUN
iajs-108	153	32	,	,	PUNCT
iajs-108	153	33	em	em	PRON
iajs-108	153	34	.	.	PUNCT
iajs-108	153	35	&	&	CCONJ
iajs-108	153	36	maranhao	maranhao	PROPN
iajs-108	153	37	tm	tm	PROPN
iajs-108	153	38	.	.	PROPN
iajs-108	153	39	,	,	PUNCT
iajs-108	153	40	(	(	PUNCT
iajs-108	153	41	2006	2006	NUM
iajs-108	153	42	)	)	PUNCT
iajs-108	153	43	menstrual	menstrual	ADJ
iajs-108	153	44	cycle	cycle	NOUN
iajs-108	153	45	irregularity	irregularity	NOUN
iajs-108	153	46	as	as	ADP
iajs-108	153	47	a	a	DET
iajs-108	153	48	marker	marker	NOUN
iajs-108	153	49	of	of	ADP
iajs-108	153	50	cardiovascular	cardiovascular	ADJ
iajs-108	153	51	risk	risk	NOUN
iajs-108	153	52	factors	factor	NOUN
iajs-108	153	53	at	at	ADP
iajs-108	153	54	postmenopausal	postmenopausal	ADJ
iajs-108	153	55	years	year	NOUN
iajs-108	153	56	.	.	PUNCT
iajs-108	154	1	arq	arq	PROPN
iajs-108	154	2	bras	bras	PROPN
iajs-108	154	3	endocrinol	endocrinol	NOUN
iajs-108	154	4	metabol	metabol	NOUN
iajs-108	154	5	.	.	PUNCT
iajs-108	155	1	50	50	NUM
iajs-108	155	2	(	(	PUNCT
iajs-108	155	3	5	5	NUM
iajs-108	155	4	):	):	PUNCT
iajs-108	155	5	876–883	876–883	NUM
iajs-108	155	6	.	.	PUNCT
iajs-108	156	1	6	6	NUM
iajs-108	156	2	.	.	X
iajs-108	156	3	varghese	varghese	PROPN
iajs-108	156	4	,	,	PUNCT
iajs-108	156	5	j.	j.	PROPN
iajs-108	156	6	;	;	PUNCT
iajs-108	156	7	kantharaju	kantharaju	NOUN
iajs-108	156	8	,	,	PUNCT
iajs-108	156	9	s.	s.	PROPN
iajs-108	156	10	;	;	PUNCT
iajs-108	156	11	thunga	thunga	PROPN
iajs-108	156	12	,	,	PUNCT
iajs-108	156	13	s.	s.	PROPN
iajs-108	156	14	;	;	PUNCT
iajs-108	156	15	joseph	joseph	PROPN
iajs-108	156	16	,	,	PUNCT
iajs-108	156	17	n.	n.	PROPN
iajs-108	156	18	;	;	PUNCT
iajs-108	156	19	and	and	CCONJ
iajs-108	156	20	singh	singh	PROPN
iajs-108	156	21	.pk	.pk	PUNCT
iajs-108	156	22	.	.	PUNCT
iajs-108	157	1	(	(	PUNCT
iajs-108	157	2	2015	2015	NUM
iajs-108	157	3	)	)	PUNCT
iajs-108	157	4	prevalence	prevalence	NOUN
iajs-108	157	5	and	and	CCONJ
iajs-108	157	6	predictors	predictor	NOUN
iajs-108	157	7	of	of	ADP
iajs-108	157	8	metabolic	metabolic	NOUN
iajs-108	157	9	syndrome	syndrome	NOUN
iajs-108	157	10	in	in	ADP
iajs-108	157	11	women	woman	NOUN
iajs-108	157	12	with	with	ADP
iajs-108	157	13	polycystic	polycystic	ADJ
iajs-108	157	14	ovarian	ovarian	ADJ
iajs-108	157	15	syndrome	syndrome	NOUN
iajs-108	157	16	:	:	PUNCT
iajs-108	157	17	a	a	DET
iajs-108	157	18	study	study	NOUN
iajs-108	157	19	from	from	ADP
iajs-108	157	20	southern	southern	PROPN
iajs-108	157	21	india	india	PROPN
iajs-108	157	22	.	.	PUNCT
iajs-108	158	1	j	j	PROPN
iajs-108	158	2	reprod	reprod	PROPN
iajs-108	158	3	contracept	contracept	NOUN
iajs-108	158	4	obstet	obstet	NOUN
iajs-108	158	5	gynecol	gynecol	PROPN
iajs-108	158	6	.	.	PUNCT
iajs-108	159	1	4(1):113	4(1):113	NUM
iajs-108	159	2	-	-	SYM
iajs-108	159	3	118	118	NUM
iajs-108	159	4	.	.	PUNCT
iajs-108	160	1	7	7	X
iajs-108	160	2	.	.	X
iajs-108	160	3	ge´rald	ge´rald	PROPN
iajs-108	160	4	j	j	PROPN
iajs-108	160	5	prud’homme	prud’homme	ADJ
iajs-108	160	6	.	.	PUNCT
iajs-108	161	1	(	(	PUNCT
iajs-108	161	2	2007	2007	NUM
iajs-108	161	3	)	)	PUNCT
iajs-108	161	4	pathobiology	pathobiology	NOUN
iajs-108	161	5	of	of	ADP
iajs-108	161	6	transforming	transform	VERB
iajs-108	161	7	growth	growth	NOUN
iajs-108	161	8	factor	factor	NOUN
iajs-108	161	9	b	b	PROPN
iajs-108	161	10	in	in	ADP
iajs-108	161	11	cancer	cancer	NOUN
iajs-108	161	12	,	,	PUNCT
iajs-108	161	13	fibrosis	fibrosis	NOUN
iajs-108	161	14	,	,	PUNCT
iajs-108	161	15	and	and	CCONJ
iajs-108	161	16	immunologic	immunologic	ADJ
iajs-108	161	17	disease	disease	NOUN
iajs-108	161	18	,	,	PUNCT
iajs-108	161	19	and	and	CCONJ
iajs-108	161	20	therapeutic	therapeutic	ADJ
iajs-108	161	21	considerations	consideration	NOUN
iajs-108	161	22	.	.	PUNCT
iajs-108	162	1	laboratory	laboratory	NOUN
iajs-108	162	2	investigation	investigation	NOUN
iajs-108	162	3	.	.	PUNCT
iajs-108	163	1	87	87	NUM
iajs-108	163	2	:	:	SYM
iajs-108	163	3	1077–1091	1077–1091	NUM
iajs-108	163	4	.	.	NOUN
iajs-108	163	5	8	8	NUM
iajs-108	163	6	.	.	PUNCT
iajs-108	164	1	hyytiainen	hyytiainen	PROPN
iajs-108	164	2	,	,	PUNCT
iajs-108	164	3	m.	m.	NOUN
iajs-108	164	4	;	;	PUNCT
iajs-108	164	5	penttinen	penttinen	NOUN
iajs-108	164	6	,	,	PUNCT
iajs-108	164	7	c.	c.	PROPN
iajs-108	164	8	;	;	PUNCT
iajs-108	164	9	and	and	CCONJ
iajs-108	164	10	keski	keski	PROPN
iajs-108	164	11	-	-	PUNCT
iajs-108	164	12	oja	oja	NOUN
iajs-108	164	13	,	,	PUNCT
iajs-108	164	14	j.	j.	PROPN
iajs-108	164	15	(	(	PUNCT
iajs-108	164	16	2004	2004	NUM
iajs-108	164	17	)	)	PUNCT
iajs-108	164	18	latent	latent	PROPN
iajs-108	164	19	tgf	tgf	PROPN
iajs-108	164	20	-	-	PUNCT
iajs-108	164	21	beta	beta	ADJ
iajs-108	164	22	binding	bind	VERB
iajs-108	164	23	proteins	protein	NOUN
iajs-108	164	24	:	:	PUNCT
iajs-108	164	25	extracellular	extracellular	ADJ
iajs-108	164	26	matrix	matrix	NOUN
iajs-108	164	27	association	association	NOUN
iajs-108	164	28	and	and	CCONJ
iajs-108	164	29	roles	role	NOUN
iajs-108	164	30	in	in	ADP
iajs-108	164	31	tgf	tgf	NOUN
iajs-108	164	32	-	-	PUNCT
iajs-108	164	33	beta	beta	NOUN
iajs-108	164	34	activation	activation	NOUN
iajs-108	164	35	.	.	PUNCT
iajs-108	165	1	crit	crit	PROPN
iajs-108	165	2	rev	rev	PROPN
iajs-108	165	3	clin	clin	PROPN
iajs-108	165	4	lab	lab	PROPN
iajs-108	165	5	sci	sci	PROPN
iajs-108	165	6	.	.	PROPN
iajs-108	166	1	4	4	NUM
iajs-108	166	2	:	:	SYM
iajs-108	166	3	233–264	233–264	NUM
iajs-108	166	4	.	.	PUNCT
iajs-108	167	1	9	9	X
iajs-108	167	2	.	.	X
iajs-108	167	3	welt	welt	PROPN
iajs-108	167	4	,	,	PUNCT
iajs-108	167	5	ck	ck	PROPN
iajs-108	167	6	.	.	PUNCT
iajs-108	167	7	;	;	PUNCT
iajs-108	168	1	taylor	taylor	PROPN
iajs-108	168	2	,	,	PUNCT
iajs-108	168	3	ae	ae	PROPN
iajs-108	168	4	.	.	PUNCT
iajs-108	168	5	;	;	PUNCT
iajs-108	168	6	fox	fox	PROPN
iajs-108	168	7	,	,	PUNCT
iajs-108	168	8	j.	j.	PROPN
iajs-108	168	9	;	;	PUNCT
iajs-108	168	10	messerlian	messerlian	PROPN
iajs-108	168	11	,	,	PUNCT
iajs-108	168	12	gm	gm	PROPN
iajs-108	168	13	.	.	PUNCT
iajs-108	168	14	;	;	PUNCT
iajs-108	168	15	adams	adams	PROPN
iajs-108	168	16	,	,	PUNCT
iajs-108	168	17	jm	jm	PROPN
iajs-108	168	18	.	.	PROPN
iajs-108	168	19	;	;	PUNCT
iajs-108	168	20	and	and	CCONJ
iajs-108	168	21	schneyer	schneyer	PROPN
iajs-108	168	22	al	al	PROPN
iajs-108	168	23	.	.	PROPN
iajs-108	168	24	(	(	PUNCT
iajs-108	168	25	2005	2005	NUM
iajs-108	168	26	)	)	PUNCT
iajs-108	168	27	follicular	follicular	ADJ
iajs-108	168	28	arrest	arrest	NOUN
iajs-108	168	29	in	in	ADP
iajs-108	168	30	polycystic	polycystic	ADJ
iajs-108	168	31	ovary	ovary	ADJ
iajs-108	168	32	syndrome	syndrome	NOUN
iajs-108	168	33	is	be	AUX
iajs-108	168	34	associated	associate	VERB
iajs-108	168	35	with	with	ADP
iajs-108	168	36	deficient	deficient	ADJ
iajs-108	168	37	inhibin	inhibin	ADJ
iajs-108	168	38	a	a	DET
iajs-108	168	39	and	and	CCONJ
iajs-108	168	40	b	b	NOUN
iajs-108	168	41	biosynthesis	biosynthesis	NOUN
iajs-108	168	42	.	.	PUNCT
iajs-108	169	1	j	j	PROPN
iajs-108	169	2	clin	clin	PROPN
iajs-108	169	3	endocrinol	endocrinol	PROPN
iajs-108	169	4	metab	metab	NOUN
iajs-108	169	5	.	.	PUNCT
iajs-108	170	1	90(10):5582	90(10):5582	NUM
iajs-108	170	2	-	-	SYM
iajs-108	170	3	5587	5587	NUM
iajs-108	170	4	.	.	PUNCT
iajs-108	171	1	10	10	NUM
iajs-108	171	2	.	.	X
iajs-108	172	1	raja	raja	PROPN
iajs-108	172	2	,	,	PUNCT
iajs-108	172	3	n.	n.	NOUN
iajs-108	172	4	;	;	PUNCT
iajs-108	172	5	margrit	margrit	NOUN
iajs-108	172	6	,	,	PUNCT
iajs-108	172	7	u.	u.	PROPN
iajs-108	172	8	;	;	PUNCT
iajs-108	172	9	raymond	raymond	PROPN
iajs-108	172	10	,	,	PUNCT
iajs-108	172	11	j.	j.	PROPN
iajs-108	172	12	r.	r.	PROPN
iajs-108	172	13	;	;	PUNCT
iajs-108	172	14	and	and	CCONJ
iajs-108	172	15	richard	richard	PROPN
iajs-108	172	16	,	,	PUNCT
iajs-108	172	17	s.	s.	PROPN
iajs-108	172	18	l.	l.	PROPN
iajs-108	172	19	(	(	PUNCT
iajs-108	172	20	2014	2014	NUM
iajs-108	172	21	)	)	PUNCT
iajs-108	172	22	the	the	DET
iajs-108	172	23	role	role	NOUN
iajs-108	172	24	of	of	ADP
iajs-108	172	25	tgf	tgf	PROPN
iajs-108	172	26	-	-	PUNCT
iajs-108	172	27	b	b	PROPN
iajs-108	172	28	in	in	ADP
iajs-108	172	29	polycystic	polycystic	ADJ
iajs-108	172	30	ovary	ovary	ADJ
iajs-108	172	31	syndrome	syndrome	NOUN
iajs-108	172	32	.	.	PUNCT
iajs-108	173	1	reproductive	reproductive	ADJ
iajs-108	173	2	sciences	sciences	PROPN
iajs-108	173	3	.	.	PUNCT
iajs-108	174	1	21(1	21(1	NUM
iajs-108	174	2	):	):	PUNCT
iajs-108	174	3	20	20	NUM
iajs-108	174	4	-	-	SYM
iajs-108	174	5	31	31	NUM
iajs-108	174	6	.	.	PUNCT
iajs-108	175	1	11	11	NUM
iajs-108	175	2	.	.	PUNCT
iajs-108	176	1	victor	victor	PROPN
iajs-108	176	2	,	,	PUNCT
iajs-108	176	3	h.	h.	PROPN
iajs-108	176	4	;	;	PUNCT
iajs-108	176	5	elizabeth	elizabeth	PROPN
iajs-108	176	6	,	,	PUNCT
iajs-108	176	7	j.	j.	PROPN
iajs-108	176	8	;	;	PUNCT
iajs-108	176	9	spencer	spencer	PROPN
iajs-108	176	10	,	,	PUNCT
iajs-108	176	11	s.	s.	PROPN
iajs-108	176	12	;	;	PUNCT
iajs-108	176	13	alan	alan	PROPN
iajs-108	176	14	,	,	PUNCT
iajs-108	176	15	s.r	s.r	PROPN
iajs-108	176	16	.	.	PROPN
iajs-108	176	17	;	;	PUNCT
iajs-108	176	18	and	and	CCONJ
iajs-108	176	19	patricia	patricia	PROPN
iajs-108	176	20	,	,	PUNCT
iajs-108	176	21	g.	g.	PROPN
iajs-108	176	22	(	(	PUNCT
iajs-108	176	23	1997	1997	NUM
iajs-108	176	24	)	)	PUNCT
iajs-108	176	25	serum	serum	NOUN
iajs-108	176	26	ferritin	ferritin	ADJ
iajs-108	176	27	iron	iron	NOUN
iajs-108	176	28	,	,	PUNCT
iajs-108	176	29	a	a	DET
iajs-108	176	30	new	new	ADJ
iajs-108	176	31	test	test	NOUN
iajs-108	176	32	,	,	PUNCT
iajs-108	176	33	measures	measure	VERB
iajs-108	176	34	human	human	ADJ
iajs-108	176	35	body	body	NOUN
iajs-108	176	36	iron	iron	NOUN
iajs-108	176	37	stores	store	NOUN
iajs-108	176	38	uncompounded	uncompounde	VERB
iajs-108	176	39	by	by	ADP
iajs-108	176	40	inflammation	inflammation	NOUN
iajs-108	176	41	.	.	PUNCT
iajs-108	177	1	stem	stem	NOUN
iajs-108	177	2	cells	cell	NOUN
iajs-108	177	3	.	.	PUNCT
iajs-108	178	1	15	15	NUM
iajs-108	178	2	:	:	PUNCT
iajs-108	178	3	291	291	NUM
iajs-108	178	4	-	-	SYM
iajs-108	178	5	296	296	NUM
iajs-108	178	6	.	.	PUNCT
iajs-108	179	1	12	12	NUM
iajs-108	179	2	.	.	X
iajs-108	180	1	po	po	NOUN
iajs-108	180	2	-	-	PUNCT
iajs-108	180	3	chun	chun	PROPN
iajs-108	180	4	ko	ko	PROPN
iajs-108	180	5	;	;	PUNCT
iajs-108	180	6	shih	shih	PROPN
iajs-108	180	7	-	-	PUNCT
iajs-108	180	8	yi	yi	PROPN
iajs-108	180	9	huang	huang	PROPN
iajs-108	180	10	;	;	PUNCT
iajs-108	180	11	ching	che	VERB
iajs-108	180	12	-	-	PUNCT
iajs-108	180	13	hung	hang	VERB
iajs-108	180	14	hsieh	hsieh	PROPN
iajs-108	180	15	;	;	PUNCT
iajs-108	180	16	ming	me	VERB
iajs-108	180	17	-	-	PUNCT
iajs-108	180	18	i	i	PRON
iajs-108	180	19	hsu	hsu	PROPN
iajs-108	180	20	;	;	PUNCT
iajs-108	180	21	chun	chun	PROPN
iajs-108	180	22	-	-	PUNCT
iajs-108	180	23	sen	sen	PROPN
iajs-108	180	24	hsu	hsu	PROPN
iajs-108	180	25	.	.	PUNCT
iajs-108	181	1	(	(	PUNCT
iajs-108	181	2	2015	2015	NUM
iajs-108	181	3	)	)	PUNCT
iajs-108	181	4	serum	serum	NOUN
iajs-108	181	5	ferritin	ferritin	ADJ
iajs-108	181	6	levels	level	NOUN
iajs-108	181	7	and	and	CCONJ
iajs-108	181	8	polycystic	polycystic	ADJ
iajs-108	181	9	ovary	ovary	ADJ
iajs-108	181	10	syndrome	syndrome	NOUN
iajs-108	181	11	in	in	ADP
iajs-108	181	12	obese	obese	NOUN
iajs-108	181	13	and	and	CCONJ
iajs-108	181	14	nonobese	nonobese	ADJ
iajs-108	181	15	women	woman	NOUN
iajs-108	181	16	.	.	PUNCT
iajs-108	182	1	taiwanese	taiwanese	ADJ
iajs-108	182	2	journal	journal	NOUN
iajs-108	182	3	of	of	ADP
iajs-108	182	4	obstetrics	obstetric	NOUN
iajs-108	182	5	&	&	CCONJ
iajs-108	182	6	gynecology	gynecology	NOUN
iajs-108	182	7	.	.	PUNCT
iajs-108	183	1	54	54	NUM
iajs-108	183	2	:	:	PUNCT
iajs-108	183	3	403	403	NUM
iajs-108	183	4	-	-	SYM
iajs-108	183	5	407	407	NUM
iajs-108	183	6	.	.	PUNCT
iajs-108	184	1	13	13	NUM
iajs-108	184	2	.	.	PUNCT
iajs-108	185	1	ferna´ndez	ferna´ndez	NOUN
iajs-108	185	2	-	-	PUNCT
iajs-108	185	3	real	real	ADJ
iajs-108	185	4	,	,	PUNCT
iajs-108	185	5	j.m	j.m	PROPN
iajs-108	185	6	;	;	PUNCT
iajs-108	185	7	abel	abel	PROPN
iajs-108	185	8	l.b	l.b	PROPN
iajs-108	185	9	;	;	PUNCT
iajs-108	185	10	and	and	CCONJ
iajs-108	185	11	wifredo	wifredo	PROPN
iajs-108	185	12	ricart	ricart	PROPN
iajs-108	185	13	.	.	PUNCT
iajs-108	186	1	(	(	PUNCT
iajs-108	186	2	2002	2002	NUM
iajs-108	186	3	)	)	PUNCT
iajs-108	186	4	cross	cross	NOUN
iajs-108	186	5	-	-	NOUN
iajs-108	186	6	talk	talk	NOUN
iajs-108	186	7	between	between	ADP
iajs-108	186	8	iron	iron	NOUN
iajs-108	186	9	metabolism	metabolism	NOUN
iajs-108	186	10	and	and	CCONJ
iajs-108	186	11	diabetes	diabetes	NOUN
iajs-108	186	12	.	.	PUNCT
iajs-108	187	1	diabetes	diabetes	NOUN
iajs-108	187	2	.	.	PUNCT
iajs-108	188	1	51	51	NUM
iajs-108	188	2	:	:	SYM
iajs-108	188	3	2348–2354	2348–2354	NUM
iajs-108	188	4	.	.	NOUN
iajs-108	189	1	14	14	NUM
iajs-108	189	2	.	.	PUNCT
iajs-108	190	1	luque	luque	PROPN
iajs-108	190	2	-	-	PUNCT
iajs-108	190	3	ramirez	ramirez	PROPN
iajs-108	190	4	,	,	PUNCT
iajs-108	190	5	m	m	PROPN
iajs-108	190	6	;	;	PUNCT
iajs-108	190	7	francisco	francisco	PROPN
iajs-108	190	8	a	a	NOUN
iajs-108	190	9	;	;	PUNCT
iajs-108	190	10	lvarez	lvarez	NOUN
iajs-108	190	11	-	-	PUNCT
iajs-108	190	12	blasco	blasco	PROPN
iajs-108	190	13	;	;	PUNCT
iajs-108	190	14	macarena	macarena	PROPN
iajs-108	190	15	alpan	alpan	PROPN
iajs-108	190	16	;	;	PUNCT
iajs-108	190	17	and	and	CCONJ
iajs-108	190	18	hector	hector	PROPN
iajs-108	190	19	f.	f.	PROPN
iajs-108	190	20	(	(	PUNCT
iajs-108	190	21	2011	2011	NUM
iajs-108	190	22	)	)	PUNCT
iajs-108	190	23	role	role	NOUN
iajs-108	190	24	of	of	ADP
iajs-108	190	25	decreased	decrease	VERB
iajs-108	190	26	circulating	circulate	VERB
iajs-108	190	27	hepcidin	hepcidin	VERB
iajs-108	190	28	concentrations	concentration	NOUN
iajs-108	190	29	in	in	ADP
iajs-108	190	30	the	the	DET
iajs-108	190	31	iron	iron	NOUN
iajs-108	190	32	excess	excess	NOUN
iajs-108	190	33	of	of	ADP
iajs-108	190	34	women	woman	NOUN
iajs-108	190	35	with	with	ADP
iajs-108	190	36	the	the	DET
iajs-108	190	37	polycystic	polycystic	ADJ
iajs-108	190	38	ovary	ovary	ADJ
iajs-108	190	39	syndrome	syndrome	NOUN
iajs-108	190	40	.	.	PUNCT
iajs-108	191	1	j.	j.	PROPN
iajs-108	191	2	clin	clin	PROPN
iajs-108	191	3	.	.	PUNCT
iajs-108	192	1	endocrinol	endocrinol	NOUN
iajs-108	192	2	.	.	PUNCT
iajs-108	193	1	metab	metab	NOUN
iajs-108	193	2	.	.	PUNCT
iajs-108	194	1	96	96	NUM
iajs-108	194	2	:	:	PUNCT
iajs-108	194	3	846–852	846–852	NUM
iajs-108	194	4	.	.	PUNCT
iajs-108	195	1	15	15	NUM
iajs-108	195	2	.	.	X
iajs-108	195	3	bachman	bachman	NOUN
iajs-108	195	4	,	,	PUNCT
iajs-108	195	5	e.	e.	PROPN
iajs-108	195	6	;	;	PUNCT
iajs-108	195	7	rui	rui	PROPN
iajs-108	195	8	feng	feng	PROPN
iajs-108	195	9	;	;	PUNCT
iajs-108	195	10	thomas	thomas	PROPN
iajs-108	195	11	travison	travison	PROPN
iajs-108	195	12	;	;	PUNCT
iajs-108	195	13	michelle	michelle	PROPN
iajs-108	195	14	,	,	PUNCT
iajs-108	195	15	li	li	PROPN
iajs-108	195	16	.	.	PROPN
iajs-108	195	17	;	;	PUNCT
iajs-108	195	18	gordana	gordana	PROPN
iajs-108	195	19	olbina	olbina	PROPN
iajs-108	195	20	;	;	PUNCT
iajs-108	195	21	vaughn	vaughn	PROPN
iajs-108	195	22	ostland	ostland	PROPN
iajs-108	195	23	;	;	PUNCT
iajs-108	195	24	jagadish	jagadish	PROPN
iajs-108	195	25	ulloor	ulloor	ADV
iajs-108	195	26	;	;	PUNCT
iajs-108	195	27	anqi	anqi	PROPN
iajs-108	195	28	zhang	zhang	PROPN
iajs-108	195	29	;	;	PUNCT
iajs-108	195	30	shehzad	shehzad	PROPN
iajs-108	195	31	basaria	basaria	PROPN
iajs-108	195	32	;	;	PUNCT
iajs-108	195	33	tomas	tomas	PROPN
iajs-108	195	34	ganz	ganz	PROPN
iajs-108	195	35	;	;	PUNCT
iajs-108	195	36	mark	mark	PROPN
iajs-108	195	37	westerman	westerman	PROPN
iajs-108	195	38	;	;	PUNCT
iajs-108	195	39	and	and	CCONJ
iajs-108	195	40	shalender	shalender	NOUN
iajs-108	195	41	bhasin	bhasin	NOUN
iajs-108	195	42	.	.	PUNCT
iajs-108	196	1	(	(	PUNCT
iajs-108	196	2	2010	2010	NUM
iajs-108	196	3	)	)	PUNCT
iajs-108	196	4	testosterone	testosterone	NOUN
iajs-108	196	5	suppresses	suppress	VERB
iajs-108	196	6	hepcidin	hepcidin	VERB
iajs-108	196	7	in	in	ADP
iajs-108	196	8	men	man	NOUN
iajs-108	196	9	:	:	PUNCT
iajs-108	196	10	a	a	DET
iajs-108	196	11	potential	potential	ADJ
iajs-108	196	12	mechanism	mechanism	NOUN
iajs-108	196	13	for	for	ADP
iajs-108	196	14	testosteroneinduced	testosteroneinduced	ADJ
iajs-108	196	15	erythrocytosis	erythrocytosis	NOUN
iajs-108	196	16	.	.	PUNCT
iajs-108	197	1	j.	j.	PROPN
iajs-108	197	2	clin	clin	PROPN
iajs-108	197	3	.	.	PUNCT
iajs-108	198	1	endocrinol	endocrinol	NOUN
iajs-108	198	2	.	.	PUNCT
iajs-108	199	1	metab	metab	NOUN
iajs-108	199	2	.	.	PUNCT
iajs-108	200	1	95	95	NUM
iajs-108	200	2	:	:	PUNCT
iajs-108	200	3	4743–4747	4743–4747	NUM
iajs-108	200	4	.	.	PUNCT
iajs-108	201	1	chemistry	chemistry	NOUN
iajs-108	201	2	|	|	ADV
iajs-108	201	3	177	177	NUM
iajs-108	201	4	2016	2016	NUM
iajs-108	201	5	)	)	PUNCT
iajs-108	201	6	عام	عام	ADP
iajs-108	201	7	2العدد	2العدد	NUM
iajs-108	201	8	(	(	PUNCT
iajs-108	201	9	29مجلة	29مجلة	NUM
iajs-108	201	10	إبن	إبن	VERB
iajs-108	201	11	الهيثم	الهيثم	ADJ
iajs-108	201	12	للعلوم	للعلوم	NOUN
iajs-108	201	13	الصرفة	الصرفة	NOUN
iajs-108	202	1	و	و	PRON
iajs-108	202	2	التطبيقية	التطبيقية	ADV
iajs-108	202	3	المجلد	المجلد	VERB
iajs-108	202	4	ibn	ibn	PROPN
iajs-108	202	5	al	al	PROPN
iajs-108	202	6	-	-	PUNCT
iajs-108	202	7	haitham	haitham	PROPN
iajs-108	202	8	jour	jour	X
iajs-108	202	9	.	.	PROPN
iajs-108	203	1	for	for	ADP
iajs-108	203	2	pure	pure	ADJ
iajs-108	203	3	&	&	CCONJ
iajs-108	203	4	appl	appl	PROPN
iajs-108	203	5	.	.	PUNCT
iajs-108	204	1	sci	sci	PROPN
iajs-108	204	2	.	.	PUNCT
iajs-108	204	3	vol	vol	NOUN
iajs-108	204	4	.	.	PROPN
iajs-108	204	5	29	29	NUM
iajs-108	204	6	(	(	PUNCT
iajs-108	204	7	2	2	NUM
iajs-108	204	8	)	)	PUNCT
iajs-108	204	9	2016	2016	NUM
iajs-108	204	10	16	16	NUM
iajs-108	204	11	.	.	PUNCT
iajs-108	205	1	escobar	escobar	NOUN
iajs-108	205	2	-	-	PUNCT
iajs-108	205	3	morreale	morreale	PROPN
iajs-108	205	4	,	,	PUNCT
iajs-108	205	5	h.f	h.f	PROPN
iajs-108	205	6	;	;	PUNCT
iajs-108	205	7	and	and	CCONJ
iajs-108	205	8	luque	luque	PROPN
iajs-108	205	9	-	-	PUNCT
iajs-108	205	10	ramirez	ramirez	PROPN
iajs-108	205	11	,	,	PUNCT
iajs-108	205	12	m.	m.	NOUN
iajs-108	205	13	(	(	PUNCT
iajs-108	205	14	2011	2011	NUM
iajs-108	205	15	)	)	PUNCT
iajs-108	205	16	role	role	NOUN
iajs-108	205	17	of	of	ADP
iajs-108	205	18	androgen	androgen	NOUN
iajs-108	205	19	-	-	PUNCT
iajs-108	205	20	mediated	mediate	VERB
iajs-108	205	21	enhancement	enhancement	NOUN
iajs-108	205	22	of	of	ADP
iajs-108	205	23	erythropoiesis	erythropoiesis	NOUN
iajs-108	205	24	in	in	ADP
iajs-108	205	25	the	the	DET
iajs-108	205	26	increased	increase	VERB
iajs-108	205	27	body	body	NOUN
iajs-108	205	28	iron	iron	NOUN
iajs-108	205	29	stores	store	NOUN
iajs-108	205	30	of	of	ADP
iajs-108	205	31	patients	patient	NOUN
iajs-108	205	32	with	with	ADP
iajs-108	205	33	polycystic	polycystic	ADJ
iajs-108	205	34	ovary	ovary	ADJ
iajs-108	205	35	syndrome	syndrome	NOUN
iajs-108	205	36	.	.	PUNCT
iajs-108	206	1	fertil	fertil	PROPN
iajs-108	206	2	.	.	PUNCT
iajs-108	207	1	steril	steril	PROPN
iajs-108	207	2	.	.	PROPN
iajs-108	208	1	95	95	NUM
iajs-108	208	2	:	:	SYM
iajs-108	208	3	1730–1735	1730–1735	NUM
iajs-108	208	4	.	.	PUNCT
iajs-108	209	1	17	17	NUM
iajs-108	209	2	.	.	PUNCT
iajs-108	210	1	balen	balen	VERB
iajs-108	210	2	,	,	PUNCT
iajs-108	210	3	ah	ah	INTJ
iajs-108	210	4	.	.	PUNCT
iajs-108	210	5	;	;	PUNCT
iajs-108	210	6	laven	laven	PROPN
iajs-108	210	7	,	,	PUNCT
iajs-108	210	8	js	js	PROPN
iajs-108	210	9	.	.	PUNCT
iajs-108	210	10	;	;	PUNCT
iajs-108	210	11	tan	tan	PROPN
iajs-108	210	12	sl	sl	PROPN
iajs-108	210	13	&	&	CCONJ
iajs-108	210	14	dewailly	dewailly	PROPN
iajs-108	210	15	d.	d.	PROPN
iajs-108	210	16	(	(	PUNCT
iajs-108	210	17	2003	2003	NUM
iajs-108	210	18	)	)	PUNCT
iajs-108	210	19	ultrasound	ultrasound	NOUN
iajs-108	210	20	assessment	assessment	NOUN
iajs-108	210	21	of	of	ADP
iajs-108	210	22	the	the	DET
iajs-108	210	23	polycystic	polycystic	ADJ
iajs-108	210	24	ovary	ovary	NOUN
iajs-108	210	25	:	:	PUNCT
iajs-108	210	26	international	international	ADJ
iajs-108	210	27	consensus	consensus	NOUN
iajs-108	210	28	definitions	definition	NOUN
iajs-108	210	29	.	.	PUNCT
iajs-108	211	1	hum	hum	PROPN
iajs-108	211	2	reprod	reprod	PROPN
iajs-108	211	3	update	update	NOUN
iajs-108	211	4	.	.	PUNCT
iajs-108	212	1	9(6	9(6	NUM
iajs-108	212	2	):	):	PUNCT
iajs-108	212	3	505–514	505–514	NUM
iajs-108	212	4	.	.	PUNCT
iajs-108	213	1	18	18	NUM
iajs-108	213	2	.	.	NUM
iajs-108	214	1	garabed	garabe	VERB
iajs-108	214	2	,	,	PUNCT
iajs-108	214	3	e.	e.	PROPN
iajs-108	214	4	;	;	PUNCT
iajs-108	214	5	and	and	CCONJ
iajs-108	214	6	adolphe	adolphe	PROPN
iajs-108	214	7	quetelet	quetelet	PROPN
iajs-108	214	8	(	(	PUNCT
iajs-108	214	9	1796	1796	NUM
iajs-108	214	10	-	-	SYM
iajs-108	214	11	1874	1874	NUM
iajs-108	214	12	)	)	PUNCT
iajs-108	214	13	.	.	PUNCT
iajs-108	215	1	(	(	PUNCT
iajs-108	215	2	2008	2008	NUM
iajs-108	215	3	)	)	PUNCT
iajs-108	215	4	the	the	DET
iajs-108	215	5	average	average	ADJ
iajs-108	215	6	man	man	NOUN
iajs-108	215	7	and	and	CCONJ
iajs-108	215	8	indices	index	NOUN
iajs-108	215	9	of	of	ADP
iajs-108	215	10	obesity	obesity	NOUN
iajs-108	215	11	.	.	PUNCT
iajs-108	216	1	nephrol	nephrol	PROPN
iajs-108	216	2	.	.	PUNCT
iajs-108	217	1	dial	dial	NOUN
iajs-108	217	2	.	.	PUNCT
iajs-108	218	1	transplant	transplant	NOUN
iajs-108	218	2	.	.	PUNCT
iajs-108	219	1	23(1	23(1	ADV
iajs-108	219	2	):	):	PUNCT
iajs-108	219	3	47	47	NUM
iajs-108	219	4	-	-	SYM
iajs-108	219	5	51	51	NUM
iajs-108	219	6	.	.	NOUN
iajs-108	220	1	19	19	NUM
iajs-108	220	2	.	.	PUNCT
iajs-108	221	1	trinder	trinder	PROPN
iajs-108	221	2	,	,	PUNCT
iajs-108	221	3	p.	p.	NOUN
iajs-108	221	4	(	(	PUNCT
iajs-108	221	5	1969	1969	NUM
iajs-108	221	6	)	)	PUNCT
iajs-108	221	7	determination	determination	NOUN
iajs-108	221	8	of	of	ADP
iajs-108	221	9	blood	blood	NOUN
iajs-108	221	10	glucose	glucose	NOUN
iajs-108	221	11	using	use	VERB
iajs-108	221	12	4	4	NUM
iajs-108	221	13	-	-	PUNCT
iajs-108	221	14	amino	amino	NOUN
iajs-108	221	15	phenazone	phenazone	NOUN
iajs-108	221	16	as	as	ADP
iajs-108	221	17	oxygen	oxygen	NOUN
iajs-108	221	18	acceptor	acceptor	NOUN
iajs-108	221	19	.	.	PUNCT
iajs-108	222	1	j	j	PROPN
iajs-108	222	2	clin	clin	PROPN
iajs-108	222	3	pathol	pathol	PROPN
iajs-108	222	4	.	.	PUNCT
iajs-108	223	1	22	22	NUM
iajs-108	223	2	:	:	PUNCT
iajs-108	223	3	246	246	NUM
iajs-108	223	4	-	-	SYM
iajs-108	223	5	245	245	NUM
iajs-108	223	6	.	.	NOUN
iajs-108	224	1	20	20	NUM
iajs-108	224	2	.	.	PUNCT
iajs-108	224	3	filer	filer	NOUN
iajs-108	224	4	,	,	PUNCT
iajs-108	224	5	j.	j.	PROPN
iajs-108	224	6	s.	s.	PROPN
iajs-108	224	7	;	;	PUNCT
iajs-108	224	8	kahn	kahn	PROPN
iajs-108	224	9	,	,	PUNCT
iajs-108	224	10	c.	c.	PROPN
iajs-108	224	11	r.	r.	PROPN
iajs-108	224	12	;	;	PUNCT
iajs-108	224	13	and	and	CCONJ
iajs-108	224	14	roth	roth	PROPN
iajs-108	224	15	,	,	PUNCT
iajs-108	224	16	j.	j.	PROPN
iajs-108	224	17	(	(	PUNCT
iajs-108	224	18	1979	1979	NUM
iajs-108	224	19	)	)	PUNCT
iajs-108	224	20	receptors	receptor	NOUN
iajs-108	224	21	,	,	PUNCT
iajs-108	224	22	interceptor	interceptor	NOUN
iajs-108	224	23	antibodies	antibody	NOUN
iajs-108	224	24	and	and	CCONJ
iajs-108	224	25	mechanisms	mechanism	NOUN
iajs-108	224	26	of	of	ADP
iajs-108	224	27	insulin	insulin	NOUN
iajs-108	224	28	resistance	resistance	NOUN
iajs-108	224	29	.	.	PUNCT
iajs-108	225	1	n.	n.	PROPN
iajs-108	225	2	engl	engl	PROPN
iajs-108	225	3	.	.	PUNCT
iajs-108	226	1	j.	j.	PROPN
iajs-108	226	2	med	med	PROPN
iajs-108	226	3	.	.	PUNCT
iajs-108	227	1	300(8	300(8	NUM
iajs-108	227	2	):	):	PUNCT
iajs-108	227	3	413	413	NUM
iajs-108	227	4	-	-	SYM
iajs-108	227	5	419	419	NUM
iajs-108	227	6	.	.	PUNCT
iajs-108	228	1	21	21	NUM
iajs-108	228	2	.	.	PUNCT
iajs-108	228	3	wallace	wallace	PROPN
iajs-108	228	4	,	,	PUNCT
iajs-108	228	5	tm	tm	PROPN
iajs-108	228	6	.	.	PROPN
iajs-108	228	7	;	;	PUNCT
iajs-108	228	8	levy	levy	NOUN
iajs-108	228	9	,	,	PUNCT
iajs-108	228	10	jc	jc	PROPN
iajs-108	228	11	.	.	PROPN
iajs-108	228	12	;	;	PUNCT
iajs-108	228	13	and	and	CCONJ
iajs-108	228	14	matthws	matthws	PROPN
iajs-108	228	15	dr	dr	PROPN
iajs-108	228	16	.	.	PROPN
iajs-108	228	17	(	(	PUNCT
iajs-108	228	18	2004	2004	NUM
iajs-108	228	19	)	)	PUNCT
iajs-108	228	20	use	use	NOUN
iajs-108	228	21	and	and	CCONJ
iajs-108	228	22	abuse	abuse	NOUN
iajs-108	228	23	of	of	ADP
iajs-108	228	24	homa	homa	NOUN
iajs-108	228	25	modeling	modeling	NOUN
iajs-108	228	26	.	.	PUNCT
iajs-108	229	1	diabetes	diabetes	NOUN
iajs-108	229	2	care	care	NOUN
iajs-108	229	3	.	.	PUNCT
iajs-108	230	1	27(6	27(6	NUM
iajs-108	230	2	):	):	PUNCT
iajs-108	230	3	1487	1487	NUM
iajs-108	230	4	-	-	SYM
iajs-108	230	5	1495	1495	NUM
iajs-108	230	6	.	.	PUNCT
iajs-108	231	1	22	22	NUM
iajs-108	231	2	.	.	PUNCT
iajs-108	232	1	polson	polson	PROPN
iajs-108	232	2	,	,	PUNCT
iajs-108	232	3	r.j	r.j	PROPN
iajs-108	232	4	;	;	PUNCT
iajs-108	232	5	and	and	CCONJ
iajs-108	232	6	dawson	dawson	PROPN
iajs-108	232	7	,	,	PUNCT
iajs-108	232	8	d.w	d.w	PROPN
iajs-108	232	9	.	.	PROPN
iajs-108	232	10	,	,	PUNCT
iajs-108	232	11	(	(	PUNCT
iajs-108	232	12	1988	1988	NUM
iajs-108	232	13	)	)	PUNCT
iajs-108	232	14	measurement	measurement	NOUN
iajs-108	232	15	of	of	ADP
iajs-108	232	16	ferritin	ferritin	ADJ
iajs-108	232	17	in	in	ADP
iajs-108	232	18	serum	serum	NOUN
iajs-108	232	19	by	by	ADP
iajs-108	232	20	an	an	DET
iajs-108	232	21	indirect	indirect	ADJ
iajs-108	232	22	competitive	competitive	ADJ
iajs-108	232	23	enzyme	enzyme	NOUN
iajs-108	232	24	-	-	PUNCT
iajs-108	232	25	linked	link	VERB
iajs-108	232	26	immunosorbant	immunosorbant	NOUN
iajs-108	232	27	assay	assay	PROPN
iajs-108	232	28	.	.	PUNCT
iajs-108	233	1	clin	clin	PROPN
iajs-108	233	2	.	.	PUNCT
iajs-108	233	3	chem	chem	PROPN
iajs-108	233	4	.	.	PUNCT
iajs-108	234	1	34(4	34(4	NOUN
iajs-108	234	2	):	):	PUNCT
iajs-108	234	3	661	661	NUM
iajs-108	234	4	-	-	SYM
iajs-108	234	5	664	664	NUM
iajs-108	234	6	.	.	NOUN
iajs-108	234	7	23	23	NUM
iajs-108	234	8	.	.	PUNCT
iajs-108	235	1	kropf	kropf	PROPN
iajs-108	235	2	,	,	PUNCT
iajs-108	235	3	j.	j.	PROPN
iajs-108	235	4	;	;	PUNCT
iajs-108	235	5	schurek	schurek	PROPN
iajs-108	235	6	,	,	PUNCT
iajs-108	235	7	josef	josef	PROPN
iajs-108	235	8	o.	o.	PROPN
iajs-108	235	9	;	;	PUNCT
iajs-108	235	10	wollner	wollner	NOUN
iajs-108	235	11	.a	.a	PROPN
iajs-108	235	12	;	;	PUNCT
iajs-108	235	13	und	und	ADJ
iajs-108	235	14	gressner	gressner	NOUN
iajs-108	235	15	,	,	PUNCT
iajs-108	235	16	and	and	CCONJ
iajs-108	235	17	axel	axel	PROPN
iajs-108	235	18	m.	m.	NOUN
iajs-108	235	19	(	(	PUNCT
iajs-108	235	20	1997	1997	NUM
iajs-108	235	21	)	)	PUNCT
iajs-108	235	22	methodological	methodological	ADJ
iajs-108	235	23	aspects	aspect	NOUN
iajs-108	235	24	of	of	ADP
iajs-108	235	25	the	the	DET
iajs-108	235	26	immunological	immunological	ADJ
iajs-108	235	27	measurement	measurement	NOUN
iajs-108	235	28	of	of	ADP
iajs-108	235	29	transforming	transform	VERB
iajs-108	235	30	growth	growth	NOUN
iajs-108	235	31	factor	factor	NOUN
iajs-108	235	32	-	-	PUNCT
iajs-108	235	33	beta1	beta1	NOUN
iajs-108	235	34	(	(	PUNCT
iajs-108	235	35	tgf	tgf	NOUN
iajs-108	235	36	-	-	PUNCT
iajs-108	235	37	β1	β1	PROPN
iajs-108	235	38	)	)	PUNCT
iajs-108	235	39	in	in	ADP
iajs-108	235	40	blood	blood	NOUN
iajs-108	235	41	.	.	PUNCT
iajs-108	236	1	assay	assay	PROPN
iajs-108	236	2	development	development	NOUN
iajs-108	236	3	and	and	CCONJ
iajs-108	236	4	comparison	comparison	NOUN
iajs-108	236	5	.	.	PUNCT
iajs-108	237	1	clinical	clinical	ADJ
iajs-108	237	2	chemistry	chemistry	NOUN
iajs-108	237	3	.	.	PUNCT
iajs-108	238	1	43:10	43:10	NUM
iajs-108	238	2	.	.	PUNCT
iajs-108	239	1	24	24	NUM
iajs-108	239	2	.	.	X
iajs-108	239	3	faranak	faranak	PROPN
iajs-108	239	4	sharifi	sharifi	PROPN
iajs-108	239	5	;	;	PUNCT
iajs-108	239	6	sahar	sahar	PROPN
iajs-108	239	7	mazloomi	mazloomi	NOUN
iajs-108	239	8	;	;	PUNCT
iajs-108	239	9	and	and	CCONJ
iajs-108	239	10	nouraddin	nouraddin	ADV
iajs-108	239	11	mousavinasab	mousavinasab	ADJ
iajs-108	239	12	.	.	PUNCT
iajs-108	240	1	(	(	PUNCT
iajs-108	240	2	2011	2011	NUM
iajs-108	240	3	)	)	PUNCT
iajs-108	240	4	high	high	ADJ
iajs-108	240	5	serum	serum	NOUN
iajs-108	240	6	ferritin	ferritin	ADJ
iajs-108	240	7	concentrations	concentration	NOUN
iajs-108	240	8	in	in	ADP
iajs-108	240	9	polycystic	polycystic	ADJ
iajs-108	240	10	ovary	ovary	ADJ
iajs-108	240	11	syndrome	syndrome	NOUN
iajs-108	240	12	is	be	AUX
iajs-108	240	13	not	not	PART
iajs-108	240	14	related	relate	VERB
iajs-108	240	15	to	to	ADP
iajs-108	240	16	insulin	insulin	NOUN
iajs-108	240	17	resistance	resistance	NOUN
iajs-108	240	18	.	.	PUNCT
iajs-108	241	1	j.	j.	PROPN
iajs-108	241	2	iranian	iranian	PROPN
iajs-108	241	3	of	of	ADP
iajs-108	241	4	diabetes	diabetes	NOUN
iajs-108	241	5	and	and	CCONJ
iajs-108	241	6	obesity	obesity	NOUN
iajs-108	241	7	.	.	PUNCT
iajs-108	242	1	3(2	3(2	NUM
iajs-108	242	2	):	):	PUNCT
iajs-108	242	3	47	47	NUM
iajs-108	242	4	-	-	SYM
iajs-108	242	5	53	53	NUM
iajs-108	242	6	.	.	PUNCT
iajs-108	243	1	25	25	NUM
iajs-108	243	2	.	.	PUNCT
iajs-108	244	1	he´ctor	he´ctor	NOUN
iajs-108	244	2	f	f	NOUN
iajs-108	244	3	;	;	PUNCT
iajs-108	244	4	escobar	escobar	NOUN
iajs-108	244	5	-	-	PUNCT
iajs-108	244	6	morreale	morreale	PROPN
iajs-108	244	7	;	;	PUNCT
iajs-108	244	8	manuel	manuel	NOUN
iajs-108	244	9	luque	luque	PROPN
iajs-108	244	10	-	-	PUNCT
iajs-108	244	11	ramírez	ramírez	NOUN
iajs-108	244	12	;	;	PUNCT
iajs-108	244	13	francisco	francisco	PROPN
iajs-108	244	14	álvarez	álvarez	PROPN
iajs-108	244	15	-	-	PUNCT
iajs-108	244	16	blasco	blasco	PROPN
iajs-108	244	17	;	;	PUNCT
iajs-108	244	18	josé	josé	PROPN
iajs-108	244	19	i.	i.	PROPN
iajs-108	244	20	botellacarretero	botellacarretero	PROPN
iajs-108	244	21	;	;	PUNCT
iajs-108	244	22	josé	josé	PROPN
iajs-108	244	23	sancho	sancho	PROPN
iajs-108	244	24	;	;	PUNCT
iajs-108	244	25	and	and	CCONJ
iajs-108	244	26	josé	josé	PROPN
iajs-108	244	27	l.	l.	PROPN
iajs-108	244	28	san	san	PROPN
iajs-108	244	29	millán	millán	PROPN
iajs-108	244	30	.	.	PUNCT
iajs-108	245	1	(	(	PUNCT
iajs-108	245	2	2005	2005	NUM
iajs-108	245	3	)	)	PUNCT
iajs-108	245	4	body	body	NOUN
iajs-108	245	5	iron	iron	NOUN
iajs-108	245	6	stores	store	NOUN
iajs-108	245	7	are	be	AUX
iajs-108	245	8	increased	increase	VERB
iajs-108	245	9	in	in	ADP
iajs-108	245	10	overweight	overweight	NOUN
iajs-108	245	11	and	and	CCONJ
iajs-108	245	12	obese	obese	ADJ
iajs-108	245	13	women	woman	NOUN
iajs-108	245	14	with	with	ADP
iajs-108	245	15	polycystic	polycystic	ADJ
iajs-108	245	16	ovary	ovary	ADJ
iajs-108	245	17	syndrome	syndrome	NOUN
iajs-108	245	18	.	.	PUNCT
iajs-108	246	1	diabetes	diabetes	NOUN
iajs-108	246	2	care	care	NOUN
iajs-108	246	3	.	.	PUNCT
iajs-108	247	1	28:2042	28:2042	NUM
iajs-108	247	2	-	-	SYM
iajs-108	247	3	2044	2044	NUM
iajs-108	247	4	.	.	PUNCT
iajs-108	248	1	26	26	NUM
iajs-108	248	2	.	.	PUNCT
iajs-108	249	1	luque	luque	ADJ
iajs-108	249	2	-	-	PUNCT
iajs-108	249	3	ramírez	ramírez	NOUN
iajs-108	249	4	,	,	PUNCT
iajs-108	249	5	m.	m.	NOUN
iajs-108	249	6	;	;	PUNCT
iajs-108	249	7	álvarez	álvarez	PROPN
iajs-108	249	8	-	-	PUNCT
iajs-108	249	9	blasco	blasco	PROPN
iajs-108	249	10	,	,	PUNCT
iajs-108	249	11	f.	f.	PROPN
iajs-108	249	12	;	;	PUNCT
iajs-108	249	13	botella	botella	NOUN
iajs-108	249	14	-	-	PUNCT
iajs-108	249	15	carretero	carretero	NOUN
iajs-108	249	16	,	,	PUNCT
iajs-108	249	17	j.	j.	PROPN
iajs-108	249	18	;	;	PUNCT
iajs-108	249	19	sanchón	sanchón	PROPN
iajs-108	249	20	,	,	PUNCT
iajs-108	249	21	r.	r.	PROPN
iajs-108	249	22	;	;	PUNCT
iajs-108	249	23	san	san	PROPN
iajs-108	249	24	millán	millán	PROPN
iajs-108	249	25	j.	j.	PROPN
iajs-108	249	26	,	,	PUNCT
iajs-108	249	27	and	and	CCONJ
iajs-108	249	28	escobar	escobar	NOUN
iajs-108	249	29	-	-	PUNCT
iajs-108	249	30	morreale	morreale	NOUN
iajs-108	249	31	hf	hf	NOUN
iajs-108	249	32	.	.	PUNCT
iajs-108	250	1	(	(	PUNCT
iajs-108	250	2	2007	2007	NUM
iajs-108	250	3	)	)	PUNCT
iajs-108	250	4	increased	increase	VERB
iajs-108	250	5	body	body	NOUN
iajs-108	250	6	iron	iron	NOUN
iajs-108	250	7	stores	store	NOUN
iajs-108	250	8	of	of	ADP
iajs-108	250	9	obese	obese	ADJ
iajs-108	250	10	women	woman	NOUN
iajs-108	250	11	with	with	ADP
iajs-108	250	12	polycystic	polycystic	ADJ
iajs-108	250	13	ovary	ovary	ADJ
iajs-108	250	14	syndrome	syndrome	NOUN
iajs-108	250	15	are	be	AUX
iajs-108	250	16	a	a	DET
iajs-108	250	17	consequence	consequence	NOUN
iajs-108	250	18	of	of	ADP
iajs-108	250	19	insulin	insulin	NOUN
iajs-108	250	20	resistance	resistance	NOUN
iajs-108	250	21	and	and	CCONJ
iajs-108	250	22	hyperinsulinism	hyperinsulinism	NOUN
iajs-108	250	23	and	and	CCONJ
iajs-108	250	24	are	be	AUX
iajs-108	250	25	not	not	PART
iajs-108	250	26	a	a	DET
iajs-108	250	27	result	result	NOUN
iajs-108	250	28	of	of	ADP
iajs-108	250	29	reduced	reduce	VERB
iajs-108	250	30	menstrual	menstrual	ADJ
iajs-108	250	31	losses	loss	NOUN
iajs-108	250	32	.	.	PUNCT
iajs-108	251	1	diabetes	diabetes	NOUN
iajs-108	251	2	care	care	NOUN
iajs-108	251	3	.	.	PUNCT
iajs-108	252	1	30	30	NUM
iajs-108	252	2	:	:	PUNCT
iajs-108	252	3	2309	2309	NUM
iajs-108	252	4	-	-	SYM
iajs-108	252	5	2313	2313	NUM
iajs-108	252	6	.	.	PUNCT
iajs-108	253	1	27	27	NUM
iajs-108	253	2	.	.	PUNCT
iajs-108	254	1	guenno	guenno	PROPN
iajs-108	254	2	,	,	PUNCT
iajs-108	254	3	le	le	X
iajs-108	254	4	g.	g.	PROPN
iajs-108	254	5	;	;	PUNCT
iajs-108	254	6	chanseaume	chanseaume	PROPN
iajs-108	254	7	,	,	PUNCT
iajs-108	254	8	e.	e.	PROPN
iajs-108	254	9	;	;	PUNCT
iajs-108	254	10	ruivard	ruivard	ADJ
iajs-108	254	11	,	,	PUNCT
iajs-108	254	12	m.	m.	NOUN
iajs-108	254	13	;	;	PUNCT
iajs-108	254	14	morio	morio	NOUN
iajs-108	254	15	,	,	PUNCT
iajs-108	254	16	b.	b.	PROPN
iajs-108	254	17	and	and	CCONJ
iajs-108	254	18	mazur	mazur	PROPN
iajs-108	254	19	,	,	PUNCT
iajs-108	254	20	a.	a.	NOUN
iajs-108	254	21	,	,	PUNCT
iajs-108	254	22	(	(	PUNCT
iajs-108	254	23	2007	2007	NUM
iajs-108	254	24	)	)	PUNCT
iajs-108	254	25	study	study	NOUN
iajs-108	254	26	of	of	ADP
iajs-108	254	27	iron	iron	NOUN
iajs-108	254	28	metabolism	metabolism	NOUN
iajs-108	254	29	disturbances	disturbance	NOUN
iajs-108	254	30	in	in	ADP
iajs-108	254	31	an	an	DET
iajs-108	254	32	animal	animal	NOUN
iajs-108	254	33	model	model	NOUN
iajs-108	254	34	of	of	ADP
iajs-108	254	35	insulin	insulin	NOUN
iajs-108	254	36	resistance	resistance	NOUN
iajs-108	254	37	.	.	PUNCT
iajs-108	255	1	diabetes	diabetes	NOUN
iajs-108	255	2	res	re	VERB
iajs-108	255	3	clin	clin	PROPN
iajs-108	255	4	pract	pract	PROPN
iajs-108	255	5	77(24):363	77(24):363	PROPN
iajs-108	255	6	-	-	SYM
iajs-108	255	7	370	370	NUM
iajs-108	255	8	.	.	PUNCT
iajs-108	256	1	28	28	NUM
iajs-108	256	2	.	.	PUNCT
iajs-108	257	1	botella	botella	NOUN
iajs-108	257	2	-	-	PUNCT
iajs-108	257	3	carretero	carretero	NOUN
iajs-108	257	4	,	,	PUNCT
iajs-108	257	5	ji	ji	PROPN
iajs-108	257	6	.	.	PROPN
iajs-108	257	7	;	;	PUNCT
iajs-108	257	8	luque	luque	PROPN
iajs-108	257	9	-	-	PUNCT
iajs-108	257	10	ramirez	ramirez	PROPN
iajs-108	257	11	,	,	PUNCT
iajs-108	257	12	m.	m.	NOUN
iajs-108	257	13	;	;	PUNCT
iajs-108	257	14	alvarez	alvarez	PROPN
iajs-108	257	15	-	-	PUNCT
iajs-108	257	16	blasco	blasco	PROPN
iajs-108	257	17	,	,	PUNCT
iajs-108	257	18	f.	f.	PROPN
iajs-108	257	19	;	;	PUNCT
iajs-108	257	20	san	san	PROPN
iajs-108	257	21	millan	millan	PROPN
iajs-108	257	22	,	,	PUNCT
iajs-108	257	23	jl	jl	NOUN
iajs-108	257	24	,	,	PUNCT
iajs-108	257	25	;	;	PUNCT
iajs-108	257	26	and	and	CCONJ
iajs-108	257	27	escobarmorreale	escobarmorreale	ADJ
iajs-108	257	28	hf	hf	NOUN
iajs-108	257	29	.	.	PUNCT
iajs-108	258	1	(	(	PUNCT
iajs-108	258	2	2006	2006	NUM
iajs-108	258	3	)	)	PUNCT
iajs-108	258	4	mutations	mutation	NOUN
iajs-108	258	5	in	in	ADP
iajs-108	258	6	the	the	DET
iajs-108	258	7	hereditary	hereditary	ADJ
iajs-108	258	8	hemochromatosis	hemochromatosis	NOUN
iajs-108	258	9	gene	gene	NOUN
iajs-108	258	10	are	be	AUX
iajs-108	258	11	not	not	PART
iajs-108	258	12	associated	associate	VERB
iajs-108	258	13	with	with	ADP
iajs-108	258	14	the	the	DET
iajs-108	258	15	increased	increase	VERB
iajs-108	258	16	body	body	NOUN
iajs-108	258	17	iron	iron	NOUN
iajs-108	258	18	stores	store	NOUN
iajs-108	258	19	observed	observe	VERB
iajs-108	258	20	in	in	ADP
iajs-108	258	21	overweight	overweight	NOUN
iajs-108	258	22	and	and	CCONJ
iajs-108	258	23	obese	obese	ADJ
iajs-108	258	24	women	woman	NOUN
iajs-108	258	25	with	with	ADP
iajs-108	258	26	polycystic	polycystic	ADJ
iajs-108	258	27	ovary	ovary	ADJ
iajs-108	258	28	syndrome	syndrome	NOUN
iajs-108	258	29	(	(	PUNCT
iajs-108	258	30	letter	letter	NOUN
iajs-108	258	31	)	)	PUNCT
iajs-108	258	32	.	.	PUNCT
iajs-108	259	1	diabetes	diabetes	NOUN
iajs-108	259	2	care	care	NOUN
iajs-108	259	3	.	.	PUNCT
iajs-108	260	1	29	29	NUM
iajs-108	260	2	:	:	PUNCT
iajs-108	260	3	2556	2556	NUM
iajs-108	260	4	.	.	X
iajs-108	261	1	29	29	NUM
iajs-108	261	2	.	.	X
iajs-108	261	3	jung	jung	PROPN
iajs-108	261	4	,	,	PUNCT
iajs-108	261	5	c.h	c.h	PROPN
iajs-108	261	6	.	.	PROPN
iajs-108	261	7	;	;	PUNCT
iajs-108	261	8	lee	lee	PROPN
iajs-108	261	9	,	,	PUNCT
iajs-108	261	10	m.j	m.j	PROPN
iajs-108	261	11	.	.	PROPN
iajs-108	261	12	;	;	PUNCT
iajs-108	261	13	hwang	hwang	PROPN
iajs-108	261	14	,	,	PUNCT
iajs-108	261	15	j.y	j.y	PROPN
iajs-108	261	16	.	.	PROPN
iajs-108	261	17	;	;	PUNCT
iajs-108	261	18	jang	jang	PROPN
iajs-108	261	19	,	,	PUNCT
iajs-108	261	20	j.e	j.e	PROPN
iajs-108	261	21	.	.	PROPN
iajs-108	261	22	;	;	PUNCT
iajs-108	261	23	leem	leem	PROPN
iajs-108	261	24	,	,	PUNCT
iajs-108	261	25	j.	j.	PROPN
iajs-108	261	26	;	;	PUNCT
iajs-108	261	27	park	park	PROPN
iajs-108	261	28	,	,	PUNCT
iajs-108	261	29	j.y	j.y	PROPN
iajs-108	261	30	.	.	PROPN
iajs-108	261	31	;	;	PUNCT
iajs-108	261	32	lee	lee	PROPN
iajs-108	261	33	,	,	PUNCT
iajs-108	261	34	j.	j.	PROPN
iajs-108	261	35	;	;	PUNCT
iajs-108	261	36	kim	kim	PROPN
iajs-108	261	37	,	,	PUNCT
iajs-108	261	38	h.k	h.k	PROPN
iajs-108	261	39	.	.	PROPN
iajs-108	261	40	and	and	CCONJ
iajs-108	261	41	,	,	PUNCT
iajs-108	261	42	lee	lee	PROPN
iajs-108	261	43	w.j	w.j	PROPN
iajs-108	261	44	.	.	PROPN
iajs-108	262	1	(	(	PUNCT
iajs-108	262	2	2013	2013	NUM
iajs-108	262	3	)	)	PUNCT
iajs-108	262	4	elevated	elevated	ADJ
iajs-108	262	5	serum	serum	NOUN
iajs-108	262	6	ferritin	ferritin	ADJ
iajs-108	262	7	level	level	NOUN
iajs-108	262	8	is	be	AUX
iajs-108	262	9	associated	associate	VERB
iajs-108	262	10	with	with	ADP
iajs-108	262	11	the	the	DET
iajs-108	262	12	i̇ncident	i̇ncident	NOUN
iajs-108	262	13	type	type	NOUN
iajs-108	262	14	2	2	NUM
iajs-108	262	15	diabetes	diabetes	NOUN
iajs-108	262	16	in	in	ADP
iajs-108	262	17	healthy	healthy	ADJ
iajs-108	262	18	korean	korean	ADJ
iajs-108	262	19	men	man	NOUN
iajs-108	262	20	:	:	PUNCT
iajs-108	262	21	a	a	DET
iajs-108	262	22	4	4	NUM
iajs-108	262	23	year	year	NOUN
iajs-108	262	24	longitudinal	longitudinal	ADJ
iajs-108	262	25	study	study	NOUN
iajs-108	262	26	.	.	PUNCT
iajs-108	263	1	plos	plos	PROPN
iajs-108	263	2	one	one	NUM
iajs-108	263	3	.	.	PUNCT
iajs-108	264	1	8	8	NUM
iajs-108	264	2	:	:	PUNCT
iajs-108	264	3	e752	e752	NUM
iajs-108	264	4	.	.	PROPN
iajs-108	264	5	30	30	NUM
iajs-108	264	6	.	.	PUNCT
iajs-108	265	1	fulden	fulden	PROPN
iajs-108	265	2	,	,	PUNCT
iajs-108	265	3	s.	s.	PROPN
iajs-108	265	4	;	;	PUNCT
iajs-108	265	5	sumru	sumru	PROPN
iajs-108	265	6	,	,	PUNCT
iajs-108	265	7	s.	s.	PROPN
iajs-108	265	8	;	;	PUNCT
iajs-108	265	9	sefa	sefa	PROPN
iajs-108	265	10	,	,	PUNCT
iajs-108	265	11	s.	s.	PROPN
iajs-108	265	12	;	;	PUNCT
iajs-108	265	13	and	and	CCONJ
iajs-108	265	14	fehmi	fehmi	NOUN
iajs-108	265	15	,	,	PUNCT
iajs-108	265	16	a.	a.	NOUN
iajs-108	265	17	,	,	PUNCT
iajs-108	265	18	(	(	PUNCT
iajs-108	265	19	2014	2014	NUM
iajs-108	265	20	)	)	PUNCT
iajs-108	265	21	elevated	elevated	ADJ
iajs-108	265	22	ferritin	ferritin	ADJ
iajs-108	265	23	levels	level	NOUN
iajs-108	265	24	and	and	CCONJ
iajs-108	265	25	the	the	DET
iajs-108	265	26	relationship	relationship	NOUN
iajs-108	265	27	with	with	ADP
iajs-108	265	28	fasting	fast	VERB
iajs-108	265	29	insulin	insulin	NOUN
iajs-108	265	30	levels	level	NOUN
iajs-108	265	31	in	in	ADP
iajs-108	265	32	elderly	elderly	ADJ
iajs-108	265	33	patients	patient	NOUN
iajs-108	265	34	with	with	ADP
iajs-108	265	35	metabolic	metabolic	NOUN
iajs-108	265	36	syndrome	syndrome	NOUN
iajs-108	265	37	.	.	PUNCT
iajs-108	266	1	journal	journal	NOUN
iajs-108	266	2	of	of	ADP
iajs-108	266	3	diabetes	diabete	NOUN
iajs-108	266	4	mellitus	mellitus	NOUN
iajs-108	266	5	.	.	PUNCT
iajs-108	267	1	4	4	NUM
iajs-108	267	2	:	:	SYM
iajs-108	267	3	242	242	NUM
iajs-108	267	4	-	-	SYM
iajs-108	267	5	248	248	NUM
iajs-108	267	6	.	.	PUNCT
iajs-108	268	1	31	31	NUM
iajs-108	268	2	.	.	PUNCT
iajs-108	269	1	gonzalez	gonzalez	PROPN
iajs-108	269	2	,	,	PUNCT
iajs-108	269	3	a.s	a.s	PROPN
iajs-108	269	4	.	.	PROPN
iajs-108	269	5	;	;	PUNCT
iajs-108	269	6	guerrero	guerrero	PROPN
iajs-108	269	7	,	,	PUNCT
iajs-108	269	8	d.b	d.b	PROPN
iajs-108	269	9	.	.	PROPN
iajs-108	269	10	;	;	PUNCT
iajs-108	269	11	soto	soto	PROPN
iajs-108	269	12	,	,	PUNCT
iajs-108	269	13	m.b	m.b	PROPN
iajs-108	269	14	.	.	PROPN
iajs-108	269	15	;	;	PUNCT
iajs-108	269	16	diaz	diaz	PROPN
iajs-108	269	17	,	,	PUNCT
iajs-108	269	18	s.p	s.p	PROPN
iajs-108	269	19	.	.	PROPN
iajs-108	269	20	;	;	PUNCT
iajs-108	269	21	martinez	martinez	PROPN
iajs-108	269	22	-	-	PUNCT
iajs-108	269	23	olmos	olmos	PROPN
iajs-108	269	24	;	;	PUNCT
iajs-108	269	25	m.	m.	NOUN
iajs-108	269	26	and	and	CCONJ
iajs-108	269	27	vidal	vidal	PROPN
iajs-108	269	28	o.	o.	PROPN
iajs-108	269	29	(	(	PUNCT
iajs-108	269	30	2006	2006	NUM
iajs-108	269	31	)	)	PUNCT
iajs-108	269	32	metabolic	metabolic	NOUN
iajs-108	269	33	syndrome	syndrome	NOUN
iajs-108	269	34	,	,	PUNCT
iajs-108	269	35	insulin	insulin	NOUN
iajs-108	269	36	resistance	resistance	NOUN
iajs-108	269	37	and	and	CCONJ
iajs-108	269	38	the	the	DET
iajs-108	269	39	inflammation	inflammation	NOUN
iajs-108	269	40	markers	marker	NOUN
iajs-108	269	41	c	c	PROPN
iajs-108	269	42	reactive	reactive	ADJ
iajs-108	269	43	protein	protein	NOUN
iajs-108	269	44	and	and	CCONJ
iajs-108	269	45	ferritin	ferritin	ADJ
iajs-108	269	46	.	.	PUNCT
iajs-108	270	1	european	european	ADJ
iajs-108	270	2	journal	journal	PROPN
iajs-108	270	3	of	of	ADP
iajs-108	270	4	clinical	clinical	ADJ
iajs-108	270	5	nutrition	nutrition	NOUN
iajs-108	270	6	.	.	PUNCT
iajs-108	271	1	60	60	NUM
iajs-108	271	2	:	:	PUNCT
iajs-108	271	3	802	802	NUM
iajs-108	271	4	-	-	SYM
iajs-108	271	5	809	809	NUM
iajs-108	271	6	.	.	PUNCT
iajs-108	272	1	32	32	NUM
iajs-108	272	2	.	.	PUNCT
iajs-108	273	1	ashraf	ashraf	PROPN
iajs-108	273	2	moini1	moini1	PROPN
iajs-108	273	3	,	,	PUNCT
iajs-108	273	4	m.d	m.d	PROPN
iajs-108	273	5	.	.	PROPN
iajs-108	273	6	;	;	PUNCT
iajs-108	273	7	fatemeh	fatemeh	PROPN
iajs-108	273	8	javanmard	javanmard	NOUN
iajs-108	273	9	,	,	PUNCT
iajs-108	273	10	m.d	m.d	PROPN
iajs-108	273	11	.	.	PROPN
iajs-108	273	12	;	;	PUNCT
iajs-108	273	13	bita	bita	PROPN
iajs-108	273	14	eslami1	eslami1	PROPN
iajs-108	273	15	,	,	PUNCT
iajs-108	273	16	m.p.h	m.p.h	PROPN
iajs-108	273	17	.	.	PROPN
iajs-108	273	18	;	;	PUNCT
iajs-108	273	19	and	and	CCONJ
iajs-108	273	20	najmeh	najmeh	NOUN
iajs-108	273	21	aletaha	aletaha	NOUN
iajs-108	273	22	m.d	m.d	PROPN
iajs-108	273	23	.	.	PROPN
iajs-108	273	24	(	(	PUNCT
iajs-108	273	25	2012	2012	NUM
iajs-108	273	26	)	)	PUNCT
iajs-108	273	27	prevalence	prevalence	NOUN
iajs-108	273	28	of	of	ADP
iajs-108	273	29	metabolic	metabolic	NOUN
iajs-108	273	30	syndrome	syndrome	NOUN
iajs-108	273	31	in	in	ADP
iajs-108	273	32	polycystic	polycystic	ADJ
iajs-108	273	33	ovarian	ovarian	ADJ
iajs-108	273	34	syndrome	syndrome	NOUN
iajs-108	273	35	women	woman	NOUN
iajs-108	273	36	in	in	ADP
iajs-108	273	37	a	a	DET
iajs-108	273	38	hospital	hospital	NOUN
iajs-108	273	39	of	of	ADP
iajs-108	273	40	tehran	tehran	PROPN
iajs-108	273	41	.	.	PUNCT
iajs-108	274	1	iran	iran	PROPN
iajs-108	274	2	j	j	PROPN
iajs-108	274	3	reprod	reprod	PROPN
iajs-108	274	4	med	med	PROPN
iajs-108	274	5	.	.	PUNCT
iajs-108	275	1	10(2	10(2	NUM
iajs-108	275	2	):	):	PUNCT
iajs-108	275	3	127	127	NUM
iajs-108	275	4	-	-	SYM
iajs-108	275	5	130	130	NUM
iajs-108	275	6	.	.	PUNCT
iajs-108	276	1	33	33	NUM
iajs-108	276	2	.	.	PUNCT
iajs-108	277	1	ehrmann	ehrmann	PROPN
iajs-108	277	2	,	,	PUNCT
iajs-108	277	3	da	da	PROPN
iajs-108	277	4	.	.	PUNCT
iajs-108	277	5	(	(	PUNCT
iajs-108	277	6	2005	2005	NUM
iajs-108	277	7	)	)	PUNCT
iajs-108	277	8	polycystic	polycystic	ADJ
iajs-108	277	9	ovary	ovary	ADJ
iajs-108	277	10	syndrome	syndrome	NOUN
iajs-108	277	11	.	.	PUNCT
iajs-108	278	1	n	n	PROPN
iajs-108	278	2	engl	engl	PROPN
iajs-108	278	3	j	j	PROPN
iajs-108	278	4	med	med	PROPN
iajs-108	278	5	.	.	PUNCT
iajs-108	279	1	352	352	NUM
iajs-108	279	2	:	:	PUNCT
iajs-108	279	3	1223	1223	NUM
iajs-108	279	4	-	-	SYM
iajs-108	279	5	1236	1236	NUM
iajs-108	279	6	.	.	PUNCT
iajs-108	280	1	34	34	NUM
iajs-108	280	2	.	.	PUNCT
iajs-108	280	3	raja	raja	PROPN
iajs-108	280	4	-	-	PUNCT
iajs-108	280	5	khan	khan	PROPN
iajs-108	280	6	,	,	PUNCT
iajs-108	280	7	n.	n.	PROPN
iajs-108	280	8	;	;	PUNCT
iajs-108	280	9	allen	allen	PROPN
iajs-108	280	10	,	,	PUNCT
iajs-108	280	11	r.	r.	PROPN
iajs-108	280	12	kunselman	kunselman	NOUN
iajs-108	280	13	;	;	PUNCT
iajs-108	280	14	laurence	laurence	PROPN
iajs-108	280	15	.	.	PUNCT
iajs-108	281	1	demers	demers	PROPN
iajs-108	281	2	;	;	PUNCT
iajs-108	281	3	kathryn	kathryn	PROPN
iajs-108	281	4	,	,	PUNCT
iajs-108	281	5	g.	g.	PROPN
iajs-108	281	6	ewens	ewens	PROPN
iajs-108	281	7	.	.	PUNCT
iajs-108	281	8	;	;	PUNCT
iajs-108	281	9	richard	richard	PROPN
iajs-108	281	10	,	,	PUNCT
iajs-108	281	11	s.	s.	PROPN
iajs-108	281	12	spielman	spielman	PROPN
iajs-108	281	13	;	;	PUNCT
iajs-108	281	14	and	and	CCONJ
iajs-108	281	15	richard	richard	PROPN
iajs-108	281	16	,	,	PUNCT
iajs-108	281	17	s.	s.	PROPN
iajs-108	281	18	legro.m	legro.m	PROPN
iajs-108	281	19	.	.	PUNCT
iajs-108	282	1	(	(	PUNCT
iajs-108	282	2	2010	2010	NUM
iajs-108	282	3	)	)	PUNCT
iajs-108	282	4	a	a	DET
iajs-108	282	5	variant	variant	NOUN
iajs-108	282	6	in	in	ADP
iajs-108	282	7	the	the	DET
iajs-108	282	8	fibrillin-3	fibrillin-3	PROPN
iajs-108	282	9	gene	gene	NOUN
iajs-108	282	10	is	be	AUX
iajs-108	282	11	associated	associate	VERB
iajs-108	282	12	with	with	ADP
iajs-108	282	13	chemistry	chemistry	NOUN
iajs-108	282	14	|	|	ADV
iajs-108	282	15	178	178	NUM
iajs-108	282	16	2016	2016	NUM
iajs-108	282	17	)	)	PUNCT
iajs-108	282	18	عام	عام	ADP
iajs-108	282	19	2العدد	2العدد	NUM
iajs-108	282	20	(	(	PUNCT
iajs-108	282	21	29مجلة	29مجلة	NUM
iajs-108	282	22	إبن	إبن	VERB
iajs-108	282	23	الهيثم	الهيثم	ADJ
iajs-108	282	24	للعلوم	للعلوم	NOUN
iajs-108	282	25	الصرفة	الصرفة	NOUN
iajs-108	283	1	و	و	PRON
iajs-108	283	2	التطبيقية	التطبيقية	ADV
iajs-108	283	3	المجلد	المجلد	VERB
iajs-108	283	4	ibn	ibn	PROPN
iajs-108	283	5	al	al	PROPN
iajs-108	283	6	-	-	PUNCT
iajs-108	283	7	haitham	haitham	PROPN
iajs-108	283	8	jour	jour	X
iajs-108	283	9	.	.	PROPN
iajs-108	284	1	for	for	ADP
iajs-108	284	2	pure	pure	ADJ
iajs-108	284	3	&	&	CCONJ
iajs-108	284	4	appl	appl	PROPN
iajs-108	284	5	.	.	PUNCT
iajs-108	285	1	sci	sci	PROPN
iajs-108	285	2	.	.	PUNCT
iajs-108	285	3	vol	vol	NOUN
iajs-108	285	4	.	.	PROPN
iajs-108	285	5	29	29	NUM
iajs-108	285	6	(	(	PUNCT
iajs-108	285	7	2	2	NUM
iajs-108	285	8	)	)	PUNCT
iajs-108	285	9	2016	2016	NUM
iajs-108	285	10	tgf	tgf	PROPN
iajs-108	285	11	-	-	PUNCT
iajs-108	285	12	β	β	PROPN
iajs-108	285	13	and	and	CCONJ
iajs-108	285	14	inhibin	inhibin	PROPN
iajs-108	285	15	b	b	PROPN
iajs-108	285	16	levels	level	NOUN
iajs-108	285	17	in	in	ADP
iajs-108	285	18	women	woman	NOUN
iajs-108	285	19	with	with	ADP
iajs-108	285	20	polycystic	polycystic	ADJ
iajs-108	285	21	ovary	ovary	ADJ
iajs-108	285	22	syndrome	syndrome	NOUN
iajs-108	285	23	.	.	PUNCT
iajs-108	286	1	fertil	fertil	PROPN
iajs-108	286	2	steril	steril	PROPN
iajs-108	286	3	.	.	PUNCT
iajs-108	287	1	94(7	94(7	NUM
iajs-108	287	2	):	):	PUNCT
iajs-108	287	3	2916	2916	NUM
iajs-108	287	4	–	–	PUNCT
iajs-108	287	5	2919	2919	NUM
iajs-108	287	6	.	.	PUNCT
iajs-108	288	1	35.reshef	35.reshef	NUM
iajs-108	288	2	,	,	PUNCT
iajs-108	288	3	tal	tal	PROPN
iajs-108	288	4	.	.	PUNCT
iajs-108	288	5	;	;	PUNCT
iajs-108	288	6	david	david	PROPN
iajs-108	288	7	b.	b.	PROPN
iajs-108	288	8	seifer	seifer	PROPN
iajs-108	288	9	;	;	PUNCT
iajs-108	288	10	aya	aya	PROPN
iajs-108	288	11	shohat	shohat	PROPN
iajs-108	288	12	-	-	PUNCT
iajs-108	288	13	tal	tal	PROPN
iajs-108	288	14	;	;	PUNCT
iajs-108	288	15	richard	richard	PROPN
iajs-108	288	16	v	v	PROPN
iajs-108	288	17	;	;	PUNCT
iajs-108	288	18	grazi	grazi	PROPN
iajs-108	288	19	,	,	PUNCT
iajs-108	288	20	m.d	m.d	PROPN
iajs-108	288	21	.	.	PROPN
iajs-108	288	22	;	;	PUNCT
iajs-108	288	23	and	and	CCONJ
iajs-108	288	24	henry	henry	PROPN
iajs-108	288	25	e.	e.	PROPN
iajs-108	288	26	malter	malter	PROPN
iajs-108	288	27	.	.	PUNCT
iajs-108	289	1	(	(	PUNCT
iajs-108	289	2	2013	2013	NUM
iajs-108	289	3	)	)	PUNCT
iajs-108	289	4	transforming	transform	VERB
iajs-108	289	5	growth	growth	NOUN
iajs-108	289	6	factor	factor	NOUN
iajs-108	289	7	-	-	PUNCT
iajs-108	289	8	b1	b1	NOUN
iajs-108	289	9	and	and	CCONJ
iajs-108	289	10	its	its	PRON
iajs-108	289	11	receptor	receptor	NOUN
iajs-108	289	12	soluble	soluble	ADJ
iajs-108	289	13	endoglin	endoglin	NOUN
iajs-108	289	14	are	be	AUX
iajs-108	289	15	altered	alter	VERB
iajs-108	289	16	in	in	ADP
iajs-108	289	17	polycystic	polycystic	ADJ
iajs-108	289	18	ovary	ovary	ADJ
iajs-108	289	19	syndrome	syndrome	NOUN
iajs-108	289	20	during	during	ADP
iajs-108	289	21	controlled	control	VERB
iajs-108	289	22	ovarian	ovarian	ADJ
iajs-108	289	23	stimulation	stimulation	NOUN
iajs-108	289	24	.	.	PUNCT
iajs-108	290	1	reproductive	reproductive	ADJ
iajs-108	290	2	endocrinology	endocrinology	NOUN
iajs-108	290	3	.	.	PUNCT
iajs-108	291	1	100	100	NUM
iajs-108	291	2	(	(	PUNCT
iajs-108	291	3	2	2	NUM
iajs-108	291	4	):	):	PUNCT
iajs-108	291	5	538543	538543	NUM
iajs-108	291	6	.	.	PUNCT
iajs-108	292	1	36	36	NUM
iajs-108	292	2	.	.	X
iajs-108	293	1	romano	romano	NOUN
iajs-108	293	2	,	,	PUNCT
iajs-108	293	3	m.	m.	NOUN
iajs-108	293	4	;	;	PUNCT
iajs-108	293	5	guagnano	guagnano	PROPN
iajs-108	293	6	,	,	PUNCT
iajs-108	293	7	mt	mt	PROPN
iajs-108	293	8	.	.	PROPN
iajs-108	293	9	;	;	PUNCT
iajs-108	294	1	pacini	pacini	PROPN
iajs-108	294	2	,	,	PUNCT
iajs-108	294	3	g.	g.	PROPN
iajs-108	294	4	;	;	PUNCT
iajs-108	294	5	vigneri	vigneri	PROPN
iajs-108	294	6	,	,	PUNCT
iajs-108	294	7	s.	s.	PROPN
iajs-108	294	8	;	;	PUNCT
iajs-108	294	9	falco	falco	PROPN
iajs-108	294	10	,	,	PUNCT
iajs-108	294	11	a.	a.	NOUN
iajs-108	294	12	;	;	PUNCT
iajs-108	294	13	marinopiccoli	marinopiccoli	NOUN
iajs-108	294	14	,	,	PUNCT
iajs-108	294	15	m.	m.	NOUN
iajs-108	294	16	;	;	PUNCT
iajs-108	294	17	manigrasso.mr	manigrasso.mr	PROPN
iajs-108	294	18	;	;	PUNCT
iajs-108	294	19	basili	basili	NOUN
iajs-108	294	20	.s	.s	NOUN
iajs-108	294	21	;	;	PUNCT
iajs-108	294	22	and	and	CCONJ
iajs-108	294	23	davi	davi	PROPN
iajs-108	294	24	.g	.g	PROPN
iajs-108	294	25	.	.	PUNCT
iajs-108	295	1	(	(	PUNCT
iajs-108	295	2	2003	2003	NUM
iajs-108	295	3	)	)	PUNCT
iajs-108	295	4	association	association	NOUN
iajs-108	295	5	of	of	ADP
iajs-108	295	6	inflammation	inflammation	NOUN
iajs-108	295	7	markers	marker	NOUN
iajs-108	295	8	with	with	ADP
iajs-108	295	9	impaired	impaired	ADJ
iajs-108	295	10	insulin	insulin	NOUN
iajs-108	295	11	sensitivity	sensitivity	NOUN
iajs-108	295	12	and	and	CCONJ
iajs-108	295	13	coagulative	coagulative	NOUN
iajs-108	295	14	activation	activation	NOUN
iajs-108	295	15	in	in	ADP
iajs-108	295	16	obese	obese	ADJ
iajs-108	295	17	healthy	healthy	ADJ
iajs-108	295	18	women	woman	NOUN
iajs-108	295	19	.	.	PUNCT
iajs-108	296	1	j	j	PROPN
iajs-108	296	2	clin	clin	PROPN
iajs-108	296	3	endocrinol	endocrinol	PROPN
iajs-108	296	4	metab	metab	NOUN
iajs-108	296	5	.	.	PUNCT
iajs-108	297	1	88	88	NUM
iajs-108	297	2	:	:	PUNCT
iajs-108	297	3	5321–5326	5321–5326	NOUN
iajs-108	297	4	.	.	PUNCT
iajs-108	298	1	37	37	NUM
iajs-108	298	2	.	.	X
iajs-108	298	3	festa	festa	X
iajs-108	298	4	,	,	PUNCT
iajs-108	298	5	a.	a.	NOUN
iajs-108	298	6	;	;	PUNCT
iajs-108	298	7	d’agostino	d’agostino	PROPN
iajs-108	298	8	jr	jr	PROPN
iajs-108	298	9	r	r	PROPN
iajs-108	298	10	;	;	PUNCT
iajs-108	298	11	howard	howard	PROPN
iajs-108	298	12	g	g	PROPN
iajs-108	298	13	;	;	PUNCT
iajs-108	298	14	mykkanen	mykkanen	PROPN
iajs-108	298	15	l	l	NOUN
iajs-108	298	16	;	;	PUNCT
iajs-108	298	17	tracy	tracy	PROPN
iajs-108	298	18	rp	rp	NOUN
iajs-108	298	19	;	;	PUNCT
iajs-108	298	20	and	and	CCONJ
iajs-108	298	21	haffner	haffner	NOUN
iajs-108	298	22	sm	sm	INTJ
iajs-108	298	23	.	.	PUNCT
iajs-108	298	24	(	(	PUNCT
iajs-108	298	25	2000	2000	NUM
iajs-108	298	26	)	)	PUNCT
iajs-108	298	27	chronic	chronic	ADJ
iajs-108	298	28	subclinical	subclinical	ADJ
iajs-108	298	29	inflammation	inflammation	NOUN
iajs-108	298	30	as	as	ADP
iajs-108	298	31	part	part	NOUN
iajs-108	298	32	of	of	ADP
iajs-108	298	33	the	the	DET
iajs-108	298	34	insulin	insulin	NOUN
iajs-108	298	35	resistance	resistance	NOUN
iajs-108	298	36	syndrome	syndrome	NOUN
iajs-108	298	37	:	:	PUNCT
iajs-108	298	38	the	the	DET
iajs-108	298	39	insulin	insulin	NOUN
iajs-108	298	40	resistance	resistance	NOUN
iajs-108	298	41	atherosclerosis	atherosclerosis	NOUN
iajs-108	298	42	study	study	NOUN
iajs-108	298	43	(	(	PUNCT
iajs-108	298	44	iras	ira	NOUN
iajs-108	298	45	)	)	PUNCT
iajs-108	298	46	.	.	PUNCT
iajs-108	299	1	circulation	circulation	NOUN
iajs-108	299	2	.	.	PUNCT
iajs-108	300	1	102	102	NUM
iajs-108	300	2	:	:	PUNCT
iajs-108	300	3	42–47	42–47	NUM
iajs-108	300	4	.	.	NOUN
iajs-108	300	5	38	38	NUM
iajs-108	300	6	.	.	PUNCT
iajs-108	301	1	wang	wang	PROPN
iajs-108	301	2	.y	.y	PROPN
iajs-108	301	3	;	;	PUNCT
iajs-108	301	4	xuwei	xuwei	PROPN
iajs-108	301	5	hou	hou	PROPN
iajs-108	301	6	;	;	PUNCT
iajs-108	301	7	and	and	CCONJ
iajs-108	301	8	yuliang	yuliang	PROPN
iajs-108	301	9	,	,	PUNCT
iajs-108	301	10	li	li	PROPN
iajs-108	301	11	.	.	PROPN
iajs-108	301	12	(	(	PUNCT
iajs-108	301	13	2010	2010	NUM
iajs-108	301	14	)	)	PUNCT
iajs-108	301	15	association	association	NOUN
iajs-108	301	16	between	between	ADP
iajs-108	301	17	transforming	transform	VERB
iajs-108	301	18	growth	growth	NOUN
iajs-108	301	19	factor	factor	NOUN
iajs-108	301	20	β1	β1	NOUN
iajs-108	301	21	polymorphisms	polymorphism	NOUN
iajs-108	301	22	and	and	CCONJ
iajs-108	301	23	atrial	atrial	ADJ
iajs-108	301	24	fibrillation	fibrillation	NOUN
iajs-108	301	25	in	in	ADP
iajs-108	301	26	essential	essential	ADJ
iajs-108	301	27	hypertensive	hypertensive	ADJ
iajs-108	301	28	subjects	subject	NOUN
iajs-108	301	29	damage	damage	NOUN
iajs-108	301	30	.	.	PUNCT
iajs-108	302	1	journal	journal	NOUN
iajs-108	302	2	of	of	ADP
iajs-108	302	3	biomedical	biomedical	ADJ
iajs-108	302	4	science	science	NOUN
iajs-108	302	5	.	.	PUNCT
iajs-108	303	1	17(23):1	17(23):1	NOUN
iajs-108	303	2	-	-	SYM
iajs-108	303	3	5	5	NUM
iajs-108	303	4	.	.	NOUN
iajs-108	303	5	39	39	NUM
iajs-108	303	6	.	.	PUNCT
iajs-108	304	1	aihara	aihara	PROPN
iajs-108	304	2	,	,	PUNCT
iajs-108	304	3	k.	k.	PROPN
iajs-108	304	4	;	;	PUNCT
iajs-108	304	5	ikeda	ikeda	PROPN
iajs-108	304	6	,	,	PUNCT
iajs-108	304	7	y.	y.	NOUN
iajs-108	304	8	;	;	PUNCT
iajs-108	304	9	yagi	yagi	NOUN
iajs-108	304	10	,	,	PUNCT
iajs-108	304	11	s.	s.	PROPN
iajs-108	304	12	;	;	PUNCT
iajs-108	304	13	akaike	akaike	ADJ
iajs-108	304	14	,	,	PUNCT
iajs-108	304	15	m.	m.	NOUN
iajs-108	304	16	;	;	PUNCT
iajs-108	304	17	and	and	CCONJ
iajs-108	304	18	matsumoto	matsumoto	NOUN
iajs-108	304	19	,	,	PUNCT
iajs-108	304	20	t.	t.	PROPN
iajs-108	304	21	,	,	PUNCT
iajs-108	304	22	(	(	PUNCT
iajs-108	304	23	2011	2011	NUM
iajs-108	304	24	)	)	PUNCT
iajs-108	304	25	transforming	transform	VERB
iajs-108	304	26	growth	growth	NOUN
iajs-108	304	27	factor	factor	NOUN
iajs-108	304	28	-	-	PUNCT
iajs-108	304	29	β1	β1	PROPN
iajs-108	304	30	as	as	ADP
iajs-108	304	31	a	a	DET
iajs-108	304	32	common	common	ADJ
iajs-108	304	33	target	target	NOUN
iajs-108	304	34	molecule	molecule	NOUN
iajs-108	304	35	for	for	ADP
iajs-108	304	36	development	development	NOUN
iajs-108	304	37	of	of	ADP
iajs-108	304	38	cardiovascular	cardiovascular	ADJ
iajs-108	304	39	diseases	disease	NOUN
iajs-108	304	40	,	,	PUNCT
iajs-108	304	41	renal	renal	ADJ
iajs-108	304	42	insufficiency	insufficiency	NOUN
iajs-108	304	43	,	,	PUNCT
iajs-108	304	44	and	and	CCONJ
iajs-108	304	45	metabolic	metabolic	NOUN
iajs-108	304	46	syndrome	syndrome	NOUN
iajs-108	304	47	.	.	PUNCT
iajs-108	305	1	cardiology	cardiology	NOUN
iajs-108	305	2	research	research	NOUN
iajs-108	305	3	and	and	CCONJ
iajs-108	305	4	practice	practice	NOUN
iajs-108	305	5	.	.	PUNCT
iajs-108	306	1	10	10	NUM
iajs-108	306	2	:	:	SYM
iajs-108	306	3	1	1	NUM
iajs-108	306	4	-	-	SYM
iajs-108	306	5	9	9	NUM
iajs-108	306	6	.	.	NUM
iajs-108	306	7	40	40	NUM
iajs-108	306	8	.	.	PUNCT
iajs-108	307	1	pfeiffer	pfeiffer	PROPN
iajs-108	307	2	,	,	PUNCT
iajs-108	307	3	md	md	PROPN
iajs-108	307	4	.	.	PROPN
iajs-108	307	5	;	;	PUNCT
iajs-108	307	6	krishna	krishna	PROPN
iajs-108	307	7	middelberg	middelberg	PROPN
iajs-108	307	8	-	-	PUNCT
iajs-108	307	9	bisping	bisping	NOUN
iajs-108	307	10	;	;	PUNCT
iajs-108	307	11	cordula	cordula	NOUN
iajs-108	307	12	;	;	PUNCT
iajs-108	307	13	and	and	CCONJ
iajs-108	307	14	drewes	drewe	NOUN
iajs-108	307	15	,	,	PUNCT
iajs-108	307	16	md	md	PROPN
iajs-108	307	17	;	;	PUNCT
iajs-108	307	18	helmut	helmut	PROPN
iajs-108	307	19	schatz	schatz	PROPN
iajs-108	307	20	,	,	PUNCT
iajs-108	307	21	md	md	PROPN
iajs-108	307	22	.	.	PROPN
iajs-108	308	1	(	(	PUNCT
iajs-108	308	2	1996	1996	NUM
iajs-108	308	3	)	)	PUNCT
iajs-108	308	4	elevated	elevated	ADJ
iajs-108	308	5	plasma	plasma	NOUN
iajs-108	308	6	levels	level	NOUN
iajs-108	308	7	of	of	ADP
iajs-108	308	8	transforming	transform	VERB
iajs-108	308	9	growth	growth	NOUN
iajs-108	308	10	factor	factor	NOUN
iajs-108	308	11	-	-	PUNCT
iajs-108	308	12	β1	β1	PROPN
iajs-108	308	13	in	in	ADP
iajs-108	308	14	niddm	niddm	PROPN
iajs-108	308	15	.	.	PUNCT
iajs-108	309	1	19(10	19(10	NUM
iajs-108	309	2	):	):	PUNCT
iajs-108	309	3	1113	1113	NUM
iajs-108	309	4	-	-	SYM
iajs-108	309	5	1120	1120	NUM
iajs-108	309	6	.	.	PUNCT
iajs-108	310	1	41	41	NUM
iajs-108	310	2	.	.	PUNCT
iajs-108	310	3	coucke	coucke	PROPN
iajs-108	310	4	,	,	PUNCT
iajs-108	310	5	pj	pj	PROPN
iajs-108	310	6	.	.	PROPN
iajs-108	310	7	;	;	PUNCT
iajs-108	310	8	willaert	willaert	PROPN
iajs-108	310	9	,	,	PUNCT
iajs-108	310	10	a.	a.	NOUN
iajs-108	310	11	;	;	PUNCT
iajs-108	310	12	wessels	wessels	PROPN
iajs-108	310	13	,	,	PUNCT
iajs-108	310	14	mw	mw	PROPN
iajs-108	310	15	.	.	PROPN
iajs-108	310	16	;	;	PUNCT
iajs-108	310	17	bert	bert	PROPN
iajs-108	310	18	,	,	PUNCT
iajs-108	310	19	c.	c.	PROPN
iajs-108	310	20	;	;	PUNCT
iajs-108	310	21	nicoletta	nicoletta	PROPN
iajs-108	310	22	,	,	PUNCT
iajs-108	310	23	z.	z.	PROPN
iajs-108	310	24	;	;	PUNCT
iajs-108	310	25	julie	julie	PROPN
iajs-108	310	26	de	de	PROPN
iajs-108	310	27	,	,	PUNCT
iajs-108	310	28	b.	b.	PROPN
iajs-108	310	29	;	;	PUNCT
iajs-108	310	30	joyce	joyce	PROPN
iajs-108	310	31	,	,	PUNCT
iajs-108	310	32	e.f	e.f	PROPN
iajs-108	310	33	;	;	PUNCT
iajs-108	310	34	grazia	grazia	PROPN
iajs-108	310	35	m	m	PROPN
iajs-108	310	36	s	s	NOUN
iajs-108	310	37	;	;	PUNCT
iajs-108	310	38	marios	mario	NOUN
iajs-108	310	39	,	,	PUNCT
iajs-108	310	40	k.	k.	PROPN
iajs-108	310	41	;	;	PUNCT
iajs-108	310	42	rita	rita	PROPN
iajs-108	310	43	.g	.g	PROPN
iajs-108	310	44	;	;	PUNCT
iajs-108	310	45	fabio	fabio	PROPN
iajs-108	310	46	.f	.f	PROPN
iajs-108	310	47	;	;	PUNCT
iajs-108	310	48	patrick	patrick	PROPN
iajs-108	310	49	j	j	PROPN
iajs-108	310	50	.w	.w	PROPN
iajs-108	310	51	;	;	PUNCT
iajs-108	310	52	ramses	ramses	PROPN
iajs-108	310	53	.f	.f	PROPN
iajs-108	310	54	;	;	PUNCT
iajs-108	310	55	harry	harry	PROPN
iajs-108	310	56	c	c	PROPN
iajs-108	310	57	d	d	PROPN
iajs-108	310	58	;	;	PUNCT
iajs-108	310	59	sergio	sergio	PROPN
iajs-108	310	60	b	b	PROPN
iajs-108	310	61	;	;	PUNCT
iajs-108	310	62	marina	marina	NOUN
iajs-108	310	63	c	c	X
iajs-108	310	64	;	;	PUNCT
iajs-108	310	65	bart	bart	PROPN
iajs-108	310	66	l	l	PROPN
iajs-108	310	67	and	and	CCONJ
iajs-108	310	68	anne	anne	PROPN
iajs-108	310	69	d	d	PROPN
iajs-108	310	70	p.	p.	PROPN
iajs-108	310	71	(	(	PUNCT
iajs-108	310	72	2006	2006	NUM
iajs-108	310	73	)	)	PUNCT
iajs-108	310	74	mutations	mutation	NOUN
iajs-108	310	75	in	in	ADP
iajs-108	310	76	the	the	DET
iajs-108	310	77	facilitative	facilitative	ADJ
iajs-108	310	78	glucose	glucose	NOUN
iajs-108	310	79	transporter	transporter	NOUN
iajs-108	310	80	glut10	glut10	NOUN
iajs-108	310	81	alter	alter	VERB
iajs-108	310	82	angiogenesis	angiogenesis	NOUN
iajs-108	310	83	and	and	CCONJ
iajs-108	310	84	cause	cause	VERB
iajs-108	310	85	arterial	arterial	ADJ
iajs-108	310	86	tortuosity	tortuosity	NOUN
iajs-108	310	87	syndrome	syndrome	NOUN
iajs-108	310	88	.	.	PUNCT
iajs-108	311	1	nat	nat	PROPN
iajs-108	311	2	genet	genet	PROPN
iajs-108	311	3	.	.	PUNCT
iajs-108	312	1	38(4):452	38(4):452	NUM
iajs-108	312	2	-	-	SYM
iajs-108	312	3	457	457	NUM
iajs-108	312	4	.	.	PUNCT
iajs-108	313	1	42	42	NUM
iajs-108	313	2	.	.	PUNCT
iajs-108	314	1	bobik	bobik	PROPN
iajs-108	314	2	,	,	PUNCT
iajs-108	314	3	a.	a.	NOUN
iajs-108	314	4	(	(	PUNCT
iajs-108	314	5	2006	2006	NUM
iajs-108	314	6	)	)	PUNCT
iajs-108	314	7	transforming	transform	VERB
iajs-108	314	8	growth	growth	NOUN
iajs-108	314	9	factor	factor	NOUN
iajs-108	314	10	-	-	PUNCT
iajs-108	314	11	betas	beta	NOUN
iajs-108	314	12	and	and	CCONJ
iajs-108	314	13	vascular	vascular	ADJ
iajs-108	314	14	disorders	disorder	NOUN
iajs-108	314	15	.	.	PUNCT
iajs-108	315	1	arterioscler	arterioscler	PROPN
iajs-108	315	2	thromb	thromb	PROPN
iajs-108	315	3	vasc	vasc	PROPN
iajs-108	315	4	biol	biol	PROPN
iajs-108	315	5	.	.	PUNCT
iajs-108	316	1	26(8):1712	26(8):1712	NUM
iajs-108	316	2	-	-	PUNCT
iajs-108	316	3	1720	1720	NUM
iajs-108	316	4	.	.	PUNCT
iajs-108	317	1	43	43	NUM
iajs-108	317	2	.	.	PUNCT
iajs-108	318	1	gonzález	gonzález	PROPN
iajs-108	318	2	,	,	PUNCT
iajs-108	318	3	f.	f.	PROPN
iajs-108	318	4	;	;	PUNCT
iajs-108	318	5	rote	rote	VERB
iajs-108	318	6	,	,	PUNCT
iajs-108	318	7	ns	ns	INTJ
iajs-108	318	8	.	.	PROPN
iajs-108	318	9	;	;	PUNCT
iajs-108	318	10	minium	minium	PROPN
iajs-108	318	11	,	,	PUNCT
iajs-108	318	12	j.	j.	PROPN
iajs-108	318	13	;	;	PUNCT
iajs-108	318	14	and	and	CCONJ
iajs-108	318	15	kirwan	kirwan	PROPN
iajs-108	318	16	,	,	PUNCT
iajs-108	319	1	jp	jp	INTJ
iajs-108	319	2	.	.	PUNCT
iajs-108	320	1	(	(	PUNCT
iajs-108	320	2	2006	2006	NUM
iajs-108	320	3	)	)	PUNCT
iajs-108	320	4	increased	increase	VERB
iajs-108	320	5	activation	activation	NOUN
iajs-108	320	6	of	of	ADP
iajs-108	320	7	nuclear	nuclear	ADJ
iajs-108	320	8	factor	factor	NOUN
iajs-108	320	9	kb	kb	PROPN
iajs-108	320	10	triggers	trigger	VERB
iajs-108	320	11	inflammation	inflammation	NOUN
iajs-108	320	12	and	and	CCONJ
iajs-108	320	13	insulin	insulin	NOUN
iajs-108	320	14	resistance	resistance	NOUN
iajs-108	320	15	in	in	ADP
iajs-108	320	16	polycystic	polycystic	ADJ
iajs-108	320	17	ovary	ovary	ADJ
iajs-108	320	18	syndrome	syndrome	NOUN
iajs-108	320	19	.	.	PUNCT
iajs-108	321	1	journal	journal	PROPN
iajs-108	321	2	of	of	ADP
iajs-108	321	3	clin	clin	PROPN
iajs-108	321	4	endocrinol	endocrinol	PROPN
iajs-108	321	5	metab	metab	NOUN
iajs-108	321	6	.	.	PUNCT
iajs-108	322	1	91:1508–1512	91:1508–1512	X
iajs-108	322	2	.	.	NOUN
iajs-108	322	3	44	44	NUM
iajs-108	322	4	.	.	PUNCT
iajs-108	323	1	gonzález	gonzález	PROPN
iajs-108	323	2	,	,	PUNCT
iajs-108	323	3	f.	f.	PROPN
iajs-108	323	4	;	;	PUNCT
iajs-108	323	5	minium	minium	PROPN
iajs-108	323	6	,	,	PUNCT
iajs-108	323	7	j.	j.	PROPN
iajs-108	323	8	;	;	PUNCT
iajs-108	323	9	rote	rote	VERB
iajs-108	323	10	,	,	PUNCT
iajs-108	323	11	ns	ns	ADJ
iajs-108	323	12	.	.	PUNCT
iajs-108	323	13	;	;	PUNCT
iajs-108	323	14	and	and	CCONJ
iajs-108	323	15	kirwan	kirwan	PROPN
iajs-108	323	16	,	,	PUNCT
iajs-108	323	17	jp	jp	INTJ
iajs-108	323	18	.	.	PUNCT
iajs-108	324	1	(	(	PUNCT
iajs-108	324	2	2005	2005	NUM
iajs-108	324	3	)	)	PUNCT
iajs-108	324	4	hyperglycemia	hyperglycemia	NOUN
iajs-108	324	5	alters	alter	VERB
iajs-108	324	6	tumor	tumor	NOUN
iajs-108	324	7	necrosis	necrosis	NOUN
iajs-108	324	8	factor	factor	NOUN
iajs-108	324	9	-	-	PUNCT
iajs-108	324	10	a	a	DET
iajs-108	324	11	release	release	NOUN
iajs-108	324	12	from	from	ADP
iajs-108	324	13	mononuclear	mononuclear	ADJ
iajs-108	324	14	cells	cell	NOUN
iajs-108	324	15	in	in	ADP
iajs-108	324	16	women	woman	NOUN
iajs-108	324	17	with	with	ADP
iajs-108	324	18	polycystic	polycystic	ADJ
iajs-108	324	19	ovary	ovary	ADJ
iajs-108	324	20	syndrome	syndrome	NOUN
iajs-108	324	21	.	.	PUNCT
iajs-108	325	1	j	j	PROPN
iajs-108	325	2	clin	clin	PROPN
iajs-108	325	3	endocrinol	endocrinol	PROPN
iajs-108	325	4	metab	metab	NOUN
iajs-108	325	5	.	.	PUNCT
iajs-108	326	1	90:5336–5342	90:5336–5342	NUM
iajs-108	326	2	.	.	PUNCT
iajs-108	327	1	45	45	NUM
iajs-108	327	2	.	.	PUNCT
iajs-108	327	3	gonzález	gonzález	PROPN
iajs-108	327	4	,	,	PUNCT
iajs-108	327	5	f.	f.	PROPN
iajs-108	327	6	;	;	PUNCT
iajs-108	327	7	rote	rote	VERB
iajs-108	327	8	,	,	PUNCT
iajs-108	327	9	ns	ns	INTJ
iajs-108	327	10	.	.	PROPN
iajs-108	327	11	;	;	PUNCT
iajs-108	327	12	minium	minium	PROPN
iajs-108	327	13	,	,	PUNCT
iajs-108	327	14	j.	j.	PROPN
iajs-108	327	15	;	;	PUNCT
iajs-108	327	16	and	and	CCONJ
iajs-108	327	17	kirwan	kirwan	PROPN
iajs-108	327	18	jp	jp	PROPN
iajs-108	327	19	.	.	PUNCT
iajs-108	328	1	(	(	PUNCT
iajs-108	328	2	2009	2009	NUM
iajs-108	328	3	)	)	PUNCT
iajs-108	328	4	evidence	evidence	NOUN
iajs-108	328	5	of	of	ADP
iajs-108	328	6	proatherogenic	proatherogenic	ADJ
iajs-108	328	7	inflammation	inflammation	NOUN
iajs-108	328	8	in	in	ADP
iajs-108	328	9	polycystic	polycystic	ADJ
iajs-108	328	10	ovary	ovary	ADJ
iajs-108	328	11	syndrome	syndrome	NOUN
iajs-108	328	12	.	.	PUNCT
iajs-108	329	1	metabolism	metabolism	NOUN
iajs-108	329	2	.	.	PUNCT
iajs-108	330	1	58:954–962	58:954–962	NUM
iajs-108	330	2	.	.	PUNCT
iajs-108	331	1	46	46	NUM
iajs-108	331	2	.	.	PUNCT
iajs-108	332	1	gonzález	gonzález	PROPN
iajs-108	332	2	,	,	PUNCT
iajs-108	332	3	f.	f.	PROPN
iajs-108	332	4	;	;	PUNCT
iajs-108	332	5	nair	nair	PROPN
iajs-108	332	6	,	,	PUNCT
iajs-108	332	7	ks	ks	PROPN
iajs-108	332	8	.	.	PROPN
iajs-108	332	9	;	;	PUNCT
iajs-108	332	10	daniels	daniels	PROPN
iajs-108	332	11	,	,	PUNCT
iajs-108	332	12	jk	jk	PROPN
iajs-108	332	13	.	.	PROPN
iajs-108	332	14	;	;	PUNCT
iajs-108	332	15	basal	basal	PROPN
iajs-108	332	16	,	,	PUNCT
iajs-108	332	17	e.	e.	PROPN
iajs-108	332	18	;	;	PUNCT
iajs-108	332	19	and	and	CCONJ
iajs-108	332	20	schimke	schimke	ADJ
iajs-108	332	21	,	,	PUNCT
iajs-108	332	22	jm	jm	PROPN
iajs-108	332	23	.	.	PROPN
iajs-108	333	1	(	(	PUNCT
iajs-108	333	2	2012	2012	NUM
iajs-108	333	3	)	)	PUNCT
iajs-108	333	4	hyperandrogenism	hyperandrogenism	NOUN
iajs-108	333	5	sensitizes	sensitize	VERB
iajs-108	333	6	mononuclear	mononuclear	ADJ
iajs-108	333	7	cells	cell	NOUN
iajs-108	333	8	to	to	PART
iajs-108	333	9	promote	promote	VERB
iajs-108	333	10	glucose	glucose	NOUN
iajs-108	333	11	-	-	PUNCT
iajs-108	333	12	induced	induce	VERB
iajs-108	333	13	inflammation	inflammation	NOUN
iajs-108	333	14	in	in	ADP
iajs-108	333	15	lean	lean	ADJ
iajs-108	333	16	reproductive	reproductive	ADJ
iajs-108	333	17	-	-	PUNCT
iajs-108	333	18	age	age	NOUN
iajs-108	333	19	women	woman	NOUN
iajs-108	333	20	.	.	PUNCT
iajs-108	334	1	am	be	AUX
iajs-108	334	2	j	j	PROPN
iajs-108	334	3	physiol	physiol	PROPN
iajs-108	334	4	endocrinol	endocrinol	VERB
iajs-108	334	5	metab	metab	PROPN
iajs-108	334	6	302(3	302(3	NUM
iajs-108	334	7	):	):	PUNCT
iajs-108	334	8	e297	e297	PROPN
iajs-108	334	9	-	-	PUNCT
iajs-108	334	10	306	306	NUM
iajs-108	334	11	.	.	PUNCT
iajs-108	335	1	47	47	NUM
iajs-108	335	2	.	.	PUNCT
iajs-108	336	1	gonzález	gonzález	PROPN
iajs-108	336	2	,	,	PUNCT
iajs-108	336	3	f.	f.	PROPN
iajs-108	336	4	;	;	PUNCT
iajs-108	336	5	nair	nair	PROPN
iajs-108	336	6	,	,	PUNCT
iajs-108	336	7	ks	ks	PROPN
iajs-108	336	8	.	.	PROPN
iajs-108	336	9	;	;	PUNCT
iajs-108	336	10	coddington	coddington	PROPN
iajs-108	336	11	,	,	PUNCT
iajs-108	336	12	cc	cc	PROPN
iajs-108	336	13	.	.	PROPN
iajs-108	336	14	;	;	PUNCT
iajs-108	336	15	and	and	CCONJ
iajs-108	336	16	blair	blair	PROPN
iajs-108	336	17	,	,	PUNCT
iajs-108	336	18	he	he	PRON
iajs-108	336	19	.	.	PUNCT
iajs-108	337	1	(	(	PUNCT
iajs-108	337	2	2010	2010	NUM
iajs-108	337	3	)	)	PUNCT
iajs-108	337	4	anti	anti	ADJ
iajs-108	337	5	-	-	ADJ
iajs-108	337	6	inflammatory	inflammatory	ADJ
iajs-108	337	7	effect	effect	NOUN
iajs-108	337	8	of	of	ADP
iajs-108	337	9	hyperandrogenism	hyperandrogenism	NOUN
iajs-108	337	10	in	in	ADP
iajs-108	337	11	polycystic	polycystic	ADJ
iajs-108	337	12	ovary	ovary	ADJ
iajs-108	337	13	syndrome	syndrome	NOUN
iajs-108	337	14	.	.	PUNCT
iajs-108	338	1	reprod	reprod	PROPN
iajs-108	338	2	sci	sci	PROPN
iajs-108	338	3	.	.	PROPN
iajs-108	338	4	17(3):249a–250a	17(3):249a–250a	NUM
iajs-108	338	5	.	.	PUNCT
iajs-108	339	1	chemistry	chemistry	NOUN
iajs-108	339	2	|	|	ADV
iajs-108	339	3	179	179	NUM
iajs-108	339	4	2016	2016	NUM
iajs-108	339	5	)	)	PUNCT
iajs-108	339	6	عام	عام	ADP
iajs-108	339	7	2العدد	2العدد	NUM
iajs-108	339	8	(	(	PUNCT
iajs-108	339	9	29مجلة	29مجلة	NUM
iajs-108	339	10	إبن	إبن	VERB
iajs-108	339	11	الهيثم	الهيثم	ADJ
iajs-108	339	12	للعلوم	للعلوم	NOUN
iajs-108	339	13	الصرفة	الصرفة	NOUN
iajs-108	340	1	و	و	PRON
iajs-108	340	2	التطبيقية	التطبيقية	ADV
iajs-108	340	3	المجلد	المجلد	VERB
iajs-108	340	4	ibn	ibn	PROPN
iajs-108	340	5	al	al	PROPN
iajs-108	340	6	-	-	PUNCT
iajs-108	340	7	haitham	haitham	PROPN
iajs-108	340	8	jour	jour	X
iajs-108	340	9	.	.	PROPN
iajs-108	341	1	for	for	ADP
iajs-108	341	2	pure	pure	ADJ
iajs-108	341	3	&	&	CCONJ
iajs-108	341	4	appl	appl	PROPN
iajs-108	341	5	.	.	PUNCT
iajs-108	342	1	sci	sci	PROPN
iajs-108	342	2	.	.	PUNCT
iajs-108	342	3	vol	vol	NOUN
iajs-108	342	4	.	.	PROPN
iajs-108	342	5	29	29	NUM
iajs-108	342	6	(	(	PUNCT
iajs-108	342	7	2	2	NUM
iajs-108	342	8	)	)	SYM
iajs-108	342	9	2016	2016	NUM
iajs-108	342	10	table	table	NOUN
iajs-108	342	11	(	(	PUNCT
iajs-108	342	12	1	1	NUM
iajs-108	342	13	):	):	PUNCT
iajs-108	342	14	mean	mean	NOUN
iajs-108	342	15	(	(	PUNCT
iajs-108	342	16	±sd	±sd	NOUN
iajs-108	342	17	)	)	PUNCT
iajs-108	342	18	level	level	NOUN
iajs-108	342	19	of	of	ADP
iajs-108	342	20	bmi	bmi	NOUN
iajs-108	342	21	,	,	PUNCT
iajs-108	342	22	fsg	fsg	PROPN
iajs-108	342	23	,	,	PUNCT
iajs-108	342	24	insulin	insulin	NOUN
iajs-108	342	25	,	,	PUNCT
iajs-108	342	26	homa2	homa2	NOUN
iajs-108	342	27	parameters	parameter	NOUN
iajs-108	342	28	,	,	PUNCT
iajs-108	342	29	ferritin	ferritin	ADJ
iajs-108	342	30	and	and	CCONJ
iajs-108	342	31	tgf	tgf	PROPN
iajs-108	342	32	-	-	PUNCT
iajs-108	342	33	β1	β1	PROPN
iajs-108	342	34	of	of	ADP
iajs-108	342	35	control	control	NOUN
iajs-108	342	36	and	and	CCONJ
iajs-108	342	37	patients	patient	NOUN
iajs-108	342	38	groups	group	NOUN
iajs-108	342	39	(	(	PUNCT
iajs-108	342	40	lean	lean	ADJ
iajs-108	342	41	,	,	PUNCT
iajs-108	342	42	overweight	overweight	ADJ
iajs-108	342	43	and	and	CCONJ
iajs-108	342	44	obese	obese	ADJ
iajs-108	342	45	)	)	PUNCT
iajs-108	342	46	.	.	PUNCT
iajs-108	343	1	parameters	parameter	NOUN
iajs-108	343	2	control	control	PROPN
iajs-108	343	3	group	group	PROPN
iajs-108	343	4	n=20	n=20	PROPN
iajs-108	343	5	lean	lean	ADJ
iajs-108	343	6	group	group	NOUN
iajs-108	343	7	n=	n=	ADJ
iajs-108	343	8	20	20	NUM
iajs-108	343	9	overweight	overweight	NOUN
iajs-108	343	10	group	group	NOUN
iajs-108	343	11	n=17	n=17	NOUN
iajs-108	343	12	obese	obese	PROPN
iajs-108	343	13	group	group	NOUN
iajs-108	343	14	n=24	n=24	PROPN
iajs-108	343	15	p	p	PROPN
iajs-108	343	16	value	value	NOUN
iajs-108	343	17	bmi	bmi	NOUN
iajs-108	343	18	22.7	22.7	NUM
iajs-108	343	19	±1.68	±1.68	PROPN
iajs-108	343	20	22.84±1.65	22.84±1.65	PROPN
iajs-108	343	21	26.84±1.34***a	26.84±1.34***a	NOUN
iajs-108	343	22	,	,	PUNCT
iajs-108	343	23	b	b	NOUN
iajs-108	343	24	35.04±4.12	35.04±4.12	NUM
iajs-108	343	25	*	*	PUNCT
iajs-108	343	26	*	*	PUNCT
iajs-108	343	27	*	*	PUNCT
iajs-108	343	28	a	a	PRON
iajs-108	343	29	,	,	PUNCT
iajs-108	343	30	b,*c	b,*c	PROPN
iajs-108	343	31	0.000	0.000	NUM
iajs-108	343	32	fsg	fsg	PROPN
iajs-108	343	33	(	(	PUNCT
iajs-108	343	34	mg	mg	PROPN
iajs-108	343	35	/	/	SYM
iajs-108	343	36	dl	dl	PROPN
iajs-108	343	37	)	)	PUNCT
iajs-108	343	38	82.32±5.93	82.32±5.93	PROPN
iajs-108	343	39	93.96±9.85**a	93.96±9.85**a	NUM
iajs-108	343	40	98.3±11.2***a	98.3±11.2***a	NUM
iajs-108	343	41	99.96±11.3***a	99.96±11.3***a	NUM
iajs-108	343	42	0.000	0.000	NUM
iajs-108	343	43	insulin(µlu	insulin(µlu	NOUN
iajs-108	343	44	/	/	SYM
iajs-108	343	45	ml	ml	NOUN
iajs-108	343	46	)	)	PUNCT
iajs-108	343	47	09.99±1.87	09.99±1.87	PROPN
iajs-108	344	1	14.65±5.28*a	14.65±5.28*a	NUM
iajs-108	344	2	21.25±5.4***a,**b	21.25±5.4***a,**b	NUM
iajs-108	344	3	21.6±5.7***a	21.6±5.7***a	NUM
iajs-108	344	4	,	,	PUNCT
iajs-108	344	5	b	b	NOUN
iajs-108	344	6	0.000	0.000	NUM
iajs-108	344	7	homa2	homa2	NOUN
iajs-108	344	8	-	-	PUNCT
iajs-108	344	9	β	β	NOUN
iajs-108	344	10	cell	cell	NOUN
iajs-108	344	11	(	(	PUNCT
iajs-108	344	12	%	%	INTJ
iajs-108	344	13	)	)	PUNCT
iajs-108	344	14	136.4±22.37	136.4±22.37	NUM
iajs-108	344	15	134.7±32.33	134.7±32.33	NUM
iajs-108	344	16	165.29±27.2**a	165.29±27.2**a	NOUN
iajs-108	344	17	,	,	PUNCT
iajs-108	344	18	b	b	NOUN
iajs-108	344	19	157.71±23.74*a	157.71±23.74*a	NUM
iajs-108	344	20	,	,	PUNCT
iajs-108	344	21	b	b	NOUN
iajs-108	344	22	0.01	0.01	NUM
iajs-108	344	23	homa2	homa2	NOUN
iajs-108	344	24	-	-	PUNCT
iajs-108	344	25	s	s	PART
iajs-108	344	26	cell	cell	NOUN
iajs-108	344	27	(	(	PUNCT
iajs-108	344	28	%	%	INTJ
iajs-108	344	29	)	)	PUNCT
iajs-108	344	30	82.26±18.22	82.26±18.22	NOUN
iajs-108	344	31	59.95±20.85**a	59.95±20.85**a	NUM
iajs-108	344	32	40.98±14.3***a,**b	40.98±14.3***a,**b	NUM
iajs-108	344	33	38.1±10.6***a	38.1±10.6***a	NUM
iajs-108	344	34	,	,	PUNCT
iajs-108	344	35	b	b	NOUN
iajs-108	344	36	0.000	0.000	NUM
iajs-108	344	37	homa2	homa2	NOUN
iajs-108	344	38	-	-	PUNCT
iajs-108	344	39	ir	ir	PROPN
iajs-108	344	40	1.27±0.24	1.27±0.24	NUM
iajs-108	344	41	1.9±0.69*a	1.9±0.69*a	NUM
iajs-108	344	42	2.73±0.71***a,**b	2.73±0.71***a,**b	NUM
iajs-108	344	43	2.8±0.75***a	2.8±0.75***a	NUM
iajs-108	344	44	,	,	PUNCT
iajs-108	344	45	b	b	PROPN
iajs-108	344	46	0.000	0.000	NUM
iajs-108	344	47	ferritin(ng	ferritin(ng	NOUN
iajs-108	344	48	/	/	SYM
iajs-108	344	49	ml	ml	NOUN
iajs-108	344	50	)	)	PUNCT
iajs-108	344	51	   	   	SPACE
iajs-108	344	52	45.14±14.2	45.14±14.2	NUM
iajs-108	344	53	  	  	SPACE
iajs-108	344	54	57.87	57.87	NUM
iajs-108	344	55	 	 	SPACE
iajs-108	344	56	±7.31*a	±7.31*a	NOUN
iajs-108	344	57	  	  	SPACE
iajs-108	344	58	60.7±10.58**a	60.7±10.58**a	NOUN
iajs-108	344	59	  	  	SPACE
iajs-108	344	60	67.3±18.3***a	67.3±18.3***a	NUM
iajs-108	344	61	  	  	SPACE
iajs-108	344	62	0.000	0.000	NUM
iajs-108	344	63	  	  	SPACE
iajs-108	344	64	tgf‐β1(pg	tgf‐β1(pg	NOUN
iajs-108	344	65	/	/	SYM
iajs-108	344	66	ml	ml	NOUN
iajs-108	344	67	)	)	PUNCT
iajs-108	344	68	  	  	SPACE
iajs-108	344	69	16.76±4.23	16.76±4.23	NUM
iajs-108	344	70	20.6±4.97	20.6±4.97	NUM
iajs-108	344	71	  	  	SPACE
iajs-108	344	72	21.12±5.0*a	21.12±5.0*a	NOUN
iajs-108	344	73	  	  	SPACE
iajs-108	344	74	22.1±5.2**a	22.1±5.2**a	NOUN
iajs-108	344	75	  	  	SPACE
iajs-108	344	76	0.005	0.005	NUM
iajs-108	344	77	  	  	SPACE
iajs-108	344	78	*	*	NOUN
iajs-108	344	79	p<0.05	p<0.05	NOUN
iajs-108	344	80	;	;	PUNCT
iajs-108	344	81	*	*	PUNCT
iajs-108	344	82	*	*	PUNCT
iajs-108	344	83	p<0.01	p<0.01	PROPN
iajs-108	344	84	;	;	PUNCT
iajs-108	344	85	*	*	PUNCT
iajs-108	344	86	*	*	PUNCT
iajs-108	344	87	*	*	PUNCT
iajs-108	344	88	p<0.001	p<0.001	ADJ
iajs-108	344	89	.	.	PUNCT
iajs-108	345	1	no	no	DET
iajs-108	345	2	asterisk	asterisk	NOUN
iajs-108	345	3	:	:	PUNCT
iajs-108	345	4	p≥0.05	p≥0.05	NOUN
iajs-108	345	5	.	.	PUNCT
iajs-108	346	1	(	(	PUNCT
iajs-108	346	2	a	a	X
iajs-108	346	3	)	)	PUNCT
iajs-108	346	4	indicates	indicate	VERB
iajs-108	346	5	significant	significant	ADJ
iajs-108	346	6	difference	difference	NOUN
iajs-108	346	7	between	between	ADP
iajs-108	346	8	groups	group	NOUN
iajs-108	346	9	controls	control	VERB
iajs-108	346	10	with	with	ADP
iajs-108	346	11	lean	lean	ADJ
iajs-108	346	12	,	,	PUNCT
iajs-108	346	13	overweight	overweight	ADJ
iajs-108	346	14	and	and	CCONJ
iajs-108	346	15	obese	obese	ADJ
iajs-108	346	16	.	.	PUNCT
iajs-108	347	1	(	(	PUNCT
iajs-108	347	2	b	b	X
iajs-108	347	3	)	)	PUNCT
iajs-108	347	4	indicates	indicate	VERB
iajs-108	347	5	significant	significant	ADJ
iajs-108	347	6	difference	difference	NOUN
iajs-108	347	7	between	between	ADP
iajs-108	347	8	group	group	NOUN
iajs-108	347	9	leans	lean	VERB
iajs-108	347	10	with	with	ADP
iajs-108	347	11	overweight	overweight	NOUN
iajs-108	347	12	and	and	CCONJ
iajs-108	347	13	obese	obese	ADJ
iajs-108	347	14	.	.	PUNCT
iajs-108	348	1	(	(	PUNCT
iajs-108	348	2	c	c	X
iajs-108	348	3	)	)	PUNCT
iajs-108	348	4	indicates	indicate	VERB
iajs-108	348	5	significant	significant	ADJ
iajs-108	348	6	difference	difference	NOUN
iajs-108	348	7	between	between	ADP
iajs-108	348	8	group	group	NOUN
iajs-108	348	9	overweight	overweight	NOUN
iajs-108	348	10	with	with	ADP
iajs-108	348	11	obese	obese	PROPN
iajs-108	348	12	.	.	PUNCT
iajs-108	349	1	chemistry	chemistry	NOUN
iajs-108	349	2	|	|	ADV
iajs-108	349	3	180	180	NUM
iajs-108	349	4	2016	2016	NUM
iajs-108	349	5	)	)	PUNCT
iajs-108	349	6	عام	عام	ADP
iajs-108	349	7	2العدد	2العدد	NUM
iajs-108	349	8	(	(	PUNCT
iajs-108	349	9	29مجلة	29مجلة	NUM
iajs-108	349	10	إبن	إبن	VERB
iajs-108	349	11	الهيثم	الهيثم	ADJ
iajs-108	349	12	للعلوم	للعلوم	NOUN
iajs-108	349	13	الصرفة	الصرفة	NOUN
iajs-108	350	1	و	و	PRON
iajs-108	350	2	التطبيقية	التطبيقية	ADV
iajs-108	350	3	المجلد	المجلد	VERB
iajs-108	350	4	ibn	ibn	PROPN
iajs-108	350	5	al	al	PROPN
iajs-108	350	6	-	-	PUNCT
iajs-108	350	7	haitham	haitham	PROPN
iajs-108	350	8	jour	jour	X
iajs-108	350	9	.	.	PROPN
iajs-108	351	1	for	for	ADP
iajs-108	351	2	pure	pure	ADJ
iajs-108	351	3	&	&	CCONJ
iajs-108	351	4	appl	appl	PROPN
iajs-108	351	5	.	.	PUNCT
iajs-108	352	1	sci	sci	PROPN
iajs-108	352	2	.	.	PUNCT
iajs-108	352	3	vol	vol	NOUN
iajs-108	352	4	.	.	PROPN
iajs-108	352	5	29	29	NUM
iajs-108	352	6	(	(	PUNCT
iajs-108	352	7	2	2	NUM
iajs-108	352	8	)	)	SYM
iajs-108	352	9	2016	2016	NUM
iajs-108	352	10	table	table	NOUN
iajs-108	352	11	(	(	PUNCT
iajs-108	352	12	2	2	NUM
iajs-108	352	13	):	):	PUNCT
iajs-108	352	14	pearson	pearson	NOUN
iajs-108	352	15	correlation	correlation	NOUN
iajs-108	352	16	analysis	analysis	NOUN
iajs-108	352	17	of	of	ADP
iajs-108	352	18	ferritin	ferritin	ADJ
iajs-108	352	19	level	level	NOUN
iajs-108	352	20	in	in	ADP
iajs-108	352	21	patients	patient	NOUN
iajs-108	352	22	lean	lean	ADJ
iajs-108	352	23	,	,	PUNCT
iajs-108	352	24	overweight	overweight	ADJ
iajs-108	352	25	and	and	CCONJ
iajs-108	352	26	obese	obese	ADJ
iajs-108	352	27	groups	group	NOUN
iajs-108	352	28	.	.	PUNCT
iajs-108	353	1	ferritin	ferritin	ADJ
iajs-108	353	2	parameters	parameter	NOUN
iajs-108	353	3	r	r	NOUN
iajs-108	353	4	value	value	NOUN
iajs-108	353	5	obese	obese	NOUN
iajs-108	353	6	r	r	NOUN
iajs-108	353	7	value	value	NOUN
iajs-108	353	8	overweight	overweight	NOUN
iajs-108	353	9	r	r	NOUN
iajs-108	353	10	value	value	NOUN
iajs-108	353	11	lean	lean	VERB
iajs-108	353	12	0.734	0.734	NUM
iajs-108	353	13	*	*	NOUN
iajs-108	353	14	*	*	NOUN
iajs-108	353	15	0.682	0.682	NUM
iajs-108	353	16	*	*	PUNCT
iajs-108	353	17	*	*	NOUN
iajs-108	353	18	0.579	0.579	NUM
iajs-108	353	19	*	*	PUNCT
iajs-108	353	20	*	*	NOUN
iajs-108	353	21	insulin	insulin	NOUN
iajs-108	353	22	(	(	PUNCT
iajs-108	353	23	μiu	μiu	PROPN
iajs-108	353	24	/	/	SYM
iajs-108	353	25	ml	ml	NOUN
iajs-108	353	26	)	)	PUNCT
iajs-108	353	27	*	*	PUNCT
iajs-108	354	1	*	*	PUNCT
iajs-108	354	2	0.627	0.627	NUM
iajs-108	354	3	*	*	PUNCT
iajs-108	354	4	0.553	0.553	NUM
iajs-108	354	5	*	*	NUM
iajs-108	354	6	0.462homa2	0.462homa2	NOUN
iajs-108	354	7	s	s	PART
iajs-108	354	8	(	(	PUNCT
iajs-108	354	9	%	%	INTJ
iajs-108	354	10	)	)	PUNCT
iajs-108	354	11	*	*	PUNCT
iajs-108	355	1	*	*	X
iajs-108	355	2	0.711	0.711	NUM
iajs-108	355	3	*	*	NUM
iajs-108	355	4	0.637	0.637	NUM
iajs-108	355	5	*	*	PUNCT
iajs-108	355	6	*	*	PUNCT
iajs-108	355	7	0.589	0.589	NUM
iajs-108	355	8	homa2	homa2	NOUN
iajs-108	356	1	ir	ir	INTJ
iajs-108	357	1	*	*	PUNCT
iajs-108	357	2	0.522	0.522	NUM
iajs-108	357	3	*	*	PUNCT
iajs-108	357	4	*	*	NUM
iajs-108	357	5	0.691	0.691	NUM
iajs-108	357	6	0.366	0.366	NUM
iajs-108	357	7	tgf	tgf	PROPN
iajs-108	357	8	-	-	PUNCT
iajs-108	357	9	β1	β1	PROPN
iajs-108	357	10	(	(	PUNCT
iajs-108	357	11	pg	pg	NOUN
iajs-108	357	12	/	/	SYM
iajs-108	357	13	ml	ml	VERB
iajs-108	357	14	)	)	PUNCT
iajs-108	357	15	*	*	PUNCT
iajs-108	358	1	p	p	X
iajs-108	358	2	<	<	X
iajs-108	358	3	0.05	0.05	NUM
iajs-108	358	4	;	;	PUNCT
iajs-108	358	5	*	*	PUNCT
iajs-108	358	6	*	*	PUNCT
iajs-108	358	7	p<0.01	p<0.01	PROPN
iajs-108	358	8	;	;	PUNCT
iajs-108	358	9	no	no	DET
iajs-108	358	10	asterisk	asterisk	NOUN
iajs-108	358	11	:	:	PUNCT
iajs-108	358	12	p≥0.05	p≥0.05	NOUN
iajs-108	358	13	.	.	NOUN
iajs-108	358	14	table	table	NOUN
iajs-108	358	15	(	(	PUNCT
iajs-108	358	16	3	3	NUM
iajs-108	358	17	):	):	PUNCT
iajs-108	358	18	pearson	pearson	NOUN
iajs-108	358	19	correlation	correlation	NOUN
iajs-108	358	20	analysis	analysis	NOUN
iajs-108	358	21	of	of	ADP
iajs-108	358	22	tgf	tgf	PROPN
iajs-108	358	23	-	-	PUNCT
iajs-108	358	24	β1	β1	PROPN
iajs-108	358	25	in	in	ADP
iajs-108	358	26	patients	patient	NOUN
iajs-108	358	27	lean	lean	ADJ
iajs-108	358	28	,	,	PUNCT
iajs-108	358	29	overweight	overweight	ADJ
iajs-108	358	30	and	and	CCONJ
iajs-108	358	31	obese	obese	ADJ
iajs-108	358	32	groups	group	NOUN
iajs-108	358	33	.	.	PUNCT
iajs-108	359	1	tgf	tgf	PROPN
iajs-108	359	2	-	-	PUNCT
iajs-108	359	3	β1	β1	PROPN
iajs-108	359	4	parameters	parameter	NOUN
iajs-108	359	5	r	r	NOUN
iajs-108	359	6	value	value	NOUN
iajs-108	359	7	obese	obese	NOUN
iajs-108	359	8	r	r	NOUN
iajs-108	359	9	value	value	NOUN
iajs-108	359	10	overweight	overweight	NOUN
iajs-108	359	11	r	r	NOUN
iajs-108	359	12	value	value	NOUN
iajs-108	359	13	lean	lean	VERB
iajs-108	359	14	0.432	0.432	NUM
iajs-108	359	15	*	*	NOUN
iajs-108	359	16	0.326	0.326	NUM
iajs-108	359	17	0.407	0.407	NUM
iajs-108	359	18	fsg	fsg	NOUN
iajs-108	359	19	(	(	PUNCT
iajs-108	359	20	mg	mg	PROPN
iajs-108	359	21	/	/	SYM
iajs-108	359	22	dl	dl	PROPN
iajs-108	359	23	)	)	PUNCT
iajs-108	359	24	0.624	0.624	NUM
iajs-108	359	25	*	*	PUNCT
iajs-108	359	26	*	*	PUNCT
iajs-108	359	27	0.594	0.594	NUM
iajs-108	359	28	*	*	SYM
iajs-108	359	29	0.473	0.473	NUM
iajs-108	359	30	*	*	NOUN
iajs-108	359	31	insulin	insulin	NOUN
iajs-108	359	32	(	(	PUNCT
iajs-108	359	33	μiu	μiu	PROPN
iajs-108	359	34	/	/	SYM
iajs-108	359	35	ml	ml	NOUN
iajs-108	359	36	)	)	PUNCT
iajs-108	359	37	*	*	PUNCT
iajs-108	360	1	*	*	PUNCT
iajs-108	360	2	0.587	0.587	NUM
iajs-108	360	3	-0.405	-0.405	SYM
iajs-108	360	4	0.348	0.348	NUM
iajs-108	360	5	homa2	homa2	NOUN
iajs-108	360	6	s	s	PART
iajs-108	360	7	(	(	PUNCT
iajs-108	360	8	%	%	INTJ
iajs-108	360	9	)	)	PUNCT
iajs-108	361	1	*	*	PUNCT
iajs-108	362	1	*	*	PUNCT
iajs-108	362	2	0.648	0.648	NUM
iajs-108	362	3	*	*	SYM
iajs-108	362	4	0.579	0.579	NUM
iajs-108	362	5	*	*	NOUN
iajs-108	362	6	0.496	0.496	NUM
iajs-108	362	7	homa2	homa2	NOUN
iajs-108	362	8	ir	ir	INTJ
iajs-108	362	9	*	*	PUNCT
iajs-108	362	10	p	p	X
iajs-108	362	11	<	<	X
iajs-108	362	12	0.05	0.05	NUM
iajs-108	362	13	;	;	PUNCT
iajs-108	362	14	*	*	PUNCT
iajs-108	362	15	*	*	PUNCT
iajs-108	362	16	p<0.01	p<0.01	PROPN
iajs-108	362	17	;	;	PUNCT
iajs-108	362	18	no	no	DET
iajs-108	362	19	-	-	PUNCT
iajs-108	362	20	asterisk	asterisk	NOUN
iajs-108	362	21	:	:	PUNCT
iajs-108	362	22	p≥0.05	p≥0.05	NOUN
iajs-108	362	23	.	.	PUNCT
iajs-108	363	1	chemistry	chemistry	NOUN
iajs-108	363	2	|	|	ADV
iajs-108	363	3	181	181	NUM
iajs-108	363	4	2016	2016	NUM
iajs-108	363	5	)	)	PUNCT
iajs-108	363	6	عام	عام	ADP
iajs-108	363	7	2العدد	2العدد	NUM
iajs-108	363	8	(	(	PUNCT
iajs-108	363	9	29مجلة	29مجلة	NUM
iajs-108	363	10	إبن	إبن	VERB
iajs-108	363	11	الهيثم	الهيثم	ADJ
iajs-108	363	12	للعلوم	للعلوم	NOUN
iajs-108	363	13	الصرفة	الصرفة	NOUN
iajs-108	364	1	و	و	PRON
iajs-108	364	2	التطبيقية	التطبيقية	ADV
iajs-108	364	3	المجلد	المجلد	VERB
iajs-108	364	4	ibn	ibn	PROPN
iajs-108	364	5	al	al	PROPN
iajs-108	364	6	-	-	PUNCT
iajs-108	364	7	haitham	haitham	PROPN
iajs-108	364	8	jour	jour	X
iajs-108	364	9	.	.	PROPN
iajs-108	365	1	for	for	ADP
iajs-108	365	2	pure	pure	ADJ
iajs-108	365	3	&	&	CCONJ
iajs-108	365	4	appl	appl	PROPN
iajs-108	365	5	.	.	PUNCT
iajs-108	366	1	sci	sci	PROPN
iajs-108	366	2	.	.	PUNCT
iajs-108	366	3	vol	vol	NOUN
iajs-108	366	4	.	.	PROPN
iajs-108	366	5	29	29	NUM
iajs-108	366	6	(	(	PUNCT
iajs-108	366	7	2	2	NUM
iajs-108	366	8	)	)	SYM
iajs-108	366	9	2016	2016	NUM
iajs-108	366	10	figure	figure	NOUN
iajs-108	366	11	(	(	PUNCT
iajs-108	366	12	1	1	NUM
iajs-108	366	13	):	):	PUNCT
iajs-108	366	14	the	the	DET
iajs-108	366	15	significant	significant	ADJ
iajs-108	366	16	correlation	correlation	NOUN
iajs-108	366	17	between	between	ADP
iajs-108	366	18	ferritin	ferritin	ADJ
iajs-108	366	19	in	in	ADP
iajs-108	366	20	patients	patient	NOUN
iajs-108	366	21	lean	lean	ADJ
iajs-108	366	22	group	group	NOUN
iajs-108	366	23	with	with	ADP
iajs-108	366	24	(	(	PUNCT
iajs-108	366	25	a	a	PRON
iajs-108	366	26	)	)	PUNCT
iajs-108	366	27	insulin	insulin	NOUN
iajs-108	366	28	,	,	PUNCT
iajs-108	366	29	(	(	PUNCT
iajs-108	366	30	b	b	X
iajs-108	366	31	)	)	PUNCT
iajs-108	366	32	homa2	homa2	PROPN
iajs-108	366	33	ir	ir	PROPN
iajs-108	366	34	,	,	PUNCT
iajs-108	366	35	(	(	PUNCT
iajs-108	366	36	c	c	X
iajs-108	366	37	)	)	PUNCT
iajs-108	366	38	homa2	homa2	NOUN
iajs-108	367	1	s	s	PART
iajs-108	367	2	%	%	NOUN
iajs-108	367	3	.	.	PUNCT
iajs-108	368	1	figure	figure	NOUN
iajs-108	368	2	(	(	PUNCT
iajs-108	368	3	2	2	NUM
iajs-108	368	4	):	):	PUNCT
iajs-108	368	5	the	the	DET
iajs-108	368	6	significant	significant	ADJ
iajs-108	368	7	correlation	correlation	NOUN
iajs-108	368	8	between	between	ADP
iajs-108	368	9	ferritin	ferritin	ADJ
iajs-108	368	10	in	in	ADP
iajs-108	368	11	patients	patient	NOUN
iajs-108	368	12	overweight	overweight	ADJ
iajs-108	368	13	group	group	NOUN
iajs-108	368	14	with	with	ADP
iajs-108	368	15	(	(	PUNCT
iajs-108	368	16	a	a	PRON
iajs-108	368	17	)	)	PUNCT
iajs-108	368	18	insulin	insulin	NOUN
iajs-108	368	19	,	,	PUNCT
iajs-108	368	20	(	(	PUNCT
iajs-108	368	21	b	b	X
iajs-108	368	22	)	)	PUNCT
iajs-108	368	23	homa2	homa2	PROPN
iajs-108	368	24	ir	ir	PROPN
iajs-108	368	25	,	,	PUNCT
iajs-108	368	26	(	(	PUNCT
iajs-108	368	27	c	c	X
iajs-108	368	28	)	)	PUNCT
iajs-108	368	29	homa2	homa2	NOUN
iajs-108	369	1	s	s	PART
iajs-108	369	2	%	%	NOUN
iajs-108	369	3	,	,	PUNCT
iajs-108	369	4	and	and	CCONJ
iajs-108	369	5	(	(	PUNCT
iajs-108	369	6	d	d	X
iajs-108	369	7	)	)	PUNCT
iajs-108	369	8	tgf	tgf	PROPN
iajs-108	369	9	-	-	PUNCT
iajs-108	369	10	β1	β1	PROPN
iajs-108	369	11	.	.	PUNCT
iajs-108	370	1	a	a	DET
iajs-108	370	2	b	b	NOUN
iajs-108	370	3	c	c	NOUN
iajs-108	370	4	a	a	DET
iajs-108	370	5	b	b	NOUN
iajs-108	370	6	c	c	NOUN
iajs-108	370	7	d	d	NOUN
iajs-108	370	8	chemistry	chemistry	NOUN
iajs-108	370	9	|	|	ADV
iajs-108	370	10	182	182	NUM
iajs-108	370	11	2016	2016	NUM
iajs-108	370	12	)	)	PUNCT
iajs-108	370	13	عام	عام	ADP
iajs-108	370	14	2العدد	2العدد	NUM
iajs-108	370	15	(	(	PUNCT
iajs-108	370	16	29مجلة	29مجلة	NUM
iajs-108	370	17	إبن	إبن	VERB
iajs-108	370	18	الهيثم	الهيثم	ADJ
iajs-108	370	19	للعلوم	للعلوم	NOUN
iajs-108	370	20	الصرفة	الصرفة	NOUN
iajs-108	371	1	و	و	PRON
iajs-108	371	2	التطبيقية	التطبيقية	ADV
iajs-108	371	3	المجلد	المجلد	VERB
iajs-108	371	4	ibn	ibn	PROPN
iajs-108	371	5	al	al	PROPN
iajs-108	371	6	-	-	PUNCT
iajs-108	371	7	haitham	haitham	PROPN
iajs-108	371	8	jour	jour	X
iajs-108	371	9	.	.	PROPN
iajs-108	372	1	for	for	ADP
iajs-108	372	2	pure	pure	ADJ
iajs-108	372	3	&	&	CCONJ
iajs-108	372	4	appl	appl	PROPN
iajs-108	372	5	.	.	PUNCT
iajs-108	373	1	sci	sci	PROPN
iajs-108	373	2	.	.	PUNCT
iajs-108	373	3	vol	vol	NOUN
iajs-108	373	4	.	.	PROPN
iajs-108	373	5	29	29	NUM
iajs-108	373	6	(	(	PUNCT
iajs-108	373	7	2	2	NUM
iajs-108	373	8	)	)	SYM
iajs-108	373	9	2016	2016	NUM
iajs-108	373	10	figure	figure	NOUN
iajs-108	373	11	(	(	PUNCT
iajs-108	373	12	3	3	NUM
iajs-108	373	13	):	):	PUNCT
iajs-108	373	14	the	the	DET
iajs-108	373	15	significant	significant	ADJ
iajs-108	373	16	correlation	correlation	NOUN
iajs-108	373	17	between	between	ADP
iajs-108	373	18	ferritin	ferritin	ADJ
iajs-108	373	19	in	in	ADP
iajs-108	373	20	patients	patient	NOUN
iajs-108	373	21	obese	obese	VERB
iajs-108	373	22	group	group	NOUN
iajs-108	373	23	with	with	ADP
iajs-108	373	24	(	(	PUNCT
iajs-108	373	25	a	a	PRON
iajs-108	373	26	)	)	PUNCT
iajs-108	373	27	insulin	insulin	NOUN
iajs-108	373	28	,	,	PUNCT
iajs-108	373	29	(	(	PUNCT
iajs-108	373	30	b	b	X
iajs-108	373	31	)	)	PUNCT
iajs-108	373	32	homa2	homa2	PROPN
iajs-108	373	33	ir	ir	PROPN
iajs-108	373	34	,	,	PUNCT
iajs-108	373	35	(	(	PUNCT
iajs-108	373	36	c	c	X
iajs-108	373	37	)	)	PUNCT
iajs-108	373	38	homa2	homa2	NOUN
iajs-108	374	1	s	s	PART
iajs-108	375	1	%	%	NOUN
iajs-108	375	2	and	and	CCONJ
iajs-108	375	3	(	(	PUNCT
iajs-108	375	4	d	d	NOUN
iajs-108	375	5	)	)	PUNCT
iajs-108	375	6	tgf	tgf	PROPN
iajs-108	375	7	-	-	PUNCT
iajs-108	375	8	β1	β1	PROPN
iajs-108	375	9	.	.	PUNCT
iajs-108	376	1	figure	figure	NOUN
iajs-108	376	2	(	(	PUNCT
iajs-108	376	3	4	4	NUM
iajs-108	376	4	):	):	PUNCT
iajs-108	376	5	the	the	DET
iajs-108	376	6	significant	significant	ADJ
iajs-108	376	7	correlation	correlation	NOUN
iajs-108	376	8	between	between	ADP
iajs-108	376	9	tgf	tgf	PROPN
iajs-108	376	10	-	-	PUNCT
iajs-108	376	11	β1	β1	PROPN
iajs-108	376	12	in	in	ADP
iajs-108	376	13	patients	patient	NOUN
iajs-108	376	14	lean	lean	ADJ
iajs-108	376	15	group	group	NOUN
iajs-108	376	16	with	with	ADP
iajs-108	376	17	(	(	PUNCT
iajs-108	376	18	a	a	PRON
iajs-108	376	19	)	)	PUNCT
iajs-108	376	20	insulin	insulin	NOUN
iajs-108	376	21	,	,	PUNCT
iajs-108	376	22	(	(	PUNCT
iajs-108	376	23	b	b	NOUN
iajs-108	376	24	)	)	PUNCT
iajs-108	376	25	homa2ir	homa2ir	PROPN
iajs-108	376	26	.	.	PUNCT
iajs-108	377	1	a	a	DET
iajs-108	377	2	b	b	X
iajs-108	377	3	c	c	NOUN
iajs-108	377	4	d	d	NOUN
iajs-108	377	5	a	a	DET
iajs-108	377	6	b	b	NOUN
iajs-108	377	7	chemistry	chemistry	NOUN
iajs-108	377	8	|	|	ADV
iajs-108	377	9	183	183	NUM
iajs-108	377	10	2016	2016	NUM
iajs-108	377	11	)	)	PUNCT
iajs-108	377	12	عام	عام	ADP
iajs-108	377	13	2العدد	2العدد	NUM
iajs-108	377	14	(	(	PUNCT
iajs-108	377	15	29مجلة	29مجلة	NUM
iajs-108	377	16	إبن	إبن	VERB
iajs-108	377	17	الهيثم	الهيثم	ADJ
iajs-108	377	18	للعلوم	للعلوم	NOUN
iajs-108	377	19	الصرفة	الصرفة	NOUN
iajs-108	378	1	و	و	PRON
iajs-108	378	2	التطبيقية	التطبيقية	ADV
iajs-108	378	3	المجلد	المجلد	VERB
iajs-108	378	4	ibn	ibn	PROPN
iajs-108	378	5	al	al	PROPN
iajs-108	378	6	-	-	PUNCT
iajs-108	378	7	haitham	haitham	PROPN
iajs-108	378	8	jour	jour	X
iajs-108	378	9	.	.	PROPN
iajs-108	379	1	for	for	ADP
iajs-108	379	2	pure	pure	ADJ
iajs-108	379	3	&	&	CCONJ
iajs-108	379	4	appl	appl	PROPN
iajs-108	379	5	.	.	PUNCT
iajs-108	380	1	sci	sci	PROPN
iajs-108	380	2	.	.	PUNCT
iajs-108	380	3	vol	vol	NOUN
iajs-108	380	4	.	.	PROPN
iajs-108	380	5	29	29	NUM
iajs-108	380	6	(	(	PUNCT
iajs-108	380	7	2	2	NUM
iajs-108	380	8	)	)	SYM
iajs-108	380	9	2016	2016	NUM
iajs-108	380	10	figure	figure	NOUN
iajs-108	380	11	(	(	PUNCT
iajs-108	380	12	5	5	NUM
iajs-108	380	13	):	):	PUNCT
iajs-108	380	14	the	the	DET
iajs-108	380	15	significant	significant	ADJ
iajs-108	380	16	correlation	correlation	NOUN
iajs-108	380	17	between	between	ADP
iajs-108	380	18	the	the	DET
iajs-108	380	19	tgf	tgf	PROPN
iajs-108	380	20	-	-	PUNCT
iajs-108	380	21	β1	β1	PROPN
iajs-108	380	22	in	in	ADP
iajs-108	380	23	patients	patient	NOUN
iajs-108	380	24	overweight	overweight	ADJ
iajs-108	380	25	group	group	NOUN
iajs-108	380	26	with	with	ADP
iajs-108	380	27	(	(	PUNCT
iajs-108	380	28	a	a	PRON
iajs-108	380	29	)	)	PUNCT
iajs-108	380	30	insulin	insulin	NOUN
iajs-108	380	31	,	,	PUNCT
iajs-108	380	32	(	(	PUNCT
iajs-108	380	33	b	b	NOUN
iajs-108	380	34	)	)	PUNCT
iajs-108	380	35	homa2ir	homa2ir	ADJ
iajs-108	380	36	.	.	PUNCT
iajs-108	381	1	figure	figure	NOUN
iajs-108	381	2	(	(	PUNCT
iajs-108	381	3	6	6	NUM
iajs-108	381	4	):	):	PUNCT
iajs-108	381	5	the	the	DET
iajs-108	381	6	significant	significant	ADJ
iajs-108	381	7	correlation	correlation	NOUN
iajs-108	381	8	between	between	ADP
iajs-108	381	9	tgf	tgf	PROPN
iajs-108	381	10	-	-	PUNCT
iajs-108	381	11	β1	β1	PROPN
iajs-108	381	12	in	in	ADP
iajs-108	381	13	patients	patient	NOUN
iajs-108	381	14	obese	obese	VERB
iajs-108	381	15	group	group	NOUN
iajs-108	381	16	with	with	ADP
iajs-108	381	17	(	(	PUNCT
iajs-108	381	18	a	a	X
iajs-108	381	19	)	)	PUNCT
iajs-108	381	20	fsg	fsg	NOUN
iajs-108	381	21	,	,	PUNCT
iajs-108	381	22	(	(	PUNCT
iajs-108	381	23	b	b	X
iajs-108	381	24	)	)	PUNCT
iajs-108	381	25	insulin	insulin	NOUN
iajs-108	381	26	,	,	PUNCT
iajs-108	381	27	(	(	PUNCT
iajs-108	381	28	c	c	X
iajs-108	381	29	)	)	PUNCT
iajs-108	381	30	homa2	homa2	PROPN
iajs-108	381	31	ir	ir	PROPN
iajs-108	381	32	,	,	PUNCT
iajs-108	381	33	and	and	CCONJ
iajs-108	381	34	(	(	PUNCT
iajs-108	381	35	d	d	X
iajs-108	381	36	)	)	PUNCT
iajs-108	381	37	homa2	homa2	NOUN
iajs-108	381	38	s	s	PART
iajs-108	381	39	%	%	NOUN
iajs-108	381	40	.	.	PUNCT
iajs-108	382	1	a	a	DET
iajs-108	382	2	b	b	NOUN
iajs-108	382	3	a	a	DET
iajs-108	382	4	b	b	NOUN
iajs-108	382	5	c	c	NOUN
iajs-108	382	6	d	d	NOUN
iajs-108	382	7	chemistry	chemistry	NOUN
iajs-108	382	8	|	|	ADV
iajs-108	382	9	184	184	NUM
iajs-108	382	10	2016	2016	NUM
iajs-108	382	11	)	)	PUNCT
iajs-108	382	12	عام	عام	ADP
iajs-108	382	13	2العدد	2العدد	NUM
iajs-108	382	14	(	(	PUNCT
iajs-108	382	15	29مجلة	29مجلة	NUM
iajs-108	382	16	إبن	إبن	VERB
iajs-108	382	17	الهيثم	الهيثم	ADJ
iajs-108	382	18	للعلوم	للعلوم	NOUN
iajs-108	382	19	الصرفة	الصرفة	NOUN
iajs-108	383	1	و	و	PRON
iajs-108	383	2	التطبيقية	التطبيقية	ADV
iajs-108	383	3	المجلد	المجلد	VERB
iajs-108	383	4	ibn	ibn	PROPN
iajs-108	383	5	al	al	PROPN
iajs-108	383	6	-	-	PUNCT
iajs-108	383	7	haitham	haitham	PROPN
iajs-108	383	8	jour	jour	X
iajs-108	383	9	.	.	PROPN
iajs-108	384	1	for	for	ADP
iajs-108	384	2	pure	pure	ADJ
iajs-108	384	3	&	&	CCONJ
iajs-108	384	4	appl	appl	PROPN
iajs-108	384	5	.	.	PUNCT
iajs-108	385	1	sci	sci	PROPN
iajs-108	385	2	.	.	PUNCT
iajs-108	385	3	vol	vol	NOUN
iajs-108	385	4	.	.	PROPN
iajs-108	385	5	29	29	NUM
iajs-108	385	6	(	(	PUNCT
iajs-108	385	7	2	2	NUM
iajs-108	385	8	)	)	PUNCT
iajs-108	385	9	2016	2016	NUM
iajs-108	385	10	في	في	ADP
iajs-108	385	11	transforming	transform	VERB
iajs-108	385	12	growth	growth	NOUN
iajs-108	385	13	factor	factor	NOUN
iajs-108	385	14	-	-	PUNCT
iajs-108	385	15	β1و	β1و	NOUN
iajs-108	385	16	ferritinقياس	ferritinقياس	VERB
iajs-108	385	17	مستويات	مستويات	ADJ
iajs-108	385	18	النساء	النساء	PROPN
iajs-108	385	19	العراقيات	العراقيات	PROPN
iajs-108	385	20	المصابات	المصابات	PROPN
iajs-108	385	21	بمتالزمة	بمتالزمة	PROPN
iajs-108	385	22	تكيس	تكيس	PROPN
iajs-108	385	23	المبيض	المبيض	PROPN
iajs-108	385	24	قيس	قيس	PROPN
iajs-108	385	25	احمد	احمد	PROPN
iajs-108	385	26	مهدي	مهدي	PROPN
iajs-108	385	27	مستشفى	مستشفى	PROPN
iajs-108	385	28	كمال	كمال	PROPN
iajs-108	385	29	السامرائي	السامرائي	PROPN
iajs-108	385	30	للعقم	للعقم	PROPN
iajs-108	385	31	والتلقيح	والتلقيح	PROPN
iajs-108	385	32	خارج	خارج	PROPN
iajs-108	385	33	الجسم	الجسم	PROPN
iajs-108	385	34	/	/	SYM
iajs-108	385	35	وزارة	وزارة	PROPN
iajs-108	385	36	الصحة	الصحة	PROPN
iajs-108	385	37	عبدالرحمن	عبدالرحمن	PROPN
iajs-108	385	38	شذى	شذى	X
iajs-108	385	39	عبد	عبد	VERB
iajs-108	385	40	الودود	الودود	PROPN
iajs-108	385	41	فاطمة	فاطمة	NOUN
iajs-108	386	1	مال	مال	NOUN
iajs-108	386	2	هللا	هللا	NOUN
iajs-108	386	3	محمد	محمد	VERB
iajs-108	386	4	بغداد	بغداد	PROPN
iajs-108	386	5	جامعةقسم	جامعةقسم	PROPN
iajs-108	386	6	الكيمياء	الكيمياء	PROPN
iajs-108	386	7	/	/	SYM
iajs-108	386	8	كلية	كلية	NOUN
iajs-108	386	9	العلوم/	العلوم/	NUM
iajs-108	386	10	2016	2016	NUM
iajs-108	386	11	/	/	SYM
iajs-108	386	12	كانون	كانون	NOUN
iajs-108	386	13	الثاني/7في	الثاني/7في	PROPN
iajs-108	386	14	:	:	PUNCT
iajs-108	386	15	،	،	PROPN
iajs-108	386	16	قبل2015	قبل2015	PROPN
iajs-108	386	17	/	/	SYM
iajs-108	386	18	تشرين	تشرين	PROPN
iajs-108	386	19	الثاني/22استلم	الثاني/22استلم	PROPN
iajs-108	386	20	في	في	PROPN
iajs-108	386	21	:	:	PUNCT
iajs-108	386	22	الخالصة	الخالصة	NOUN
iajs-108	386	23	,	,	PUNCT
iajs-108	386	24	تكيس	تكيس	PROPN
iajs-108	386	25	باضة	باضة	NOUN
iajs-108	386	26	المزمنة	المزمنة	NOUN
iajs-108	386	27	,	,	PUNCT
iajs-108	386	28	تشخص	تشخص	ADJ
iajs-108	386	29	بعدم	بعدم	ADJ
iajs-108	386	30	اإلشيوعا	اإلشيوعا	PROPN
iajs-108	386	31	في	في	SCONJ
iajs-108	386	32	اإلناث	اإلناث	PROPN
iajs-108	386	33	االكثر	االكثر	PROPN
iajs-108	386	34	اضطراب	اضطراب	PROPN
iajs-108	386	35	الغدد	الغدد	PROPN
iajs-108	386	36	الصماءي	الصماءي	AUX
iajs-108	386	37	ه	ه	PROPN
iajs-108	386	38	المبايض	المبايض	PROPN
iajs-108	386	39	متالزمة	متالزمة	NOUN
iajs-108	386	40	تكيس	تكيس	VERB
iajs-108	386	41	transformingو	transformingو	NOUN
iajs-108	386	42	ferritinالمبيض	ferritinالمبيض	NOUN
iajs-108	386	43	و	و	PRON
iajs-108	386	44	فرط	فرط	ADV
iajs-108	386	45	االندروجين	االندروجين	PROPN
iajs-108	386	46	.	.	PUNCT
iajs-108	387	1	الهدف	الهدف	ADP
iajs-108	387	2	من	من	ADP
iajs-108	387	3	هذه	هذه	PROPN
iajs-108	387	4	الدراسة	الدراسة	PROPN
iajs-108	387	5	توضيح	توضيح	PROPN
iajs-108	387	6	العالقة	العالقة	PROPN
iajs-108	387	7	مابين	مابين	PROPN
iajs-108	387	8	مستويات	مستويات	PROPN
iajs-108	387	9	growth	growth	NOUN
iajs-108	387	10	factor	factor	NOUN
iajs-108	387	11	-	-	PUNCT
iajs-108	387	12	β1(tgf	β1(tgf	NUM
iajs-108	387	13	-	-	PUNCT
iajs-108	387	14	β1	β1	NOUN
iajs-108	387	15	)	)	PUNCT
iajs-108	387	16	مع	مع	NUM
iajs-108	387	17	مقاومة	مقاومة	PROPN
iajs-108	387	18	االنسولين	االنسولين	PROPN
iajs-108	387	19	وخطر	وخطر	PROPN
iajs-108	387	20	االصابة	االصابة	PROPN
iajs-108	387	21	بامراض	بامراض	PROPN
iajs-108	387	22	االوعية	االوعية	PROPN
iajs-108	387	23	القلبية	القلبية	NOUN
iajs-108	388	1	و	و	PRON
iajs-108	388	2	السكري	السكري	VERB
iajs-108	388	3	من	من	ADP
iajs-108	388	4	النوع	النوع	NOUN
iajs-108	388	5	,	,	PUNCT
iajs-108	388	6	تم	تم	NOUN
iajs-108	388	7	rotterdamشخصت	rotterdamشخصت	X
iajs-108	388	8	طبقا	طبقا	NOUN
iajs-108	388	9	لمعايير	لمعايير	NOUN
iajs-108	388	10	المبايض	المبايض	VERB
iajs-108	388	11	ة	ة	PRON
iajs-108	388	12	تكيسمتالزم	تكيسمتالزم	PROPN
iajs-108	388	13	)	)	PUNCT
iajs-108	388	14	نساء	نساء	PROPN
iajs-108	388	15	عراقيات	عراقيات	PROPN
iajs-108	388	16	مصابات	مصابات	PROPN
iajs-108	388	17	ب61طراق	ب61طراق	PROPN
iajs-108	388	18	العمل	العمل	PROPN
iajs-108	388	19	:	:	PUNCT
iajs-108	388	20	(	(	PUNCT
iajs-108	388	21	الثاني	الثاني	PROPN
iajs-108	388	22	.	.	PUNCT
iajs-108	388	23	)	)	PUNCT
iajs-108	389	1	17	17	NUM
iajs-108	389	2	,	,	PUNCT
iajs-108	389	3	(	(	PUNCT
iajs-108	389	4	bmi	bmi	PROPN
iajs-108	389	5	:	:	PUNCT
iajs-108	389	6	18	18	NUM
iajs-108	389	7	-	-	SYM
iajs-108	389	8	24	24	NUM
iajs-108	389	9	)	)	PUNCT
iajs-108	389	10	)	)	PUNCT
iajs-108	389	11	نساء	نساء	VERB
iajs-108	389	12	نحيفات	نحيفات	NOUN
iajs-108	389	13	مع	مع	ADP
iajs-108	389	14	دالة	دالة	NOUN
iajs-108	389	15	كتله	كتله	VERB
iajs-108	389	16	جسم	جسم	VERB
iajs-108	389	17	طبيعية	طبيعية	ADV
iajs-108	389	18	(	(	PUNCT
iajs-108	389	19	bmi	bmi	PROPN
iajs-108	389	20	)	)	PUNCT
iajs-108	389	21	:	:	PUNCT
iajs-108	389	22	20تقسيمها	20تقسيمها	NUM
iajs-108	389	23	على	على	NOUN
iajs-108	389	24	مجاميع	مجاميع	VERB
iajs-108	389	25	طبقا	طبقا	NOUN
iajs-108	389	26	لدالة	لدالة	NOUN
iajs-108	389	27	كتلة	كتلة	PROPN
iajs-108	389	28	الجسم	الجسم	ADV
iajs-108	389	29	)	)	PUNCT
iajs-108	389	30	نساء	نساء	VERB
iajs-108	389	31	20وتمت	20وتمت	NUM
iajs-108	389	32	المقارنة	المقارنة	NOUN
iajs-108	389	33	مع	مع	X
iajs-108	389	34	(	(	PUNCT
iajs-108	389	35	)	)	PUNCT
iajs-108	389	36	bmi	bmi	X
iajs-108	389	37	>	>	X
iajs-108	389	38	30	30	NUM
iajs-108	389	39	)	)	PUNCT
iajs-108	389	40	نساء	نساء	VERB
iajs-108	389	41	بدينات	بدينات	NOUN
iajs-108	389	42	مع	مع	NOUN
iajs-108	389	43	(	(	PUNCT
iajs-108	389	44	24	24	NUM
iajs-108	389	45	)	)	PUNCT
iajs-108	389	46	و	و	PROPN
iajs-108	389	47	(	(	PUNCT
iajs-108	389	48	bmi	bmi	PROPN
iajs-108	389	49	:	:	PUNCT
iajs-108	389	50	24.9	24.9	NUM
iajs-108	389	51	-	-	PUNCT
iajs-108	389	52	29.9نساء	29.9نساء	NUM
iajs-108	389	53	فوق	فوق	ADJ
iajs-108	389	54	الوزن	الوزن	NOUN
iajs-108	390	1	مع	مع	INTJ
iajs-108	390	2	(	(	PUNCT
iajs-108	390	3	مستويات	مستويات	PROPN
iajs-108	390	4	مصل	مصل	PROPN
iajs-108	390	5	ت),تم	ت),تم	PROPN
iajs-108	390	6	تقدير	تقدير	PROPN
iajs-108	390	7	كمياfsgسكر	كمياfsgسكر	PROPN
iajs-108	390	8	مصل	مصل	PROPN
iajs-108	390	9	الدم	الدم	NOUN
iajs-108	390	10	(	(	PUNCT
iajs-108	390	11	;	;	PUNCT
iajs-108	390	12	تم	تم	PART
iajs-108	390	13	تمثيلهم	تمثيلهم	PROPN
iajs-108	390	14	من	من	NUM
iajs-108	390	15	حيث	حيث	PROPN
iajs-108	390	16	متماثلين	متماثلين	PROPN
iajs-108	390	17	من	من	PROPN
iajs-108	390	18	حيث	حيث	PROPN
iajs-108	390	19	العمر	العمر	PROPN
iajs-108	390	20	.	.	PUNCT
iajs-108	391	1	عراقيات	عراقيات	PROPN
iajs-108	391	2	اصحاء	اصحاء	PROPN
iajs-108	391	3	.	.	PUNCT
iajs-108	392	1	homeostatic	homeostatic	ADJ
iajs-108	392	2	model	model	NOUN
iajs-108	392	3	assessment	assessment	NOUN
iajs-108	392	4	(	(	PUNCT
iajs-108	392	5	homa2,تم	homa2,تم	PROPN
iajs-108	392	6	حساب	حساب	PROPN
iajs-108	392	7	عوامل	عوامل	NOUN
iajs-108	392	8	(	(	PUNCT
iajs-108	392	9	tgf	tgf	NOUN
iajs-108	392	10	-	-	PUNCT
iajs-108	392	11	β1و	β1و	NOUN
iajs-108	392	12	ferritinاالنسولين	ferritinاالنسولين	NOUN
iajs-108	392	13	,	,	PUNCT
iajs-108	392	14	و	و	PRON
iajs-108	392	15	فوق	فوق	ADV
iajs-108	392	16	الوزن	الوزن	PROPN
iajs-108	392	17	عندما	عندما	ADJ
iajs-108	392	18	قورنت	قورنت	NOUN
iajs-108	392	19	مع	مع	PROPN
iajs-108	392	20	مجموعة	مجموعة	PROPN
iajs-108	392	21	في	في	PRON
iajs-108	392	22	مجموعة	مجموعة	PROPN
iajs-108	392	23	المرضى	المرضى	PROPN
iajs-108	392	24	البدينات	البدينات	PROPN
iajs-108	392	25	ferritinالنتائج	ferritinالنتائج	NOUN
iajs-108	392	26	:	:	PUNCT
iajs-108	392	27	لوحظ	لوحظ	NOUN
iajs-108	392	28	زيادة	زيادة	NOUN
iajs-108	392	29	معنوية	معنوية	NOUN
iajs-108	392	30	عالية	عالية	NOUN
iajs-108	392	31	لل	لل	INTJ
iajs-108	392	32	في	في	INTJ
iajs-108	392	33	مجاميع	مجاميع	PROPN
iajs-108	392	34	المرضى	المرضى	PROPN
iajs-108	392	35	البدينات	البدينات	PROPN
iajs-108	392	36	وفوق	وفوق	PROPN
iajs-108	392	37	الوزن	الوزن	PROPN
iajs-108	392	38	.	.	PUNCT
iajs-108	393	1	بينما	بينما	VERB
iajs-108	393	2	لم	لم	ADP
iajs-108	393	3	يظهر	يظهر	PROPN
iajs-108	393	4	في	في	PRON
iajs-108	393	5	مجموعة	مجموعة	PROPN
iajs-108	393	6	tgf	tgf	PROPN
iajs-108	393	7	-	-	PUNCT
iajs-108	393	8	β1النحيفات	β1النحيفات	PROPN
iajs-108	393	9	.	.	PUNCT
iajs-108	394	1	كما	كما	PROPN
iajs-108	394	2	لوحظ	لوحظ	VERB
iajs-108	394	3	زيادة	زيادة	NOUN
iajs-108	394	4	معنوية	معنوية	NOUN
iajs-108	394	5	لل	لل	NOUN
iajs-108	394	6	,	,	PUNCT
iajs-108	394	7	و	و	PROPN
iajs-108	394	8	(	(	PUNCT
iajs-108	394	9	االنسولين	االنسولين	PROPN
iajs-108	394	10	ferritin	ferritin	VERB
iajs-108	394	11	لمجاميع	لمجاميع	PROPN
iajs-108	394	12	المرضى	المرضى	PROPN
iajs-108	395	1	اظهر	اظهر	ADJ
iajs-108	395	2	وجود	وجود	NOUN
iajs-108	395	3	ارتباط	ارتباط	VERB
iajs-108	395	4	معنوي	معنوي	ADJ
iajs-108	395	5	موجب	موجب	PROPN
iajs-108	395	6	مابين	مابين	NOUN
iajs-108	395	7	مستوسات	مستوسات	PROPN
iajs-108	395	8	personالنحيفات	personالنحيفات	VERB
iajs-108	395	9	.	.	PUNCT
iajs-108	396	1	ارتباط	ارتباط	AUX
iajs-108	396	2	homa2	homa2	NOUN
iajs-108	396	3	-	-	PUNCT
iajs-108	396	4	ir	ir	NOUN
iajs-108	396	5	و	و	PRON
iajs-108	396	6	,	,	PUNCT
iajs-108	396	7	(	(	PUNCT
iajs-108	396	8	tgf	tgf	PROPN
iajs-108	396	9	-	-	PUNCT
iajs-108	396	10	β1و	β1و	NOUN
iajs-108	396	11	tgf	tgf	PROPN
iajs-108	396	12	-	-	PUNCT
iajs-108	396	13	β1	β1	PROPN
iajs-108	396	14	)	)	PUNCT
iajs-108	396	15	معfsg	معfsg	NOUN
iajs-108	396	16	,	,	PUNCT
iajs-108	396	17	االنسولين	االنسولين	NOUN
iajs-108	396	18	,	,	PUNCT
iajs-108	396	19	homa2	homa2	NOUN
iajs-108	396	20	-	-	PUNCT
iajs-108	396	21	1r	1r	NUM
iajs-108	396	22	بينما	بينما	NOUN
iajs-108	396	23	.(homa2	.(homa2	PUNCT
iajs-108	396	24	s	s	PART
iajs-108	397	1	%	%	NOUN
iajs-108	397	2	اظهر	اظهر	NOUN
iajs-108	397	3	.	.	PUNCT
iajs-108	398	1	tgf	tgf	PROPN
iajs-108	398	2	-	-	PUNCT
iajs-108	398	3	β1و	β1و	NOUN
iajs-108	398	4	ferritin	ferritin	ADJ
iajs-108	398	5	ارتباطا	ارتباطا	NOUN
iajs-108	398	6	معنويا	معنويا	NOUN
iajs-108	398	7	سالبا	سالبا	NOUN
iajs-108	399	1	مع	مع	X
iajs-108	399	2	كال	كال	PROPN
iajs-108	400	1	من	من	INTJ
iajs-108	400	2	في	في	PRON
iajs-108	400	3	مرضى	مرضى	PROPN
iajs-108	400	4	tgf	tgf	PROPN
iajs-108	400	5	-	-	PUNCT
iajs-108	400	6	β1و	β1و	NOUN
iajs-108	400	7	زيادة	زيادة	ADJ
iajs-108	400	8	تركيز	تركيز	NOUN
iajs-108	400	9	ferritinاالستنتاج	ferritinاالستنتاج	NOUN
iajs-108	400	10	:	:	PUNCT
iajs-108	400	11	زيادة	زيادة	PROPN
iajs-108	400	12	مؤشر	مؤشر	PROPN
iajs-108	400	13	خزن	خزن	PROPN
iajs-108	400	14	الحديد	الحديد	PROPN
iajs-108	400	15	بالجسم	بالجسم	PROPN
iajs-108	400	16	كانعكاس	كانعكاس	PROPN
iajs-108	400	17	لزيادة	لزيادة	PROPN
iajs-108	400	18	تركيز	تركيز	NOUN
iajs-108	400	19	تركيز	تركيز	NOUN
iajs-108	400	20	االنسولين	االنسولين	PROPN
iajs-108	400	21	ومقاومة	ومقاومة	PROPN
iajs-108	401	1	االنسولين	االنسولين	PROPN
iajs-108	401	2	يمكن	يمكن	PROPN
iajs-108	402	1	ان	ان	AUX
iajs-108	402	2	يرتبطا	يرتبطا	ADV
iajs-108	402	3	مع	مع	INTJ
iajs-108	402	4	زيادة	زيادة	PROPN
iajs-108	402	5	الخطر	الخطر	PROPN
iajs-108	402	6	باالصابة	باالصابة	PROPN
iajs-108	402	7	بامراض	بامراض	PROPN
iajs-108	402	8	متالزمة	متالزمة	PROPN
iajs-108	402	9	تكيس	تكيس	PROPN
iajs-108	402	10	المبيض	المبيض	PROPN
iajs-108	402	11	وعالقتهم	وعالقتهم	VERB
iajs-108	402	12	ب	ب	PRON
iajs-108	402	13	االوعية	االوعية	PROPN
iajs-108	402	14	القلبية	القلبية	NOUN
iajs-108	402	15	والسكري	والسكري	NOUN
iajs-108	402	16	من	من	PRON
iajs-108	402	17	النوع	النوع	PROPN
iajs-108	402	18	الثاني	الثاني	PROPN
iajs-108	402	19	.	.	PUNCT
iajs-108	403	1	،	،	PROPN
iajs-108	403	2	فرط	فرط	PROPN
iajs-108	403	3	االنسولين	االنسولين	PROPN
iajs-108	403	4	ferritin	ferritin	PROPN
iajs-108	403	5	,	,	PUNCT
iajs-108	403	6	tgf	tgf	PROPN
iajs-108	403	7	-	-	PUNCT
iajs-108	403	8	b1متالزمة	b1متالزمة	PROPN
iajs-108	403	9	تكيس	تكيس	VERB
iajs-108	403	10	المبايض	المبايض	PROPN
iajs-108	403	11	،	،	PROPN
iajs-108	403	12	الكلمات	الكلمات	PROPN
iajs-108	403	13	المفتاحية	المفتاحية	PROPN
iajs-108	403	14	:	:	PUNCT